
<html lang="en"     class="pb-page"  data-request-id="323d67e7-6ff9-4ba7-b466-10d47ff4c2ab"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.7b00162;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2017.60.issue-8;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist" /></meta><meta name="dc.Creator" content="Hazel J.  Hunt" /></meta><meta name="dc.Creator" content="Joseph K.  Belanoff" /></meta><meta name="dc.Creator" content="Iain  Walters" /></meta><meta name="dc.Creator" content="Benoit  Gourdet" /></meta><meta name="dc.Creator" content="Jennifer  Thomas" /></meta><meta name="dc.Creator" content="Naomi  Barton" /></meta><meta name="dc.Creator" content="John  Unitt" /></meta><meta name="dc.Creator" content="Timothy  Phillips" /></meta><meta name="dc.Creator" content="Denise  Swift" /></meta><meta name="dc.Creator" content="Emily  Eaton" /></meta><meta name="dc.Description" content="The nonselective glucocorticoid receptor (GR) antagonist mifepristone has been approved in the U.S. for the treatment of selected patients with Cushing’s syndrome. While this drug is highly effecti..." /></meta><meta name="Description" content="The nonselective glucocorticoid receptor (GR) antagonist mifepristone has been approved in the U.S. for the treatment of selected patients with Cushing’s syndrome. While this drug is highly effecti..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 17, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00162" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00162" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00162" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00162" /></link>
        
    
    

<title>Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00162" /></meta><meta property="og:title" content="Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0018.jpeg" /></meta><meta property="og:description" content="The nonselective glucocorticoid receptor (GR) antagonist mifepristone has been approved in the U.S. for the treatment of selected patients with Cushing’s syndrome. While this drug is highly effective, lack of selectivity for GR leads to unwanted side effects in some patients. Optimization of the previously described fused azadecalin series of selective GR antagonists led to the identification of CORT125134, which is currently being evaluated in a phase 2 clinical study in patients with Cushing’s syndrome." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00162"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00162">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00162&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00162&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00162&amp;href=/doi/10.1021/acs.jmedchem.7b00162" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3405-3421</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00055" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00241" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of the Clinical Candidate (<i>R</i>)-(1-(4-Fluorophenyl)-6-((1-methyl-1<i>H</i>-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hazel+J.++Hunt">Hazel J. Hunt</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-4316-1301" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+K.++Belanoff">Joseph K. Belanoff</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Iain++Walters">Iain Walters</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benoit++Gourdet">Benoit Gourdet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer++Thomas">Jennifer Thomas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Naomi++Barton">Naomi Barton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Unitt">John Unitt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timothy++Phillips">Timothy Phillips</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Denise++Swift">Denise Swift</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emily++Eaton">Emily Eaton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, California 94025, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Sygnature Discovery, BioCity, Pennyfoot Street, Nottingham, NG1 1GF, U.K.</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#c0a8a8b5aeb480a3afb2a3a5b0b4eea3afad"><span class="__cf_email__" data-cfemail="bbd3d3ced5cffbd8d4c9d8decbcf95d8d4d6">[email protected]</span></a>. Phone: +1-650-688-2862.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00162&amp;href=/doi/10.1021%2Facs.jmedchem.7b00162" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3405–3421</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 3, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>31 January 2017</li><li><span class="item_label"><b>Published</b> online</span>17 April 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 April 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00162" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00162</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3405%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHazel%2BJ.%2BHunt%252C%2BJoseph%2BK.%2BBelanoff%252C%2BIain%2BWalters%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D8%26contentID%3Dacs.jmedchem.7b00162%26title%3DIdentification%2Bof%2Bthe%2BClinical%2BCandidate%2B%2528R%2529-%25281-%25284-Fluorophenyl%2529-6-%2528%25281-methyl-1H-pyrazol-4-yl%2529sulfonyl%2529-4%252C4a%252C5%252C6%252C7%252C8-hexahydro-1H-pyrazolo%255B3%252C4-g%255Disoquinolin-4a-yl%2529%25284-%2528trifluoromethyl%2529pyridin-2-yl%2529methanone%2B%2528CORT125134%2529%253A%2BA%2BSelective%2BGlucocorticoid%2BReceptor%2B%2528GR%2529%2BAntagonist%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3421%26publicationDate%3DApril%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00162"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1765</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">26</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00162" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hazel&quot;,&quot;last_name&quot;:&quot;J. Hunt&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;K. Belanoff&quot;},{&quot;first_name&quot;:&quot;Iain&quot;,&quot;last_name&quot;:&quot;Walters&quot;},{&quot;first_name&quot;:&quot;Benoit&quot;,&quot;last_name&quot;:&quot;Gourdet&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;Thomas&quot;},{&quot;first_name&quot;:&quot;Naomi&quot;,&quot;last_name&quot;:&quot;Barton&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Unitt&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;Phillips&quot;},{&quot;first_name&quot;:&quot;Denise&quot;,&quot;last_name&quot;:&quot;Swift&quot;},{&quot;first_name&quot;:&quot;Emily&quot;,&quot;last_name&quot;:&quot;Eaton&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;3405-3421&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00162&quot;},&quot;abstract&quot;:&quot;The nonselective glucocorticoid receptor (GR) antagonist mifepristone has been approved in the U.S. for the treatment of selected patients with Cushing’s syndrome. While this drug is highly effective, lack of selectivity for GR leads to unwanted side effects in some patients. Optimization of the previously described fused azadecalin series of selective GR antagonists led to the identification of CORT125134, which is currently being evaluated in a phase 2 clinical study in patients with Cushing’s syndrome.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00162&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00162" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00162&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00162" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00162&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00162" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00162&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00162&amp;href=/doi/10.1021/acs.jmedchem.7b00162" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00162" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00162" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00162%26sid%3Dliteratum%253Aachs%26pmid%3D28368581%26genre%3Darticle%26aulast%3DHunt%26date%3D2017%26atitle%3DIdentification%2Bof%2Bthe%2BClinical%2BCandidate%2B%2528R%2529-%25281-%25284-Fluorophenyl%2529-6-%2528%25281-methyl-1H-pyrazol-4-yl%2529sulfonyl%2529-4%252C4a%252C5%252C6%252C7%252C8-hexahydro-1H-pyrazolo%255B3%252C4-g%255Disoquinolin-4a-yl%2529%25284-%2528trifluoromethyl%2529pyridin-2-yl%2529methanone%2B%2528CORT125134%2529%253A%2BA%2BSelective%2BGlucocorticoid%2BReceptor%2B%2528GR%2529%2BAntagonist%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D8%26spage%3D3405%26epage%3D3421%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291945" title="Ketones">Ketones</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290716" title="Sulfones">Sulfones</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/jmcmar.2017.60.issue-8/20170427/jmcmar.2017.60.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The nonselective glucocorticoid receptor (GR) antagonist mifepristone has been approved in the U.S. for the treatment of selected patients with Cushing’s syndrome. While this drug is highly effective, lack of selectivity for GR leads to unwanted side effects in some patients. Optimization of the previously described fused azadecalin series of selective GR antagonists led to the identification of CORT125134, which is currently being evaluated in a phase 2 clinical study in patients with Cushing’s syndrome.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01851" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01851" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The glucocorticoid receptor (GR) is a ligand-activated transcription factor and a member of the nuclear receptor superfamily. The GR is widely expressed and is present in nearly all cell types and tissues. The essential role played by the GR is confirmed by the observation that mice with targeted disruption of the GR do not survive postpartum due to a number of defects.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The GR mediates a breadth of biological processes, including inflammation, gluconeogenesis, immunity, cardiovascular function, bone metabolism, brain function, and homeostasis/development, predominantly through transcriptional mechanisms. In the absence of ligand, the GR resides in the cytoplasm and associates with chaperone proteins, including hsp90 and hsp70. Receptor ligand binding (cortisol in humans and higher mammals, corticosterone in rodents) causes a conformational change in the GR, leading to its dissociation from the chaperones and translocation of the ligand-bound receptor to the nucleus.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Once in the nucleus, the GR regulates gene transcription by both activating and repressing mechanisms.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Analogous to other nuclear hormone receptors, the GR serves as an assembly point for transcription coregulators that can directly modify chromatin structure and/or impact the activity of the gene transcription apparatus. The GR can function either as a monomer or as a homodimer. Mechanisms by which the GR modulates gene expression include direct binding of the dimer to glucocorticoid response elements (GREs) in the promoter or enhancer region of genes and binding of the monomer to other transcription factors such as nuclear factor κB (NF-κB) and activator protein 1 (AP-1), through protein–protein interactions. Ligand structure, deoxyribonucleic acid (DNA) sequence, cellular transcription factor composition, and regulatory inputs all contribute to gene-specific regulation.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5-8)</a></div><div class="NLM_p">In healthy individuals, cortisol, the natural ligand for GR, is secreted from the cortical cells of the adrenal glands under the control of adrenocorticotropic hormone (ACTH). Endogenous Cushing’s syndrome is a rare multisystem disorder that results from overproduction of cortisol. In both adults and children, Cushing’s syndrome is most commonly caused by an ACTH-secreting pituitary tumor (Cushing’s disease). Other forms of Cushing’s syndrome result from autonomous production of cortisol from adrenal cortical tumors or overproduction of ACTH from nonpituitary tumors.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a></div><div class="NLM_p">The only curative treatment for Cushing’s syndrome is resection of the tumor that is the source of the excess ACTH or cortisol. Pharmacological treatment is not curative in Cushing’s syndrome, but it serves to control the disease after unsuccessful surgery.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> It may also be used to lower cortisol activity to improve a patient’s condition prior to surgery. Pharmacological treatment may be employed as an interim therapy under specific circumstances, such as in patients who are waiting for their radiotherapy to be effective.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">Currently, there are two United States (U.S.) Food and Drug Administration (FDA)-approved medical therapies for the treatment of endogenous Cushing’s syndrome. The first is mifepristone (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), a nonselective GR antagonist, which has been approved for use in selected adult patients with endogenous Cushing’s syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The second is pasireotide, a somatostatin receptor agonist, which has been approved for the treatment of adult patients with Cushing’s disease (a subset of Cushing’s syndrome) for whom pituitary surgery is not an option or has not been curative.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of compounds <b>1</b>, <b>2</b>, and mifepristone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As noted above, Cushing’s syndrome is caused by excessive cortisol activity. Excess cortisol activity leads to a plethora of severe symptoms, including the typical body habitus of patients with Cushing’s syndrome, as well as diabetes mellitus, hypertension, dermatologic manifestations, and psychiatric disturbances. Mifepristone is effective in reducing the clinical impact of excessive cortisol activity and improving the patients’ overall medical condition.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Its role in endogenous Cushing’s syndrome includes adjunct therapy following radiation treatment and in cases where a patient cannot safely undergo surgery or has experienced failure of surgery. Mifepristone does not decrease cortisol production; it acts by blocking the interaction of cortisol with the GR.</div><div class="NLM_p">Although mifepristone is very effective, the lack of selectivity for GR has certain disadvantages. Due to its high affinity for the progesterone receptor (PR), mifepristone causes termination of pregnancy and endometrial thickening or irregular vaginal bleeding in some patients. Our objective was to identify a selective GR antagonist that would provide all the beneficial effects of mifepristone but would not cause the side effects associated with PR antagonism.</div><div class="NLM_p last">We have previously described the discovery and optimization of a series of selective GR antagonists, based on a fused azadecalin template.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> In our most recent publication,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> we reported the identification of compounds such as CORT113176 <b>1</b>, which possess a heteroaryl ketone substituent at the ring junction position, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>. Compound <b>1</b> demonstrated modest efficacy in a rat model of olanzapine induced weight gain and also in a rat model of exogenous Cushing’s syndrome. In addition, Vendruscolo et al.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> have reported that <b>1</b> reduced alcohol intake in rats made dependent on alcohol, and Pineau et al.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> have reported the efficacy of <b>1</b> in a rat model of Alzheimer’s disease. Further investigation of the heteroaryl ketone series provided compounds such as the previously described compound <b>33</b>,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> designated compound <b>2</b> herein, with reduced activity in a manual patch clamp hERG assay, good bioavailability in rats, and efficacy in our rat model of exogenous Cushing’s syndrome. Although both compounds <b>1</b> and <b>2</b> demonstrated efficacy in our rat model of exogenous Cushing’s syndrome, neither were as effective as mifepristone and we hoped to improve on their activity by the design and synthesis of additional analogues. The structures of these compounds and the nonselective GR antagonist mifepristone are shown in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>. We now wish to report further optimization of this series of compounds and the identification of two clinical candidates, <b>7</b> and <b>12</b>.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67810" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67810" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All the compounds described herein were synthesized from the enantiopure azadecalin ester <b>3</b><a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> by two principal routes, described in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The first route is exemplified in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> by the conversion of <b>3</b> to the keto-sulfonamide <b>5</b> via the Boc-protected ketone intermediate <b>4</b>. It was found that low temperature addition of aryllithium reagents to ester <b>3</b> generally proceeded only as far as the ketone (e.g., <b>4</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), perhaps due to the steric hindrance afforded by the adjacent quaternary carbon center. Two additional Boc-ketone intermediates <b>4a</b>,<b>b</b> were similarly prepared and readily converted to several different sulfonamides described in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. A complication arose with the addition of the aryllithium reagent derived from 2-bromo-4-trifluoromethylpyridine, which gave rise to the production of an inseparable byproduct thought to be derived from loss of the entire ketone substituent at the ring junction. Since the synthesis of the para-trifluoromethyl substituted pyridyl ketone intermediate <b>6</b> was important to this program, improved conditions were developed involving aryl Grignard addition to the ester <b>3</b>, which afforded a mixture of ketone and hemiketal products, easily driven to clean ketone product <b>6</b> by in situ acidic hydrolysis. Isolation of the hemiketal intermediate suggests that double addition of the Grignard in this case is thwarted by stabilization of the initial tetrahedral intermediate, perhaps due to magnesium ion chelation to the adjacent pyridyl nitrogen atom. Again, ketone intermediate <b>6</b> was progressed to give a number of different sulfonamides such as the methylpyrazole analogue <b>7</b> shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Keto-sulfonamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-bromopyridine, <i>n</i>-BuLi, THF, −78 °C, 45 min, 53%; (b) (i) TFA, DCM, rt, 1 h; (ii) 3-methylbenzene-1-sulfonyl chloride, Hunig’s base, DCM, rt, 0.5 h, 38%; (c) (i) isopropylmagnesium chloride, 2-bromo-4-(trifluoromethyl)pyridine, ether/THF, 0 °C → rt, 2 h; (ii) aq HCl, MeCN, rt, 30 min, 84%; (d) (i) TFA, DCM, rt, 1.5 h; (ii) 1-methyl-1<i>H</i>-pyrazole-4-sulfonyl chloride, K<sub>2</sub>CO<sub>3</sub>, DCM/water, rt, 20 min, 73%.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Alternative Synthesis of Keto-sulfonamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) HCl, dioxane, rt, 45 min; (ii) 3,4-difluorobenzene-1-sulfonyl chloride, Hunig’s base, DCM, rt, 15 min, 92%; (b) 2-bromothiazole, <i>n</i>-BuLi, diethyl ether, −78 °C, 45 min, 36%.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of Substitution on the Heteroaryl Ketone Group<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0011.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">Ar</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">FP <i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">HepG2 TAT <i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center">AUC (ng·h/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mifepristone</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">0.09</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"><i>p</i>-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.28</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">6.8</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.08</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="left">5-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="left">6-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.20</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>,<i>p</i>-di F</td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.22</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">215</td><td class="colsep0 rowsep0" align="left">974</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>,<i>p</i>-di F</td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">113</td><td class="colsep0 rowsep0" align="left">421</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>,<i>m</i>-di F</td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.12</td><td class="colsep0 rowsep0" align="left">9.2</td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="left">143</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>,<i>m</i>-di F</td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">5.1</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-F,<i>p</i>-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">125</td><td class="colsep0 rowsep0" align="left">726</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-F,<i>p</i>-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.42</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">173</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-CN</td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">140</td><td class="colsep0 rowsep0" align="left">239</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-CN</td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">70</td><td class="colsep0 rowsep0" align="left">217</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-CN</td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="left">4-CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.19</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-CN</td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.32</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2-thiazole</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.48</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">103</td><td class="colsep0 rowsep0" align="left">446</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2-thiazole</td><td class="colsep0 rowsep0" align="left">5-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2-thiazole</td><td class="colsep0 rowsep0" align="left">3-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.88</td><td class="colsep0 rowsep0" align="left">63</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>,<i>p</i>-di F</td><td class="colsep0 rowsep0" align="left">2-thiazole</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.23</td><td class="colsep0 rowsep0" align="left">37</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>,<i>p</i>-di F</td><td class="colsep0 rowsep0" align="left">2-thiazole</td><td class="colsep0 rowsep0" align="left">5-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">7.4</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">135</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>,<i>p</i>-di Cl</td><td class="colsep0 rowsep0" align="left">2-thiazole</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.59</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">197</td><td class="colsep0 rowsep0" align="left">1,222</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>,<i>p</i>-di F</td><td class="colsep0 rowsep0" align="left">2-thiazole</td><td class="colsep0 rowsep0" align="left">5-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.32</td><td class="colsep0 rowsep0" align="left">7.4</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">135</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">NA = not applicable; nt = not tested.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Heteroaryl Sulfonamides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0012.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0013.gif" alt="" id="fx3" /></img><div></div></div><div class="NLM_p">In the second preparative route, the order of steps was reversed, as illustrated in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, by the synthesis of keto-sulfonamide <b>9</b> via sulfonamide ester <b>8</b>, easily prepared from Boc-ester <b>3</b>. Again, monoaddition of aryllithium reagents to give the desired ketones generally occurred with negligible overaddition to tertiary alcohol byproducts. Three alternative sulfonamides <b>8a</b>–<b>c</b> were also used to prepare some of the keto-sulfonamides listed in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_p">The core-reduced analogues of <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> were synthesized by a variant of the route shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Hydrogenation of ester <b>3</b> occurred with essentially complete diastereoselectivity to afford the <i>trans</i> azadecalin intermediate <b>10</b> shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. This ester reacted with aryllithium or aryl Grignard reagents to give ketones such as <b>11</b> or <b>11a</b>, which were deprotected and treated with a variety of sulfonyl chlorides to give keto-sulfonamides such as <b>12</b>, as shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The sense of diastereoselection shown by hydrogen addition to <b>3</b> was determined by evaluation of the X-ray crystal structure of keto-sulfonamide <b>12</b>, which clearly shows the <i>trans</i> azadecalin ring geometry <b>(</b><a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Reduced Core Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>, Pd/C, 55 °C, 45 min, H-cube, 1 mL/min, 99%; (b) 2-bromo-4-(trifluoromethyl)pyridine, isopropylmagnesium bromide, toluene, 0 °C → rt, 18 h, 45%; (i) TFA, DCM, rt, 45 min; (ii) 2-methyl-2<i>H</i>-1,2,3-triazole-4-sulfonyl chloride, Hunig’s base, DCM, rt, 2 h, 72%.</p></p></figure><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of <b>12</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Oral PK Data for Selected Compounds<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">rat</th><th class="rowsep1 colsep0" colspan="3" align="center">monkey</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center">AUC (ng·h/mL)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center">AUC (ng·h/mL)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">297</td><td class="colsep0 rowsep0" align="left">1550</td><td class="colsep0 rowsep0" align="left">89</td><td class="colsep0 rowsep0" align="left">1140</td><td class="colsep0 rowsep0" align="left">11663</td><td class="colsep0 rowsep0" align="left">88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">510</td><td class="colsep0 rowsep0" align="left">986</td><td class="colsep0 rowsep0" align="left">68</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">528</td><td class="colsep0 rowsep0" align="left">1561</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">217.4</td><td class="colsep0 rowsep0" align="left">∼1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">511</td><td class="colsep0 rowsep0" align="left">1527</td><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">20.8</td><td class="colsep0 rowsep0" align="left">193</td><td class="colsep0 rowsep0" align="left">1.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">For iv dosing in both species the compounds were formulated in 10% DMSO, 45% PEG 400, and 45% propylene glycol. For oral dosing in rats, the compounds were formulated in 10% DMSO and 0.5% methylcellulose in water. For oral dosing in monkeys, the compounds were formulated in 10% DMSO, 0.1% Tween 80, 0.5% hydroxypropylmethylcellulose in water. nt = not tested.</p></div></div></div><div class="NLM_p">Most of the sulfonyl chlorides required to make the sulfonamides described in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> were commercially available, with the exception of the triazoles <b>18</b>–<b>20</b>. These were synthesized by the route shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Benzylation of triazole thiol <b>13</b> followed by methylation afforded a mixture of methyltriazole regioisomers <b>15</b>–<b>17</b> which were readily separable by column chromatography. Oxidative debenzylation with <i>N</i>-chlorosuccinimide or chlorine then gave the three sulfonyl chlorides <b>18</b>–<b>20</b>. The regiochemistry of the 2,4-isomer <b>19</b> was readily assigned with the aid of the crystal structure of the derived keto-sulfonamide product <b>12</b> shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>. The 1,4-isomer <b>18</b> and the 1,5-isomer <b>20</b> were assigned through comparison of the <sup>1</sup>H NMR spectra of the precursor sulfides <b>15</b> and <b>17</b> with those previously reported.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a></div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Triazolesulfonyl Chlorides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnBr, EtOH, 0 °C → rt, 20 min, 87%; (b) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, 0 °C → rt, 1 h, 22% (<b>15</b>)/40% (<b>16</b>)/20% (<b>17</b>); (c) NCS, AcOH/water, rt, 2 h, 64% (<b>18</b>)/82% (<b>19</b>); (d) Cl<sub>2</sub>, DCM/water, 0 °C, 5 min, 90%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62338" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62338" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All compounds were tested for their affinity to GR using a fluorescence polarization (FP) assay. Functional activity was assessed in the human HepG2 cell line. The GR agonist, dexamethasone, induces the activity of the enzyme tyrosine amino transferase (TAT). GR antagonism is readily determined by measuring the ability of the test compounds to inhibit the effect of dexamethasone. The minimum significant ratio in this assay was 2.2 at the 95% confidence level, so potency differences of 2.2-fold can be detected. For key compounds, competitive antagonism was confirmed by Schild analysis. GR agonism of the test compounds is assessed by testing the compounds in the absence of dexamethasone and measuring any induction in TAT activity. Full details of both assays are provided in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>.</div><div class="NLM_p">The next step in our investigation of this very promising series of compounds was the incorporation of a substituent on the heteroaryl ketone. Although our compounds have excellent potency in our binding assay and standard functional GR antagonist assay, most of them are not quite as potent as mifepristone. As can been seen in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, the heteroaryl ketone substituent in <b>1</b> does not fully occupy the space filled by the dimethylanilinophenyl group in mifepristone. We wanted to determine whether we could obtain additional functional potency by the inclusion of a larger heteroaryl ketone group, by adding a substituent to the heteroaryl ring. An overlay of <b>1</b> (blue) and mifepristone (pink) is shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, which depicts the GR active site (green except for helix 12 in red). The GR and mifepristone structure comes from PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3H52">3H52</a>, chain c. A minimized conformer of <b>1</b> was placed onto mifepristone using an rms fitting procedure. The conformer of <b>1</b> was generated with Spartan software using the conformer distribution option and then minimized using MMFF94. The inclusion of a methyl substituent on the pyridyl or thiazolyl ring was investigated. We were encouraged to find that a methyl substituent para to the nitrogen often provided a modest increase in potency (see for example compound <b>5</b> compared to compound <b>21</b>; <b>26</b> vs <b>27</b>; <b>28</b> vs <b>29</b>; <b>32</b> vs <b>33</b>). A comparison of some pairs of compounds, with and without a methyl substituent, is provided in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. However, the inclusion of the methyl group meta to the pyridyl nitrogen was not advantageous (for example see compound <b>22</b>). In the thiazole series, the position of the methyl group also made a significant difference, with 5-methyl providing an enhancement in potency (compound <b>37</b>) but a 3-methyl being detrimental (compound <b>38</b>). In the pyridyl series we also investigated ethyl substitution (compound <b>34</b>) and found that this was beneficial.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlay of <b>1</b> and mifepristone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Encouraged by the improved potency of several of the methylated analogues, we conducted some cassette PK studies in rats. We included three test compounds and a reference compound in each cassette and administered a total oral dose of 12 mg/kg (3 mg/kg for each compound) by oral gavage. The additional methyl substituent appeared to have a detrimental effect on plasma concentrations, since several compounds provided low <i>C</i><sub>max</sub> and AUC when compared to the corresponding compounds lacking the methyl group; see <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. For example, the methyl analogues <b>25</b>, <b>31</b>, and <b>33</b> all provided lower <i>C</i><sub>max</sub> and AUC than the corresponding unsubstituted compounds <b>24</b>, <b>30</b>, and <b>32</b>. We considered that the additional methyl group may have been subject to metabolism, thus explaining the reduced plasma concentrations in analogues incorporating this group. On this basis, replacement of methyl by trifluoromethyl was expected to provide higher plasma concentrations, but we were concerned by the already higher than ideal lipophilicity and molecular weight of our compounds. This concern was confirmed by the low <i>C</i><sub>max</sub> and very low AUC observed with compound <b>35</b>. The corresponding unsubstituted pyridyl analogue, compound <b>32</b>, exhibited considerably better exposure; see <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</div><div class="NLM_p">In an effort to reduce lipophilicity and molecular weight, we investigated the replacement of the substituted phenyl sulfonamide by a heteroaryl sulfonamide, but we found that these compounds were typically not sufficiently potent in the HepG2 TAT assay. A representative compound, <b>42</b>, is included in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. It occurred to us that the combination of a heteroaryl sulfonamide (to reduce lipophilicity and molecular weight) with a trifluoromethyl substituted pyridyl ketone (to provide improved potency compared with the unsubstituted pyridyl) at the ring junction might provide an acceptable balance of physicochemical properties and potency. As illustrated in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, this expectation proved to be justified, and we identified a number of compounds with acceptable potency (for example compounds <b>7</b>, <b>43</b>, <b>44</b>, <b>45</b>, <b>46</b>, <b>48</b>, <b>50</b>, and <b>51</b>). Various substituted pyrazole and triazole sulfonamides provided good GR antagonist potency, although some interesting SARs emerged related to the position of methyl groups on the pyrazole sulfonamides. For example, whereas N-alkylation (compare compound <b>7</b> with compound <b>47</b>) was well tolerated, it appeared that C-alkylation was often detrimental (compare compound <b>49</b> with compound <b>47</b>). We were also very gratified to discover that the incorporation of the trifluoromethyl substituent on the pyridyl ketone did not have any negative consequences from a PK perspective. In contrast, the addition of this group appeared to be beneficial; compare compounds <b>42</b> and <b>7</b>.</div><div class="NLM_p">Having identified a number of compounds with the required potency in the HepG2 TAT assay and encouraging plasma levels in the rat cassette PK studies, we selected several compounds for additional pharmacokinetic profiling. Good plasma levels in the cassette PK studies generally correlated with good plasma levels and high bioavailability in single compound iv/po rat PK studies, using an oral dose of 5 mg/kg and an iv dose of 1 mg/kg. We also evaluated the PK profile of several of the most promising compounds in iv/po PK studies in monkeys, using an oral dose of 20 mg/kg and an iv dose of 1 mg/kg. Unfortunately, good bioavailability in rats did not always translate into good bioavailability in monkeys, as shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>. Compound <b>7</b> was the only compound with a good PK profile in monkeys. Even minor changes to the structure of the compound, such as moving the position of a nitrogen in the pyrazole ring, had a detrimental effect (compare compound <b>7</b> with compound <b>45</b>).</div><div class="NLM_p">Compound <b>7</b> was the clearly the most promising compound in this series, and it was selected for full profiling. Selectivity for GR over the progesterone receptor, androgen receptor, and estrogen receptor was assessed in radioligand binding assays, and no affinity (<10% inhibition of radioligand binding) for the other receptors was detected at a concentration of 1 μM, whereas 100% inhibition was measured in an analogous GR binding assay. GR antagonism was measured in primary hepatocytes from several species, including human, rat, dog, and monkey. Dexamethasone increases the activity of TAT in primary hepatocytes, and the ability of compound <b>7</b> to prevent this effect was determined. In addition, GR agonism was assessed by testing the compound in the absence of dexamethasone and measuring TAT activity. Whereas compound <b>7</b> demonstrated full antagonism and no agonism in human and monkey hepatocytes, the compound acted predominantly as a GR agonist in dog hepatocytes, with only modest antagonism observed. There was also evidence for incomplete antagonism and partial agonism at high (10 μM) concentrations in rat hepatocytes. These data are provided in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>. GR antagonism was also assessed in human peripheral blood mononuclear cells by testing the ability of compound <b>7</b> to prevent the dexamethasone-induced inhibition of LPS stimulated production of tumor necrosis factor α (TNFα) (data not shown). Compound <b>7</b> was selective for GR over a standard panel of diverse receptors, enzymes, and channels (data not shown).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. TAT Assay Data for Compound <b>7</b> in Primary Hepatocytes from Several Species</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center">monkey</th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">dog</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">antagonist <i>K</i><sub>i</sub> (nM)</td><td class="colsep0 rowsep0" align="left">81.2</td><td class="colsep0 rowsep0" align="left">210</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">max % antagonism</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">99</td><td class="colsep0 rowsep0" align="left">54.2</td><td class="colsep0 rowsep0" align="left">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">agonist EC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">max % agonism</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">80</td></tr></tbody></table></div></div><div class="NLM_p">In vivo efficacy was assessed in a rat model of exogenous Cushing’s syndrome as described previously.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> A dose of 30 mg/kg compound <b>7</b> administered orally twice a day significantly inhibited effects on plasma insulin and completely prevented the cortisone induced increase in plasma glucose, as shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>. Similar effects were achieved with a lower dose, 7.5 mg/kg twice a day. Mifepristone at a dose of 30 mg/kg was included for comparison. The results obtained with compound <b>7</b> were superior to those reported previously with compound <b>1</b><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and similar to results obtained with mifepristone in the same experiment.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of compound <b>7</b> in the cortisone model of exogenous Cushing’s syndrome. ∗∗∗ denotes <i>p</i> < 0.001 compared with vehicle treated mice. ### denotes <i>p</i> < 0.001 compared with cortisone treated mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>7</b> was found to have high plasma protein binding in rats, monkeys, and humans, with 99.7%, 98.9%, and 99.5% binding, respectively. Significant inhibition of CYP3A4 and CYP2C8 was observed, with modest inhibition of other CYPs as shown in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>. This CYP inhibition was not time dependent. CYP induction studies carried out in cryopreserved human hepatocytes indicated no induction of CYP1A2, CYP2B6, or CYP3A4.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. CYP Inhibition of Compound <b>7</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="8" align="center">CYP</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">1A2</th><th class="colsep0 rowsep0" align="center">2B6</th><th class="colsep0 rowsep0" align="center">2C8</th><th class="colsep0 rowsep0" align="center">2C9</th><th class="colsep0 rowsep0" align="center">2C19</th><th class="colsep0 rowsep0" align="center">2D6</th><th class="colsep0 rowsep0" align="center">3A4</th><th class="colsep0 rowsep0" align="center">3A5</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">4.9</td></tr></tbody></table></div></div><div class="NLM_p">Compound <b>7</b> (CORT125134,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> see <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a> for chemical structure) was selected for preclinical development and subjected to the usual panel of toxicology and safety pharmacology studies. We have completed a phase I study in healthy human volunteers. In addition to the usual assessment of safety, tolerability, and pharmacokinetics, we also included an assessment of pharmacological effect. This was achieved by the administration of the GR agonist, prednisone, and assessing the ability of <b>7</b> to counteract the effects of prednisone on a variety of GR mediated parameters. The results obtained in this phase I clinical study will be published elsewhere.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> A phase 2 study in patients with endogenous Cushing’s syndrome is currently in progress in the U.S. and Europe.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structure of <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having identified compound <b>7</b> as our first clinical candidate, we next turned our attention to the identification of a backup compound. A potential minor concern with compound <b>7</b> was the presence of the carbon–carbon double bond in the central ring of the fused azadecalin scaffold, since we observed some propensity for this double bond to migrate to the adjacent six-membered ring under certain conditions. In order to avoid this possibility, we opted to prepare compounds in which the double bond had been reduced. In general, reduction of the double bond resulted in decreased potency in the HepG2 TAT assay. For example, the reduced analogue of compound <b>7</b> (compound <b>54</b>) had a <i>K</i><sub>i</sub> of 34 nM, compared with 7.2 nM for compound <b>7</b>. As shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>, reduction of the double bond affected the conformation of the tricyclic ring system and altered the position of the key substituents, relative to the unsaturated analogues. Numerous other pairs of compounds (e.g., compound <b>28</b> compared to compound <b>53</b>; <b>44</b> vs <b>55</b>; and <b>50</b> vs <b>12</b>) show the same trend, as shown in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Overlay of compounds <b>7</b> and <b>12</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Reduced Core Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0015.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0016.gif" alt="" id="GRAPHIC-d276e2037-autogenerated" /></img><div></div></div><div class="NLM_p last">Compound <b>12</b> was one of the most potent compounds identified in the reduced core series, so we decided to obtain additional information to determine whether this subseries provided any benefit over the original compounds. We were very gratified to discover that compound <b>12</b> provided excellent plasma levels in rats after oral dosing, higher than any other compound we tested. Following the administration of a 5 mg/kg oral dose, the <i>C</i><sub>max</sub> was 1255 ng/mL and the AUC was 9418 ng·h/mL. Bioavailability was 100%. Compound <b>12</b> (CORT125281<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>) was selected for further profiling and will be the subject of a later publication.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37423" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37423" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">By further optimization of our fused azadecalin series of selective GR antagonists, we have identified the clinical candidate compound <b>7</b>. This compound combines excellent potency, selectivity, and oral bioavailability in several species with acceptable physicochemical properties. In vivo efficacy has been demonstrated in a relevant animal model. We have obtained proof of GR antagonism in human subjects in a phase I study in healthy subjects, and the evaluation of the compound in patients with Cushing’s syndrome is currently in progress. Although mifepristone is very effective in the treatment of selected patients with Cushing’s syndrome, the use of this compound is limited by side effects that result from its affinity for the progesterone receptor. There are also political issues in some countries concerning the use of the “abortion pill” which will be avoided by the development of a compound lacking affinity for the progesterone receptor. By removal of affinity for the progesterone receptor, compound <b>7</b> provides a significant benefit over mifepristone.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20416" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20416" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div class="NLM_p last">All starting materials and reagents were commercially available, or their synthesis had been previously described in the literature. All purchased chemicals and solvents were used without further purification. All reactions involving air or moisture sensitive reagents were performed under an inert atmosphere. Hydrogenations were performed on a Thales H-cube flow reactor under the conditions stated. Silica gel chromatography was done using the appropriate size prepacked silica filled cartridges (230–400 mesh, 40–63 μm). NMR spectra were acquired on a Bruker Avance III spectrometer at 400 MHz with chemical shifts reported in ppm relative to residual undeuterated solvent as reference. Reactions were monitored by silica gel F<sub>254</sub> TLC plates with UV visualization at 254 nm or by LCMS. LCMS analyses to determine purities and associated mass ions were performed using an Agilent Infinity 1260 LC 6120 quadrupole mass spectrometer with positive and negative ion electrospray and ELS/UV at 254 nm detection using an Agilent Zorbax Extend C18, Rapid Resolution HT 1.8 μm C18 30 mm × 4.6 mm column and a 2.5 mL/min flow rate with a 4 min run time. High resolution masses (HRMS) were determined on a Waters Xevo G2-XS QTOF mass spectrometer. Preparative reverse phase HPLC was performed using UV detection at 215 and 254 nm with a Waters X-Select Prep-C18, 5 μm, 19 mm × 50 mm column eluting with a H<sub>2</sub>O–MeCN gradient containing 0.1% v/v formic acid over 10 min. All final compounds had an HPLC purity of 95% or better. All chemical names have been generated using CambridgeSoft ENotebook 12.0.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (<i>R</i>)-<i>tert</i>-Butyl 1-(4-Fluorophenyl)-4a-picolinoyl-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate (<b>4</b>)</h3><div class="NLM_p last">2-Bromopyridine (23.6 mL, 243 mmol) in dry THF (180 mL) was added to <i>n</i>-butyllithium (99 mL, 249 mmol) in dry THF (100 mL) at −78 °C. The reaction mixture was stirred at −78 °C for 45 min. A solution of (<i>R</i>)-6-<i>tert</i>-butyl 4a-methyl 1-(4-fluorophenyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a,6(4<i>H</i>)-dicarboxylate <b>3</b><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a>(34.0 g, 80 mmol) in dry THF (280 mL) was added dropwise over 30 min, and the reaction mixture was stirred for 45 min at −78 °C. Water (400 mL) was added, and the reaction mixture was stirred at room temperature for 10 min. The aqueous phase was extracted with ethyl acetate (2 × 400 mL). The combined organic phases were washed with brine (400 mL), dried (MgSO<sub>4</sub>), and solvent was removed to give an orange oil. The crude product was purified by chromatography on silica (330 g column, 10–60% ethyl acetate/isohexane) to afford 20.5 g (53%) of <b>4</b> as a pale yellow solid. LC/MS <i>m</i>/<i>z</i> 475 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (<i>R</i>)-<i>tert</i>-Butyl 1-(4-Fluorophenyl)-4a-(4-methylpicolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate (<b>4a</b>)</h3><div class="NLM_p last">Compound <b>4a</b> was prepared using the same procedure as described for the synthesis of <b>4</b> by substituting 2-bromo-4-methylpyridine for 2-bromopyridine. LC/MS <i>m</i>/<i>z</i> 489 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (<i>R</i>)-<i>tert</i>-Butyl 4a-(4-Ethylpicolinoyl)-1-(4-fluorophenyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate (<b>4b</b>)</h3><div class="NLM_p last">Compound <b>4b</b> was prepared using the same procedure as described for the synthesis of <b>4</b> by substituting 2-bromo-4-ethylpyridine for 2-bromopyridine. LC/MS <i>m</i>/<i>z</i> 503 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (<i>R</i>)-(1-(4-Fluorophenyl)-6-(<i>m</i>-tolylsulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(pyridin-2-yl)methanone (<b>5</b>)</h3><div class="NLM_p last">A solution of (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-picolinoyl-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>4</b> (0.2 g, 0.42 mmol) in 20% TFA/DCM (6 mL) was stirred at room temperature for 1 h. Solvent was removed in vacuo, azeotroping twice with toluene, to give a dark orange oil. This was dissolved in DCM (6 mL), and 3-methylbenzene-1-sulfonyl chloride (0.073 mL, 0.504 mmol) and diisopropylethylamine (0.367 mL, 2.10 mmol) were added. The reaction mixture was stirred at room temperature for 0.5 h, before solvent was removed in vacuo. The crude product was purified by chromatography on silica (12 g column, 0–40% ethyl acetate/isohexane) and by preparative HPLC to afford 88 mg (38%) of <b>5</b> as a pale yellow solid. LC/MS <i>m</i>/<i>z</i> 529 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.66 (1H, ddd, <i>J</i> = 4.7, 1.7, 0.8 Hz), 7.91–7.89 (1H, m), 7.84 (1H, dt, <i>J</i> = 7.4, 1.7 Hz), 7.50–7.40 (5H, m), 7.36–7.34 (2H, m), 7.29 (1H, s), 7.19–7.13 (2H, m), 6.47 (1H, d, <i>J</i> = 2.1 Hz), 5.51 (1H, dd, <i>J</i> = 12.4, 2.1 Hz), 4.31 (1H, d, <i>J</i> = 16.9 Hz), 3.84–3.80 (1H, m), 2.92–2.78 (2H, m), 2.68 (1H, d, <i>J</i> = 12.4 Hz), 2.49–2.40 (5H, m).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (<i>R</i>)-<i>tert</i>-Butyl 1-(4-Fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate (<b>6</b>)</h3><div class="NLM_p last">Isopropylmagnesium chloride (2 M in THF, 35.1 mL, 70.2 mmol) was added to dry ether (100 mL) cooled to 0 °C. A solution of 2-bromo-4-(trifluoromethyl)pyridine (15.9 g, 70.2 mmol) in dry ether (50 mL) was then added over 20 min. The resulting dark colored suspension was stirred at 0 °C for 50 min, then (<i>R</i>)-6-<i>tert</i>-butyl 4a-methyl 1-(4-fluorophenyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a,6(4<i>H</i>)-dicarboxylate <b>3</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (10.0 g, 23.4 mmol) was added as a solution in dry ether/THF (4:1, total volume 100 mL) dropwise over 30 min. The reaction was stirred at 0 °C for 15 min, then at room temperature for 2 h. The reaction was recooled to 0 °C and quenched by the dropwise addition of ice-cold water (40 mL) and then diluted further with water (120 mL). The layers were then separated, and the aqueous layer was extracted with ethyl acetate (3 × 150 mL). The combined organic extractions were washed with brine (150 mL) and dried over MgSO<sub>4</sub>, and solvent was removed in vacuo to give a brown oil. This was diluted with acetonitrile (100 mL) and aqueous HCl (1 M, 23.4 mL, 23.4 mmol), and the resulting solution was stirred at room temperature for 30 min. The reaction mixture was diluted with ethyl acetate (300 mL) and washed sequentially with brine (100 mL), saturated aqueous NaHCO<sub>3</sub> (100 mL), and brine again (100 mL). The organic layer was then dried over MgSO<sub>4</sub> and solvent removed in vacuo. The crude product was purified by chromatography on silica (220 g column, 0–60% ethyl acetate/isohexane) to afford 10.9 g (84%) of <b>6</b> as a pale yellow solid. LC/MS <i>m</i>/<i>z</i> 543 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (<i>R</i>)-(1-(4-Fluorophenyl)-6-((1-methyl-1<i>H</i>-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (<b>7</b>)</h3><div class="NLM_p last">To a solution of (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>6</b> (9.59 g, 17.7 mmol) in DCM (80 mL) was added TFA (27.2 mL, 354 mmol) dropwise over 20 min, and the resulting dark colored solution stirred at room temperature for 1.5 h. The reaction mixture was diluted with toluene (30 mL) and solvent removed in vacuo. The dark brown residue was then azeotroped with toluene (3 × 30 mL). The resulting brown gum was diluted with DCM (80 mL) and water (80 mL) and potassium carbonate (12.2 g, 88 mmol) added to the biphasic mixture portionwise over 10 min. 1-Methyl-1<i>H</i>-pyrazole-4-sulfonyl chloride (3.51 g, 19.4 mmol) was then added portionwise to the reaction mixture, and the resulting biphasic solution was stirred at room temperature for 20 min. The reaction mixture was diluted with water (200 mL), and the layers were separated. The aqueous layer was extracted with DCM (2 × 100 mL), and the combined organic extractions were washed with brine (200 mL) and dried over MgSO<sub>4</sub>. The solvent was removed to give a thick brown oil, which was purified by chromatography on silica (220 g column, load in DCM, 0–70% ethyl acetate/isohexane) to afford 7.66 g (73%) of <b>7</b> as a pale orange solid. HRMS calculated for C<sub>27</sub>H<sub>22</sub>F<sub>4</sub>N<sub>6</sub>O<sub>3</sub>S [(M + H)<sup>+</sup>], 587.1483; found, 587.1483. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.87 (1H, d, <i>J</i> = 5.0 Hz), 8.16–8.15 (1H, m), 7.72–7.70 (1H, m), 7.69–7.66 (2H, m), 7.47–7.42 (2H, m), 7.30 (1H, s), 7.21–7.14 (2H, m), 6.51 (1H, d, <i>J</i> = 2.1 Hz), 5.44 (1H, dd, <i>J</i> = 12.0, 2.1 Hz), 4.21 (1H, d, <i>J</i> = 16.9 Hz), 3.93 (3H, s), 3.80–3.76 (1H, m), 2.94 (1H, <i>J</i> = 16.9 Hz), 2.88–2.79 (1H, m), 2.66 (1H, d, <i>J</i> = 12.1 Hz), 2.53–2.48 (1H, m), 2.43 (1H, ddd, <i>J</i> = 12.6, 10.5, 3.5 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 197.65 (s), 161.75 (d, <i>J</i> = 247 Hz), 153.91 (s), 148.80 (s), 139.88 (q, <i>J</i> = 35 Hz), 138.86 (s), 138.22 (s), 137.23 (s), 136.68 (s), 135.35 (d, <i>J</i> = 3 Hz), 131.87 (s), 125.60 (d, <i>J</i> = 8 Hz), 122.41 (q, <i>J</i> = 273 Hz), 122.36 (m), 120.30 (m), 117.85 (s), 116.23 (d, <i>J</i> = 23 Hz), 114.49 (s), 112.61 (s), 55.18 (s), 55.01 (s), 46.77 (s), 39.64 (s), 32.14 (s), 28.08 (s).</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (<i>R</i>)-Methyl 6-((3,4-Difluorophenyl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a-carboxylate (<b>8</b>)</h3><div class="NLM_p last">(<i>R</i>)-6-<i>tert</i>-Butyl 4a-methyl-1-(4-fluorophenyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a,6(4<i>H</i>)-dicarboxylate <b>3</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (2.0 g, 4.68 mmol) was added to a solution of HCl in dioxane (4 M, 23.4 mL, 94 mmol) and the reaction mixture stirred at room temperature for 45 min. Solvent was then removed in vacuo to give an orange solid, which was dissolved in DCM (80 mL) and diisopropylethylamine (4.09 mL, 23.4 mmol). 3,4-Difluorobenzene-1-sulfonyl chloride (0.63 mL, 4.68 mmol) was added and the reaction mixture stirred at room temperature for 15 min. Water (20 mL) and DCM (20 mL) were added, and the phases were separated. The organic phase was washed with brine (10 mL), dried (MgSO<sub>4</sub>) and solvent was removed in vacuo to give 2.2 g (92%) of <b>8</b> as a pale yellow solid. LC/MS <i>m</i>/<i>z</i> 504 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>R</i>)-Methyl 6-((3,4-Dichlorophenyl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a-carboxylate (<b>8a</b>)</h3><div class="NLM_p last">Compound <b>8a</b> was prepared using the same procedure as described for the synthesis of <b>8</b> by substituting 3,4-dichlorobenzene-1-sulfonyl chloride for 3,4-difluorobenzene-1-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 536 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (<i>R</i>)-Methyl 1-(4-Fluorophenyl)-6-(<i>m</i>-tolylsulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a-carboxylate (<b>8b</b>)</h3><div class="NLM_p last">Compound <b>8b</b> was prepared using the same procedure as described for the synthesis of <b>8</b> by substituting 3-methylbenzene-1-sulfonyl chloride for 3,4-difluorobenzene-1-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 482 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (<i>R</i>)-Methyl 1-(4-Fluorophenyl)-6-((3-(trifluoromethyl)phenyl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a-carboxylate (<b>8c</b>)</h3><div class="NLM_p last">Compound <b>8c</b> was prepared using the same procedure as described for the synthesis of <b>8</b> by substituting 3-(trifluoromethyl)benzene-1-sulfonyl chloride for 3,4-difluorobenzene-1-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 536 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (<i>R</i>)-(6-((3,4-Difluorophenyl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(thiazol-2-yl)methanone (<b>9</b>)</h3><div class="NLM_p last">A solution of 2-bromothiazole (164 μL, 1.82 mmol) in dry diethyl ether (4 mL) was added to a solution of <i>n</i>-butyllithium (2.5 M in hexanes, 745 μL, 1.862 mmol) in dry diethyl ether (2 mL) at −78 °C. The reaction mixture was stirred at −78 °C for 45 min. A solution of (<i>R</i>)-methyl 6-((3,4-difluorophenyl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a-carboxylate <b>8</b> (300 mg, 0.596 mmol) in dry diethyl ether (5 mL) was added dropwise, and the reaction mixture was stirred for 45 min at −78 °C. Water (10 mL) was added, and the reaction mixture was stirred at room temperature for 10 min. The aqueous phase was extracted with ethyl acetate (2 × 10 mL), the combined organic phases were washed with brine (10 mL), dried (MgSO<sub>4</sub>), and solvent was removed in vacuo to give a brown oil. The crude product was purified by chromatography on silica (4 g column, 10–50% ethyl acetate/isohexane) to afford 120 mg (36%) of <b>9</b> as a pale yellow solid. LC/MS <i>m</i>/<i>z</i> 557 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.02 (1H, d, <i>J</i> = 3.1 Hz), 7.68 (1H, d, <i>J</i> = 3.1 Hz), 7.55–7.47 (2H, m), 7.45–7.40 (2H, m), 7.29 (1H, s), 7.27–7.21 (1H, m), 7.20–7.13 (2H, m), 6.54 (1H, d, <i>J</i> = 2.2 Hz), 5.47 (1H, dd, <i>J</i> = 12.4, 2.0 Hz), 4.19 (1H, d, <i>J</i> = 16.8 Hz), 3.93–3.86 (1H, m), 2.93–2.79 (3H, m), 2.63–2.52 (2H, m).</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (4a<i>R</i>,8a<i>S</i>)-6-<i>tert</i>-Butyl 4a-Methyl-1-(4-fluorophenyl)-4a,5,7,8,8a,9-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a,6(4<i>H</i>)-dicarboxylate (<b>10</b>)</h3><div class="NLM_p last">A solution of (<i>R</i>)-6-<i>tert</i>-butyl 4a-methyl-1-(4-fluorophenyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a,6(4<i>H</i>)-dicarboxylate <b>3</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (2.0 g, 4.68 mmol) in methanol (80 mL) was hydrogenated in an H-cube (10% Pd/C, 30 mm × 4 mm, full hydrogen, 55 °C, 1 mL/min). Solvent was removed in vacuo to give 2.0 g (99%) of <b>10</b> as an off-white solid. LC/MS <i>m</i>/<i>z</i> 430 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.49–7.40 (3H, m), 7.17–7.10 (2H, m), 4.74–4.58 (1H, br m), 4.39–4.10 (2H, br m), 3.61 (3H, s), 3.28–3.01 (2H, br m), 2.88–2.52 (3H, br m), 2.40–2.12 (2H, br m), 1.91–1.79 (1H, m), 1.45 (9H, s).</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (4a<i>R</i>,8a<i>S</i>)-<i>tert</i>-Butyl 1-(4-Fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8,8a,9-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate (<b>11</b>)</h3><div class="NLM_p last">To a solution of (4a<i>R</i>,8a<i>S</i>)-6-<i>tert</i>-butyl 4a-methyl-1-(4-fluorophenyl)-4a,5,7,8,8a,9-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a,6(4<i>H</i>)-dicarboxylate <b>10</b> (450 mg, 1.05 mmol) in dry toluene (4 mL) was added isopropylmagnesium bromide (2.9 M in 2-methyltetrahydrofuran, 903 μL, 2.62 mmol) followed by 2-bromo-4-(trifluoromethyl)pyridine (233 μL, 1.89 mmol) at 0 °C. The reaction mixture was allowed to warm to room temperature and stirred for 18 h. Water (5 mL) and DCM (5 mL) were added, and the organic phase was separated and solvent evaporated in vacuo. The crude product was purified by chromatography on silica (12 g column, load in DCM, 0–40% ethyl acetate/isohexane) to afford 275 mg (45%) of <b>11</b> as a pale orange solid. LC/MS <i>m</i>/<i>z</i> 545 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (4a<i>R</i>,8a<i>S</i>)-<i>tert</i>-Butyl 1-(4-Fluorophenyl)-4a-picolinoyl-4a,5,7,8,8a,9-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate (<b>11a</b>)</h3><div class="NLM_p last">A solution of 2-bromopyridine (0.83 mL, 8.52 mmol) in dry THF (6 mL) was added to a solution of <i>n</i>-butyllithium (2.5 M in hexanes, 3.49 mL, 8.73 mmol) in dry THF (4 mL) at −78 °C. The reaction mixture was stirred at −78 °C for 45 min. A solution of (4a<i>R</i>,8a<i>S</i>)-6-<i>tert</i>-butyl 4a-methyl 1-(4-fluorophenyl)-4a,5,7,8,8a,9-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a,6(4<i>H</i>)-dicarboxylate <b>10</b> (1.2 g, 2.79 mmol) in dry THF (10 mL) was added dropwise, and the reaction mixture was stirred for 45 min at −78 °C. Water (12 mL) was added, and the reaction mixture was stirred at room temperature for 10 min. The aqueous phase was extracted with ethyl acetate (2 × 12 mL). The combined organic phases were washed with brine (12 mL), dried (MgSO<sub>4</sub>), and solvent was removed in vacuo to give an orange oil. The crude product was purified by chromatography on silica (40 g column, 10–70% ethyl acetate/isohexane) to afford 609 mg (43%) of <b>11a</b> as a pale yellow solid. LC/MS <i>m</i>/<i>z</i> 477 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> ((4a<i>R</i>,8a<i>S</i>)-1-(4-Fluorophenyl)-6-((2-methyl-2<i>H</i>-1,2,3-triazol-4-yl)sulfonyl)-4,4a,5,6,7,8,8a,9-octahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (<b>12</b>)</h3><div class="NLM_p last">(4a<i>R</i>,8a<i>S</i>)-<i>tert</i>-Butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8,8a,9-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>11</b> (2 g, 3.67 mmol) was stirred in 20% TFA/DCM (200 mL) at room temperature for 45 min. Solvent was removed in vacuo, and the residue was azeotroped with toluene (3 × 30 mL), then dissolved in DCM (150 mL). Diisopropylethylamine (3.21 mL, 18.4 mmol) and 2-methyl-2<i>H</i>-1,2,3-triazole-4-sulfonyl chloride <b>19</b> (0.667 g, 3.67 mmol) were added, and the reaction mixture was stirred at room temperature for 2 h, before solvent was removed in vacuo. The crude product was purified by chromatography on silica (40 g column, load in DCM, 0–75% ethyl acetate/isohexane) to afford 1.58 g (72%) of <b>12</b> as a white solid. HRMS calculated for C<sub>26</sub>H<sub>24</sub>F<sub>4</sub>N<sub>7</sub>O<sub>3</sub>S [(M + H)<sup>+</sup>], 590.1592; found, 590.1592. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.86 (1H, d, <i>J</i> = 5.0 Hz), 8.10 (1H, s), 7.81 (1H, s), 7.70–7.62 (1H, m), 7.52–7.44 (2H, m), 7.33 (1H, s), 7.20–7.11 (2H, m), 5.64 (1H, dd, <i>J</i> = 12.5, 2.0 Hz), 4.26 (3H, s), 4.25 (1H, d, <i>J</i> = 16.2 Hz), 4.02–3.90 (1H, m), 3.44 (1H, dd, <i>J</i> = 16.2, 10.8 Hz), 2.73 (1H, dd, <i>J</i> = 16.2, 5.9 Hz), 2.67–2.53 (3H, m), 2.43 (1H, qd, <i>J</i> = 13.2, 5.0 Hz), 1.88–1.75 (2H, m). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 200.47 (s), 160.45 (d, <i>J</i> = 244 Hz), 154.61 (s), 149.76 (s), 143.29 (s), 138.14 (s), 138.06 (q, <i>J</i> = 34 Hz), 137.33 (s), 136.13 (d, <i>J</i> = 3 Hz), 135.12 (s), 124.39 (d, <i>J</i> = 9 Hz), 122.55 (q, <i>J</i> = 4 Hz), 122.52 (q, <i>J</i> = 273 Hz), 118.72 (q, <i>J</i> = 4 Hz), 116.08 (d, <i>J</i> = 23 Hz), 113.97 (s), 54.35 (s), 49.99 (s), 46.74 (s), 42.59 (s), 40.04 (s), 28.07 (s), 27.63 (s), 27.04 (s).</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-(Benzylthio)-1<i>H</i>-1,2,3-triazole (<b>14</b>)</h3><div class="NLM_p last">Benzyl bromide (11.8 mL, 99 mmol) was added dropwise to a solution of sodium 1<i>H</i>-1,2,3-triazole-4-thiolate <b>13</b> (12.2 g, 99 mmol) in ethanol (100 mL) at 0 °C. The reaction mixture was allowed to warm to room temperature and stirred for 20 min. The reaction was diluted with ethyl acetate (100 mL) and washed with water (100 mL), brine (100 mL), and dried (Na<sub>2</sub>SO<sub>4</sub>). Solvent was removed in vacuo to give 16.9 g (87%) of <b>14</b> as a white solid. LC/MS <i>m</i>/<i>z</i> 192 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.72 (1H, v br s), 7.47 (1H, s), 7.30–7.21 (5H, m), 4.12 (2H, s).</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-(Benzylthio)-1-methyl-1<i>H</i>-1,2,3-triazole (<b>15</b>), 4-(Benzylthio)-2-methyl-2<i>H</i>-1,2,3-triazole (<b>16</b>), and 5-(Benzylthio)-1-methyl-1<i>H</i>-1,2,3-triazole (<b>17</b>)</h3><div class="NLM_p last">Iodomethane (2.41 mL, 38.7 mmol) was added dropwise to a mixture of 4-(benzylthio)-1<i>H</i>-1,2,3-triazole <b>14</b> (3.7 g, 19.3 mmol) and potassium carbonate (5.88 g, 42.6 mmol) in DMF (40 mL) at 0 °C. The reaction was then allowed to warm to room temperature and stirred for 1 h. Water (40 mL) and ethyl acetate (40 mL) were added, and the organic phase was separated and washed sequentially with water (2 × 40 mL) and brine (40 mL) and dried (Na<sub>2</sub>SO<sub>4</sub>) before solvent was removed in vacuo to give a yellow oil. The crude product was purified by chromatography on silica (80 g column, 0–100% ethyl acetate/isohexane) to afford first 1.61 g (40%) of <b>16</b> as a colorless oil. LC/MS <i>m</i>/<i>z</i> 206 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.68 (1H, s), 7.35–7.19 (5H, m), 4.18 (2H, s), 4.11 (3H, s); followed by 816 mg (20%) of <b>17</b> as a pale yellow oil. LC/MS <i>m</i>/<i>z</i> 206 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.71 (1H, s), 7.36–7.23 (3H, m), 7.22–7.14 (2H, m), 4.09 (2H, s), 3.73 (3H, s), and finally 883 mg (22%) of <b>15</b> as a pale yellow oil. LC/MS <i>m</i>/<i>z</i> 206 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.02 (1H, s), 7.34–7.19 (5H, m), 4.12 (2H, s), 4.00 (3H, s).</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-Methyl-1<i>H</i>-1,2,3-triazole-4-sulfonyl Chloride (<b>18</b>)</h3><div class="NLM_p last"><i>N</i>-Chlorosuccinimide (2.60 g, 19.5 mmol) was added to a solution of 4-(benzylthio)-1-methyl-1<i>H</i>-1,2,3-triazole <b>15</b> (1.0 g, 4.87 mmol) in acetic acid (26 mL) and water (13 mL) and the mixture stirred at room temperature for 2 h. Water (40 mL) was added, and the mixture was extracted with ethyl acetate (40 mL). The organic phase was washed sequentially with a saturated aqueous sodium hydrogen carbonate solution (3 × 40 mL) and brine (40 mL), then dried (MgSO<sub>4</sub>), and solvent was removed in vacuo to give 810 mg of <b>18</b> (64%) as a colorless oil, which was used without further purification. LC/MS (quenched into a solution of morpholine in methanol) <i>m</i>/<i>z</i> 233 (M + H + morpholine)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.22 (1H, s), 4.25 (3H, s).</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-Methyl-2<i>H</i>-1,2,3-triazole-4-sulfonyl Chloride (<b>19</b>)</h3><div class="NLM_p last"><i>N</i>-Chlorosuccinimide (3.38 g, 25.3 mmol) was added to a solution of 4-(benzylthio)-2-methyl-2<i>H</i>-1,2,3-triazole <b>16</b> (1.30 g, 6.33 mmol) in acetic acid (32 mL) and water (16 mL) and the mixture stirred at room temperature for 1 h. Water (40 mL) was added, and the mixture was extracted with ethyl acetate (40 mL). The organic phase was washed sequentially with a saturated aqueous sodium hydrogen carbonate solution (40 mL) and brine (40 mL), then dried (MgSO<sub>4</sub>), and solvent removed in vacuo to give 1.35 g of <b>19</b> (82%) as a pale yellow oil, which was used without further purification. LC/MS (quenched into a solution of morpholine in methanol) <i>m</i>/<i>z</i> 233, (M + H + morpholine)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.11 (1H, s), 4.36 (3H, s).</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-Methyl-1<i>H</i>-1,2,3-triazole-5-sulfonyl Chloride (<b>20</b>)</h3><div class="NLM_p last">Chlorine gas was bubbled through a solution of 5-(benzylthio)-1-methyl-1<i>H</i>-1,2,3-triazole <b>17</b> (200 mg, 0.974 mmol) in dichloromethane (15 mL) and water (3 mL) for 2 min at 0 °C, and then the reaction mixture was stirred at 0 °C for a further 5 min. Water (10 mL) was added, and the mixture was extracted with dichloromethane (10 mL). The separated organic phase was dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to give 317 mg of <b>20</b> (90%) as a colorless oil, which was used without further purification. LC/MS (quenched into a solution of morpholine in methanol) <i>m</i>/<i>z</i> 233, (M + H + morpholine)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.27 (1H, s), 4.40 (3H, s).</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>R</i>)-(1-(4-Fluorophenyl)-6-(<i>m</i>-tolylsulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-methylpyridin-2-yl)methanone (<b>21</b>)</h3><div class="NLM_p last">Compound <b>21</b> was prepared using the same procedure as described for the synthesis of <b>9</b> by treating (<i>R</i>)-methyl 1-(4-fluorophenyl)-6-(<i>m</i>-tolylsulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a-carboxylate <b>8b</b> with 2-bromo-4-methylpyridine/<i>n</i>-butyllithium. LC/MS <i>m</i>/<i>z</i> 543 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.50 (1H, dd, <i>J</i> = 3.9, 0.4 Hz), 7.71 (1H, m), 7.51–7.48 (2H, m), 7.45–7.40 (2H, m), 7.35–7.33 (2H, m), 7.28–7.26 (2H, m), 7.18–7.12 (2H, m), 6.46 (1H, d, <i>J</i> = 2.1 Hz), 5.53 (1H, dd, <i>J</i> = 12.2, 2.1 Hz), 4.30 (1H, d, <i>J</i> = 16.9 Hz), 3.84–3.80 (1H, m), 2.90–2.77 (2H, m), 2.69 (1H, d, <i>J</i> = 12.3 Hz), 2.48–2.42 (2H, m), 2.40 (3H, s), 2.39 (3H, s).</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>R</i>)-(1-(4-Fluorophenyl)-6-(<i>m</i>-tolylsulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(5-methylpyridin-2-yl)methanone (<b>22</b>)</h3><div class="NLM_p last">Compound <b>22</b> was prepared using the same procedure as described for the synthesis of <b>9</b> by treating (<i>R</i>)-methyl 1-(4-fluorophenyl)-6-(<i>m</i>-tolylsulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a-carboxylate <b>8b</b> with 2-bromo-5-methylpyridine/<i>n</i>-butyllithium. LC/MS <i>m</i>/<i>z</i> 543 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.46 (1H, m), 7.82 (1H, d, <i>J</i> = 8.0 Hz), 7.61 (1H, ddd, <i>J</i> = 8.0, 2.3, 0.9 Hz), 7.51–7.48 (2H, m), 7.45–7.40 (2H, m), 7.35–7.33 (2H, m), 7.27 (1H, s), 7.18–7.12 (2H, m), 6.46 (1H, d, <i>J</i> = 2.1 Hz), 5.57 (1H, dd, <i>J</i> = 12.2, 2.1 Hz), 4.29 (1H, d, <i>J</i> = 16.9 Hz), 3.84–3.79 (1H, m), 2.90–2.78 (2H, m), 2.70 (1H, d, <i>J</i> = 12.0 Hz), 2.48–2.39 (8H, m).</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>R</i>)-(1-(4-Fluorophenyl)-6-(<i>m</i>-tolylsulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(6-methylpyridin-2-yl)methanone (<b>23</b>)</h3><div class="NLM_p last">Compound <b>23</b> was prepared using the same procedure as described for the synthesis of <b>9</b> by treating (<i>R</i>)-methyl 1-(4-fluorophenyl)-6-(<i>m</i>-tolylsulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a-carboxylate <b>8b</b> with 2-bromo-6-methylpyridine/<i>n</i>-butyllithium. LC/MS <i>m</i>/<i>z</i> 543 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.72–7.68 (2H, m), 7.42–7.36 (4H, m), 7.34–7.30 (4H, m), 7.18–7.13 (2H, m), 6.45 (1H, d, <i>J</i> = 2.0 Hz), 5.55 (1H, dd, <i>J</i> = 12.2, 2.0 Hz), 4.19 (1H, d, <i>J</i> = 17.0 Hz), 3.84–3.80 (1H, m), 2.87 (1H, d, <i>J</i> = 17.0 Hz), 2.83–2.73 (1H, m), 2.71 (1H, d, <i>J</i> = 12.2 Hz), 2.62 (3H, s), 2.54–2.42 (2H, m), 2.39 (3H, s).</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>R</i>)-(6-((3,4-Difluorophenyl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(pyridin-2-yl)methanone (<b>24</b>)</h3><div class="NLM_p last">Compound <b>24</b> was prepared using the same procedure as described for the synthesis of <b>5</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-picolinoyl-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>4</b> with HCl (4 M in dioxane) followed by 3,4-difluorobenzene-1-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 551 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.63 (1H, ddd, <i>J</i> = 4.8, 1.7, 1.0 Hz), 7.88 (1H, ddd, <i>J</i> = 7.9, 1.7, 1.0 Hz), 7.84 (1H, dt, <i>J</i> = 7.3, 1.7 Hz), 7.52–7.40 (5H, m), 7.28 (1H, s), 7.24–7.22 (1H, m), 7.20–7.13 (2H, m), 6.49 (1H, d, <i>J</i> = 2.1 Hz), 5.53 (1H, dd, <i>J</i> = 12.2, 2.0 Hz), 4.28 (1H, d, <i>J</i> = 16.9 Hz), 3.88–3.83 (1H, m), 2.91–2.78 (3H, m), 2.59–2.48 (2H, m).</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>R</i>)-(6-((3,4-Difluorophenyl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-methylpyridin-2-yl)methanone (<b>25</b>)</h3><div class="NLM_p last">Compound <b>25</b> was prepared using the same procedure as described for the synthesis of <b>5</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-methylpicolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>4a</b> with HCl (4 M in dioxane) followed by 3,4- difluorobenzene-1-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 565 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.46 (1H, dd, <i>J</i> = 5.0, 0.5 Hz), 7.68 (1H, m), 7.50–7.40 (4H, m), 7.29–7.26 (2H, m), 7.24–7.13 (3H, m), 6.48 (1H, d, <i>J</i> = 2.1 Hz), 5.55 (1H, dd, <i>J</i> = 12.4, 2.1 Hz), 4.27 (1H, d, <i>J</i> = 16.9 Hz), 3.89–3.84 (1H, m), 2.88–2.78 (3H, m), 2.62–2.56 (1H, m), 2.53–2.48 (1H, m), 2.40 (3H, s).</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (<i>R</i>)-(6-((3,5-Difluorophenyl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(pyridin-2-yl)methanone (<b>26</b>)</h3><div class="NLM_p last">Compound <b>26</b> was prepared using the same procedure as described for the synthesis of <b>5</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-picolinoyl-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>4</b> with HCl (4 M in dioxane) followed by 3,5-difluorobenzene-1-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 551 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.67 (1H, ddd, <i>J</i> = 4.7, 1.7, 0.8 Hz), 7.88 (1H, ddd, <i>J</i> = 7.9, 1.5, 1.0 Hz), 7.84 (1H, dt, <i>J</i> = 7.3, 1.7 Hz), 7.48 (1H, ddd, <i>J</i> = 7.4, 4.7, 1.5 Hz), 7.46–7.41 (2H, m), 7.29 (1H, s), 7.22–7.13 (4H, m), 6.98 (1H, tt, <i>J</i> = 8.5, 2.3 Hz), 6.49 (1H, d, <i>J</i> = 2.1 Hz), 5.56 (1H, dd, <i>J</i> = 12.3, 2.1 Hz), 4.28 (1H, d, <i>J</i> = 16.9 Hz), 3.87–3.82 (1H, m), 2.92–2.78 (3H, m), 2.62–2.55 (1H, m), 2.53–2.48 (1H, m).</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (<i>R</i>)-(6-((3,5-Difluorophenyl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-methylpyridin-2-yl)methanone (<b>27</b>)</h3><div class="NLM_p last">Compound <b>27</b> was prepared using the same procedure as described for the synthesis of <b>5</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-methylpicolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>4a</b> with HCl (4 M in dioxane) followed by 3,5- difluorobenzene-1-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 565 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.51 (1H, br. d, <i>J</i> = 4.9 Hz), 7.72–7.69 (1H, m), 7.46–7.41 (2H, m), 7.32–7.27 (2H, m), 7.20–7.13 (4H, m), 6.97 (1H, tt, <i>J</i> = 8.5, 2.3 Hz), 6.49 (1H, d, <i>J</i> = 2.1 Hz), 5.61 (1H, dd, <i>J</i> = 12.3, 2.1 Hz), 4.29 (1H, d, <i>J</i> = 16.9 Hz), 3.85 (1H, ddt, <i>J</i> = 8.4, 3.9, 2.1 Hz), 2.90–2.77 (3H, m), 2.63–2.57 (1H, m), 2.50 (1H, br dt, <i>J</i> = 14.9, 2.0 Hz), 2.41 (3H, s).</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (<i>R</i>)-(1-(4-Fluorophenyl)-6-((3-(trifluoromethyl)phenyl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(pyridin-2-yl)methanone (<b>28</b>)</h3><div class="NLM_p last">Compound <b>28</b> was prepared using the same procedure as described for the synthesis of <b>5</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-picolinoyl-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>4</b> with TFA/DCM followed by 3-(trifluoromethyl)benzene-1-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 583 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.65–8.64 (1H, m), 7.94 (1H, m), 7.89–7.78 (4H, m), 7.63–7.59 (1H, m), 7.47 (1H, ddd, <i>J</i> = 7.3, 4.8, 1.5 Hz), 7.44–7.40 (2H, m), 7.28 (1H, s), 7.19–7.13 (2H, m), 6.48 (1H, d, <i>J</i> = 2.2 Hz), 5.56 (1H, dd, <i>J</i> = 12.4, 2.2 Hz), 4.26 (1H, d, <i>J</i> = 16.9 Hz), 3.89–3.85 (1H, m), 2.91–2.79 (3H, m), 2.58–2.48 (2H, m).</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>R</i>)-(1-(4-Fluorophenyl)-6-((3-(trifluoromethyl)phenyl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-methylpyridin-2-yl)methanone (<b>29</b>)</h3><div class="NLM_p last">Compound <b>29</b> was prepared using the same procedure as described for the synthesis of <b>5</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-methylpicolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>4a</b> with HCl (4 M in dioxane) followed by 3-(trifluoromethyl)benzene-1-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 597 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.49 (1H, dd, <i>J</i> = 4.9, 0.38 Hz), 8.00–7.88 (2H, m), 7.80–7.78 (1H, m), 7.71–7.68 (1H, m), 7.61 (1H, t, <i>J</i> = 7.8 Hz), 7.46–7.39 (2H, m), 7.29–7.27 (2H, m), 7.19–7.13 (2H, m), 6.48 (1H, d, <i>J</i> = 2.0 Hz), 5.61 (1H, dd, <i>J</i> = 12.3, 2.0 Hz), 4.27 (1H, d, <i>J</i> = 16.9 Hz), 3.91–3.81 (1H, m), 2.92–2.78 (3H, m), 2.62–2.49 (2H, m), 2.40 (3H, s).</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (<i>R</i>)-(6-((3-Fluoro-4-(trifluoromethyl)phenyl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(pyridin-2-yl)methanone (<b>30</b>)</h3><div class="NLM_p last">Compound <b>30</b> was prepared using the same procedure as described for the synthesis of <b>5</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-picolinoyl-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>4</b> with HCl (4 M in dioxane) followed by 3-fluoro-4-(trifluoromethyl)benzene-1-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 601 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.64 (1H, ddd, <i>J</i> = 4.9, 1.5, 1.1 Hz), 7.87–7.81 (2H, m), 7.71–7.67 (1H, m), 7.57 (1H, br d, <i>J</i> = 8.2 Hz), 7.51–7.47 (2H, m), 7.45–7.40 (2H, m), 7.28 (1H, s), 7.19–7.13 (2H, m), 6.50 (1H, d, <i>J</i> = 2.0 Hz), 5.59 (1H, dd, <i>J</i> = 12.4, 2.0 Hz), 4.25 (1H, d, <i>J</i> = 16.9 Hz), 3.92–3.87 (1H, m), 2.91–2.80 (3H, m), 2.67–2.61 (1H, m), 2.55–2.51 (1H, m).</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>R</i>)-(6-((3-Fluoro-4-(trifluoromethyl)phenyl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-methylpyridin-2-yl)methanone (<b>31</b>)</h3><div class="NLM_p last">Compound <b>31</b> was prepared using the same procedure as described for the synthesis of <b>5</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-methylpicolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>4a</b> with HCl (4 M in dioxane) followed by 3-fluoro-4-(trifluoromethyl)benzene-1-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 615 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.47 (1H, dd, <i>J</i> = 4.9, 0.3 Hz), 7.69–7.65 (2H, m), 7.58–7.56 (1H, m), 7.48 (1H, br d, <i>J</i> = 9.4 Hz), 7.45–7.40 (2H, m), 7.28 (1H, ddd, <i>J</i> = 4.9, 1.6, 0.7 Hz), 7.26 (1H, s), 7.19–7.13 (2H, m), 6.49 (1H, d, <i>J</i> = 2.0 Hz), 5.64 (1H, dd, <i>J</i> = 12.5, 2.0 Hz), 4.23 (1H, d, <i>J</i> = 16.9 Hz), 3.92–3.88 (1H, m), 2.91–2.80 (3H, m), 2.69–2.63 (1H, m), 2.55–2.50 (1H, m), 2.39 (3H, s).</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (<i>R</i>)-3-((1-(4-Fluorophenyl)-4a-picolinoyl-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-6(4<i>H</i>)-yl)sulfonyl)benzonitrile (<b>32</b>)</h3><div class="NLM_p last">Compound <b>32</b> was prepared using the same procedure as described for the synthesis of <b>5</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-picolinoyl-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>4</b> with HCl (4 M in dioxane) followed by 3-cyanobenzene-1-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 540 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.68–8.66 (1H, m), 7.93–7.78 (5H, m), 7.60 (1H, td, <i>J</i> = 7.8, 0.6 Hz), 7.50 (1H, ddd, <i>J</i> = 6.8, 4.8, 2.2 Hz), 7.45–7.39 (2H, m), 7.28 (1H, m), 7.19–7.13 (2H, m), 6.50 (1H, d, <i>J</i> = 2.1 Hz), 5.60 (1H, dd, <i>J</i> = 12.4, 2.1 Hz), 4.26 (1H, d, <i>J</i> = 16.9 Hz), 3.92–3.83 (1H, m), 2.90–2.78 (3H, m), 2.58–2.49 (2H, m).</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (<i>R</i>)-3-((1-(4-Fluorophenyl)-4a-(4-methylpicolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-6(4<i>H</i>)-yl)sulfonyl)benzonitrile (<b>33</b>)</h3><div class="NLM_p last">Compound <b>33</b> was prepared using the same procedure as described for the synthesis of <b>5</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-methylpicolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>4a</b> with HCl (4 M in dioxane) followed by 3-cyanobenzene-1-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 554 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.50 (1H, br. d, <i>J</i> = 4.9 Hz), 7.93–7.91 (2H, m), 7.79 (1H, dt, <i>J</i> = 7.8, 1.3 Hz), 7.69–7.68 (1H, m), 7.63–7.58 (1H, m), 7.44–7.41 (2H, m), 7.30 (1H, ddd, <i>J</i> = 4.9, 1.7, 0.7 Hz), 7.27 (1H, s), 7.19–7.13 (2H, m), 6.49 (1H, d, <i>J</i> = 2.0 Hz), 5.64 (1H, dd, <i>J</i> = 12.4, 2.0 Hz), 4.25 (1H, d, <i>J</i> = 16.9 Hz), 3.89 (1H, ddt, <i>J</i> = 8.5, 3.9, 2.0 Hz), 2.85–2.79 (3H, m), 2.63–2.50 (2H, m), 2.41 (3H, s).</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>R</i>)-3-((4a-(4-Ethylpicolinoyl)-1-(4-fluorophenyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-6(4<i>H</i>)-yl)sulfonyl)benzonitrile (<b>34</b>)</h3><div class="NLM_p last">Compound <b>34</b> was prepared using the same procedure as described for the synthesis of <b>5</b> by treating (<i>R</i>)-<i>tert</i>-butyl 4a-(4-ethylpicolinoyl)-1-(4-fluorophenyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>4b</b> with HCl (4 M in dioxane) followed by 3-cyanobenzene-1-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 568 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.53 (1H, dd, <i>J</i> = 4.9, 0.5 Hz), 7.95 (1H, m), 7.91 (1H, ddd, <i>J</i> = 7.9, 1.9, 1.2 Hz), 7.78 (1H, ddd, <i>J</i> = 7.9, 1.2, 0.3 Hz), 7.71–7.70 (1H, m), 7.59 (1H, dt, <i>J</i> = 7.9, 0.5 Hz), 7.45–7.40 (2H, m),7.33–7.32 (1H, m), 7.27 (1H, s), 7.19–7.13 (2H, m), 6.49 (1H, d, <i>J</i> = 2.0 Hz), 5.64 (1H, dd, <i>J</i> = 12.3, 2.0 Hz), 4.25 (1H, d, <i>J</i> = 16.9 Hz), 3.91–3.86 (1H, m), 2.88–2.80 (3H, m), 2.71 (2H, q, <i>J</i> = 7.7 Hz), 2.63–2.50 (2H, m), 1.27 (3H, t, <i>J</i> = 7.7 Hz).</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>R</i>)-3-((1-(4-Fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-6(4<i>H</i>)-yl)sulfonyl)benzonitrile (<b>35</b>)</h3><div class="NLM_p last">Compound <b>35</b> was prepared using the same procedure as described for the synthesis of <b>5</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>6</b> with HCl (4 M in dioxane) followed by 3-cyanobenzene-1-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 608 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.90 (1H, d, <i>J</i> = 5.0 Hz), 8.13 (1H, m), 7.98 (1H, m), 7.91–7.89 (1H, m), 7.84–7.81 (1H, m), 7.74 (1H, dd, <i>J</i> = 5.0, 0.9 Hz), 7.65–7.61 (1H, m), 7.45–7.40 (2H, m), 7.29 (1H, s), 7.20–7.14 (2H, m), 6.51 (1H, d, <i>J</i> = 2.0 Hz), 5.53 (1H, dd, <i>J</i> = 12.3, 2.0 Hz), 4.18 (1H, d, <i>J</i> = 16.9 Hz), 3.91–3.87 (1H, m), 2.90 (1H, d, <i>J</i> = 16.9 Hz), 2.88–2.77 (2H, m), 2.58–2.51 (2H, m).</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (<i>R</i>)-(1-(4-Fluorophenyl)-6-((3-(trifluoromethyl)phenyl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(thiazol-2-yl)methanone (<b>36</b>)</h3><div class="NLM_p last">Compound <b>36</b> was prepared using the same procedure as described for the synthesis of <b>9</b> by treating (<i>R</i>)-methyl 1-(4-fluorophenyl)-6-((3-(trifluoromethyl)phenyl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a-carboxylate <b>8c</b> with 2-bromothiazole/<i>n</i>-butyllithium. LC/MS <i>m</i>/<i>z</i> 589 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.04 (1H, d, <i>J</i> = 3.1 Hz), 7.97 (1H, s), 7.90 (1H, d, <i>J</i> = 7.9 Hz), 7.81 (1H, d, <i>J</i> = 7.9 Hz), 7.70–7.59 (2H, m), 7.46–7.39 (2H, m), 7.30 (1H, s), 7.13–7.19 (2H, m), 6.53 (1H, d, <i>J</i> = 2.2 Hz), 5.54 (1H, dd, <i>J</i> = 12.4, 2.0 Hz), 4.21 (1H, d, <i>J</i> = 16.8 Hz), 3.93–3.89 (1H, m), 2.95–2.84 (2H, m), 2.80 (1H, d, <i>J</i> = 12.5 Hz), 2.61–2.52 (2H, m).</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (<i>R</i>)-(1-(4-Fluorophenyl)-6-((3-(trifluoromethyl)phenyl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(5-methylthiazol-2-yl)methanone (<b>37</b>)</h3><div class="NLM_p last">Compound <b>37</b> was prepared using the same procedure as described for the synthesis of <b>9</b> by treating (<i>R</i>)-methyl 1-(4-fluorophenyl)-6-((3-(trifluoromethyl)phenyl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a-carboxylate <b>8c</b> with 2-bromo-5-methylthiazole/<i>n</i>-butyllithium. LC/MS <i>m</i>/<i>z</i> 603 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.98 (1H, s), 7.91 (1H, br d, <i>J</i> = 7.9 Hz), 7.84–7.80 (1H, m), 7.68–7.61 (2H, m), 7.46–7.39 (2H, m), 7.29 (1H, s), 7.20–7.12 (2H, m), 6.51 (1H, d, <i>J</i> = 2.1 Hz), 5.54 (1H, dd, <i>J</i> = 12.4, 2.1 Hz), 4.17 (1H, d, <i>J</i> = 16.7 Hz), 3.93–3.89 (1H, m), 2.95–2.77 (3H, m), 2.60–2.49 (5H, m).</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>R</i>)-(1-(4-Fluorophenyl)-6-((3-(trifluoromethyl)phenyl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-methylthiazol-2-yl)methanone (<b>38</b>)</h3><div class="NLM_p last">Compound <b>38</b> was prepared using the same procedure as described for the synthesis of <b>9</b> by treating (<i>R</i>)-methyl 1-(4-fluorophenyl)-6-((3-(trifluoromethyl)phenyl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a-carboxylate <b>8c</b> with 2-bromo-4-methylthiazole/<i>n</i>-butyllithium. LC/MS <i>m</i>/<i>z</i> 603 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.96 (1H, s), 7.88 (1H, d, <i>J</i> = 7.9 Hz), 7.80 (1H, d, <i>J</i> = 7.9 Hz), 7.62 (1H, t, <i>J</i> = 7.9 Hz), 7.42 (2H, ddt, <i>J</i> = 8.1, 5.6, 2.8 Hz), 7.30 (1H, s), 7.21 (1H, d, <i>J</i> = 0.9 Hz), 7.20–7.12 (2H, m), 6.52 (1H, d, <i>J</i> = 2.2 Hz), 5.56 (1H, dd, <i>J</i> = 12.4, 2.2 Hz), 4.18 (1H, d, <i>J</i> = 16.8 Hz), 3.95–3.88 (1H, m), 2.91–2.80 (3H, m), 2.63–2.50 (5H, m).</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (<i>R</i>)-(6-((3,4-Difluorophenyl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(5-methylthiazol-2-yl)methanone (<b>39</b>)</h3><div class="NLM_p last">Compound <b>39</b> was prepared using the same procedure as described for the synthesis of <b>9</b> by treating (<i>R</i>)-methyl 6-((3,4-difluorophenyl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a-carboxylate <b>8</b> with 2-bromo-5-methylthiazole/<i>n</i>-butyllithium. LC/MS <i>m</i>/<i>z</i> 571 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.63 (1H, m), 7.54–7.49 (2H, m), 7.45–7.40 (2H, m), 7.29 (1H, s), 7.27–7.21 (1H, m), 7.19–7.13 (2H, m), 6.52 (1H, d, <i>J</i> = 2.0 Hz), 5.44 (1H, dd, <i>J</i> = 12.4, 2.0 Hz), 4.15 (1H, d, <i>J</i> = 16.9 Hz), 3.93–3.89 (1H, m), 2.91–2.80 (3H, m), 2.64–2.52 (5H, m).</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (<i>R</i>)-(6-((3,4-Dichlorophenyl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(thiazol-2-yl)methanone (<b>40</b>)</h3><div class="NLM_p last">Compound <b>40</b> was prepared using the same procedure as described for the synthesis of <b>9</b> by treating (<i>R</i>)-methyl 6-((3,4-dichlorophenyl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a-carboxylate <b>8a</b> with 2-bromothiazole/<i>n</i>-butyllithium. LC/MS <i>m</i>/<i>z</i> 589 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.00 (1H, d, <i>J</i> = 3.0 Hz), 7.77 (1H, dd, <i>J</i> = 1.8, 0.9 Hz), 7.67 (1H, d, <i>J</i> = 3.0 Hz), 7.54–7.48 (2H, m), 7.45–7.40 (2H, m), 7.29 (1H, s), 7.20–7.14 (2H, m), 6.54 (1H, d, <i>J</i> = 2.1 Hz), 5.46 (1H, dd, <i>J</i> = 12.6, 2.0 Hz), 4.18 (1H, d, <i>J</i> = 16.9 Hz), 3.94–3.90 (1H, m), 2.92–2.84 (3H, m), 2.66–2.54 (2H, m).</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>R</i>)-(6-((3,4-Dichlorophenyl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(5-methylthiazol-2-yl)methanone (<b>41</b>)</h3><div class="NLM_p last">Compound <b>41</b> was prepared using the same procedure as described for the synthesis of <b>9</b> by treating (<i>R</i>)-methyl 6-((3,4-dichlorophenyl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-4a-carboxylate <b>8a</b> with 2-bromo-5-methylthiazole/<i>n</i>-butyllithium. LC/MS <i>m</i>/<i>z</i> 603 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.77 (1H, d, <i>J</i> = 1.9 Hz), 7.60 (1H, d, <i>J</i> = 1.0 Hz), 7.56–7.48 (2H, m), 7.45–7.40 (2H, m), 7.28 (1H, s), 7.21–7.13 (2H, m), 6.53 (1H, d, <i>J</i> = 2.1 Hz), 5.45 (1H, dd, <i>J</i> = 12.5, 2.1 Hz), 4.13 (1H, d, <i>J</i> = 16.6 Hz), 3.94 (1H, ddt, <i>J</i> = 8.5, 3.9, 2.0 Hz), 2.93–2.84 (3H, m), 2.68–2.61 (1H, m), 2.57 (3H, d, <i>J</i> = 1.0 Hz), 2.58–2.52 (1H, m).</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>R</i>)-(1-(4-Fluorophenyl)-6-((1-methyl-1<i>H</i>-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(pyridin-2-yl)methanone (<b>42</b>)</h3><div class="NLM_p last">Compound <b>42</b> was prepared using the same procedure as described for the synthesis of <b>5</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-picolinoyl-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>4</b> with TFA/DCM followed by 1-methyl-1<i>H</i>-pyrazole-4-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 519 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.66 (1H, ddd, <i>J</i> = 4.7, 1.7, 0.8 Hz), 7.91–7.89 (1H, m), 7.84 (1H, dt, <i>J</i> = 7.6, 1.8 Hz), 7.68–7.65 (2H, m), 7.49–7.42 (3H, m), 7.30 (1H, s), 7.20–7.14 (2H, m), 6.49 (1H, d, <i>J</i> = 2.1 Hz), 5.46 (1H, dd, <i>J</i> = 12.2, 2.1 Hz), 4.31 (1H, d, <i>J</i> = 16.9 Hz), 3.91 (3H, s), 3.80–3.76 (1H, m), 2.91 (1H, d, <i>J</i> = 16.9 Hz), 2.88–2.79 (1H, m), 2.68 (1H, d, <i>J</i> = 12.2 Hz), 2.50–2.41 (2H, m).</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (<i>R</i>)-(6-((1-Ethyl-1<i>H</i>-pyrazol-4-yl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (<b>43</b>)</h3><div class="NLM_p last">Compound <b>43</b> was prepared using the same procedure as described for the synthesis of <b>7</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>6</b> with HCl/dioxane followed by 1-ethyl-1<i>H</i>-pyrazole-4-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 601 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.88–8.87 (1H, m), 8.15 (1H, m), 7.71–7.69 (2H, m), 7.67 (1H, d, <i>J</i> = 0.6 Hz), 7.47–7.42 (2H, m), 7.30 (1H, s), 7.20–7.14 (2H, m), 6.51 (1H, d, <i>J</i> = 2.0 Hz), 5.44 (1H, dd, <i>J</i> = 12.0, 2.0 Hz), 4.22–4.16 (3H, m), 3.80–3.76 (1H, m), 2.94 (1H, d, <i>J</i> = 16.9 Hz), 2.88–2.79 (1H, m), 2.67 (1H, d, <i>J</i> = 12.3 Hz), 2.52–2.40 (2H, m), 1.51 (3H, t, <i>J</i> = 7.3 Hz).</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (<i>R</i>)-(1-(4-Fluorophenyl)-6-((1-methyl-1<i>H</i>-pyrazol-3-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (<b>44</b>)</h3><div class="NLM_p last">Compound <b>44</b> was prepared using the same procedure as described for the synthesis of <b>7</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>6</b> with HCl/dioxane followed by 1-methyl-1<i>H</i>-pyrazole-3-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 587 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.89 (1H, d, <i>J</i> = 5.0 Hz), 8.14 (1H, m), 7.70–7.68 (1H, m), 7.47–7.42 (2H, m), 7.39 (1H, d, <i>J</i> = 2.3 Hz), 7.31 (1H, s), 7.21–7.15 (2H, m), 6.57 (1H, d, <i>J</i> = 2.2 Hz), 6.52 (1H, d, <i>J</i> = 2.1 Hz), 5.56 (1H, dd, <i>J</i> = 12.6, 2.1 Hz), 4.24 (1H, d, <i>J</i> = 16.9 Hz), 3.96 (3H, s), 3.89–3.85 (1H, m), 2.96 (1H, d, <i>J</i> = 16.9 Hz), 2.93 (1H, d, <i>J</i> = 12.4 Hz), 2.88–2.79 (1H, m), 2.68–2.61 (1H, m), 2.51–2.47 (1H, m).</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (<i>R</i>)-(1-(4-Fluorophenyl)-6-((1-methyl-1<i>H</i>-pyrazol-5-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (<b>45</b>)</h3><div class="NLM_p last">Compound <b>45</b> was prepared using the same procedure as described for the synthesis of <b>7</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>6</b> with HCl/dioxane followed by 1-methyl-1<i>H</i>-pyrazole-5-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 587 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.81 (1H, d, <i>J</i> = 4.9 Hz), 8.12 (1H, m), 7.70–7.69 (1H, m), 7.47–7.41 (2H, m), 7.35 (1H, d, <i>J</i> = 2.1 Hz), 7.28 (1H, s), 7.21–7.15 (2H, m), 6.62 (1H, d, <i>J</i> = 2.1 Hz), 6.54 (1H, d, <i>J</i> = 2.0 Hz), 5.50 (1H, dd, <i>J</i> = 12.4, 2.0 Hz), 4.18 (1H, d, <i>J</i> = 16.9 Hz), 3.95 (3H, s), 3.94–3.90 (1H, m), 3.02 (1H, d, <i>J</i> = 12.6 Hz), 2.92 (1H, d, <i>J</i> = 16.9 Hz), 2.86–2.74 (2H, m), 2.60–2.55 (1H, m).</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (<i>R</i>)-(6-((1,5-Dimethyl-1<i>H</i>-pyrazol-4-yl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (<b>46</b>)</h3><div class="NLM_p last">Compound <b>46</b> was prepared using the same procedure as described for the synthesis of <b>7</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>6</b> with HCl/dioxane followed by 1,5-dimethyl-1<i>H</i>-pyrazole-4-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 601 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.84 (1H, d, <i>J</i> = 4.9 Hz), 8.13 (1H, br s), 7.69 (1H, dd, <i>J</i> = 4.9, 1.0 Hz), 7.61 (1H, s), 7.47–7.41 (2H, m), 7.28 (1H, s), 7.20–7.14 (2H, m), 6.51 (1H, d, <i>J</i> = 2.0 Hz), 5.46 (1H, dd, <i>J</i> = 12.3, 1.9 Hz), 4.16 (1H, d, <i>J</i> = 16.9 Hz), 3.85–3.79 (1H, m), 3.71 (3H, s), 2.92 (1H, d, <i>J</i> = 16.9 Hz), 2.87–2.76 (2H, m), 2.58–2.50 (2H, m), 2.34 (3H, s).</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (<i>R</i>)-(6-((1<i>H</i>-Pyrazol-4-yl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (<b>47</b>)</h3><div class="NLM_p last">Compound <b>47</b> was prepared using the same procedure as described for the synthesis of <b>7</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>6</b> with HCl/dioxane followed by 1<i>H</i>-pyrazole-4-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 573 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 11.0 (1H, br s), 8.86 (1H, d, <i>J</i> = 4.9 Hz), 8.15 (1H, m), 7.83 (2H, s), 7.71–7.69 (1H, m), 7.46–7.41 (2H, m), 7.31 (1H, s), 7.20–7.14 (2H, m), 6.50 (1H, d, <i>J</i> = 2.0 Hz), 5.44 (1H, dd, <i>J</i> = 12.1, 2.0 Hz), 4.20 (1H, d, <i>J</i> = 16.9 Hz), 3.82–3.78 (1H, m), 2.92 (1H, d, <i>J</i> = 16.9 Hz), 2.87–2.78 (1H, m), 2.67 (1H, d, <i>J</i> = 12.2 Hz), 2.52–2.40 (2H, m).</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (<i>R</i>)-(6-((1-Ethyl-1<i>H</i>-pyrazol-5-yl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (<b>48</b>)</h3><div class="NLM_p last">Compound <b>48</b> was prepared using the same procedure as described for the synthesis of <b>7</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>6</b> with HCl/dioxane followed by 1-ethyl-1<i>H</i>-pyrazole-5-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 601 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.81 (1H, d, <i>J</i> = 4.9 Hz), 8.13 (1H, m), 7.71–7.69 (1H, m), 7.47–7.42 (2H, m), 7.40 (1H, d, <i>J</i> = 2.0 Hz), 7.28 (1H, s), 7.21–7.15 (2H, m), 6.59 (1H, d, <i>J</i> = 2.0 Hz), 6.55 (1H, d, <i>J</i> = 1.6 Hz), 5.52 (1H, dd, <i>J</i> = 12.6, 2.0 Hz), 4.35–4.23 (2H, m), 4.18 (1H, d, <i>J</i> = 16.9 Hz), 3.92–3.87 (1H, m), 3.02 (1H, d, <i>J</i> = 12.8 Hz), 2.92 (1H, d, <i>J</i> = 16.9 Hz), 2.89–2.74 (2H, m), 2.59–2.55 (1H, m), 1.40 (3H, t, <i>J</i> = 7.3 Hz).</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (<i>R</i>)-(6-((3,5-Dimethyl-1<i>H</i>-pyrazol-4-yl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (<b>49</b>)</h3><div class="NLM_p last">Compound <b>49</b> was prepared using the same procedure as described for the synthesis of <b>7</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>6</b> with HCl/dioxane followed by 3,5-dimethyl-1<i>H</i>-pyrazole-4-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 601 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.79 (1H, d, <i>J</i> = 4.9 Hz), 8.12 (1H, m), 7.67 (1H, dd, <i>J</i> = 4.9, 1.0 Hz), 7.47–7.42 (2H, m), 7.27 (1H, s), 7.21–7.15 (2H, m), 6.53 (1H, d, <i>J</i> = 2.1 Hz), 5.42 (1H, dd, <i>J</i> = 12.3, 2.0 Hz), 4.19 (1H, d, <i>J</i> = 16.9 Hz), 3.87–3.83 (1H, m), 2.93 (1H, d, <i>J</i> = 16.9 Hz), 2.91 (1H, d, <i>J</i> = 12.8 Hz), 2.85–2.80 (1H, m), 2.72–2.76 (1H, m), 2.56–2.52 (1H, m), 2.32 (6H, s).</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (<i>R</i>)-(1-(4-Fluorophenyl)-6-((2-methyl-2<i>H</i>-1,2,3-triazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (<b>50</b>)</h3><div class="NLM_p last">Compound <b>50</b> was prepared using the same procedure as described for the synthesis of <b>7</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>6</b> with HCl/dioxane followed by 2-methyl-2<i>H</i>-1,2,3-triazole-4-sulfonyl chloride <b>19</b>. LC/MS <i>m</i>/<i>z</i> 588 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.89 (1H, dt, <i>J</i> = 5.0, 0.8 Hz), 8.15–8.13 (1H, m), 7.81 (1H, s), 7.70 (1H, ddd, <i>J</i> = 5.1, 1.7, 0.8 Hz), 7.48–7.42 (2H, m), 7.30 (1H, s), 7.22–7.13 (2H, m), 6.54 (1H, d, <i>J</i> = 2.2 Hz), 5.59 (1H, dd, <i>J</i> = 12.7, 2.2 Hz), 4.25 (3H, s), 4.22 (1H, d, <i>J</i> = 17.0 Hz), 3.90 (1H, ddt, <i>J</i> = 10.6, 6.0, 2.0 Hz), 2.99 (1H, d, <i>J</i> = 12.7 Hz), 2.95 (1H, d, <i>J</i> = 17.0 Hz), 2.84 (1H, tdd, <i>J</i> = 12.7, 5.9, 3.0 Hz), 2.74–2.67 (1H, m), 2.52 (1H, br dt, <i>J</i> = 14.6, 2.7 Hz).</div></div><div id="sec5_1_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (<i>R</i>)-(1-(4-Fluorophenyl)-6-((1-methyl-1<i>H</i>-1,2,3-triazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (<b>51</b>)</h3><div class="NLM_p last">Compound <b>51</b> was prepared using the same procedure as described for the synthesis of <b>7</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>6</b> with HCl/dioxane followed by 1-methyl-1<i>H</i>-1,2,3-triazole-4-sulfonyl chloride <b>18</b>. LC/MS <i>m</i>/<i>z</i> 588 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.87 (1H, d, <i>J</i> = 4.9 Hz), 8.15 (1H, m), 7.89 (1H, s), 7.70–7.69 (1H, m), 7.48–7.43 (2H, m), 7.31 (1H, s), 7.21–7.15 (2H, m), 6.54 (1H, s), 5.61 (1H, dd, <i>J</i> = 12.5, 2.0 Hz), 4.23 (1H, d, <i>J</i> = 16.9 Hz), 4.15 (3H, s), 3.95–3.87 (1H, m), 3.14 (1H, d, <i>J</i> = 12.5 Hz), 2.96 (1H, d, <i>J</i> = 16.9 Hz), 2.88–2.78 (2H, m), 2.57–2.48 (1H, m).</div></div><div id="sec5_1_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (<i>R</i>)-(1-(4-Fluorophenyl)-6-((1-methyl-1<i>H</i>-1,2,3-triazol-5-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (<b>52</b>)</h3><div class="NLM_p last">Compound <b>52</b> was prepared using the same procedure as described for the synthesis of <b>7</b> by treating (<i>R</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>6</b> with HCl/dioxane followed by 1-methyl-1<i>H</i>-1,2,3-triazole-5-sulfonyl chloride <b>20</b>. LC/MS <i>m</i>/<i>z</i> 588 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.80 (1H, d, <i>J</i> = 4.9 Hz), 8.11 (1H, m), 7.91 (1H, s), 7.73–7.71 (1H, m), 7.47–7.41 (2H, m), 7.28 (1H, s), 7.21–7.16 (2H, m), 6.56 (1H, s), 5.51 (1H, dd, <i>J</i> = 12.7, 2.1 Hz), 4.13 (1H, d, <i>J</i> = 16.9 Hz), 4.11 (3H, s), 4.01–3.93 (1H, m), 3.09 (1H, d, <i>J</i> = 12.7 Hz), 2.92 (1H, d, <i>J</i> = 16.9 Hz), 2.87–2.81 (2H, m), 2.65–2.60 (1H, m).</div></div><div id="sec5_1_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> ((4a<i>R</i>,8a<i>S</i>)-1-(4-Fluorophenyl)-6-((3-(trifluoromethyl)phenyl)sulfonyl)-4,4a,5,6,7,8,8a,9-octahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(pyridin-2-yl)methanone (<b>53</b>)</h3><div class="NLM_p last">Compound <b>53</b> was prepared using the same procedure as described for the synthesis of <b>12</b> by treating (4a<i>R</i>,8a<i>S</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-picolinoyl-4a,5,7,8,8a,9-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>11a</b> with HCl/dioxane followed by 3-(trifluoromethyl)benzene-1-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 585 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.66–8.61 (1H, m), 7.94 (1H, s), 7.88 (1H, br. d, <i>J</i> = 7.9 Hz), 7.84–7.77 (3H, m), 7.61 (1H, t, <i>J</i> = 7.8 Hz), 7.53–7.41 (3H, m), 7.33 (1H, s), 7.21–7.11 (2H, m), 5.66 (1H, dd, <i>J</i> = 12.2, 2.1 Hz), 4.31 (1H, d, <i>J</i> = 16.2 Hz), 4.03–3.91 (1H, m), 3.43 (1H, dd, <i>J</i> = 16.2, 11.2 Hz), 2.71 (1H, dd, <i>J</i> = 16.2, 5.9 Hz), 2.62–2.35 (4H, m), 1.85–1.68 (2H, m).</div></div><div id="sec5_1_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> ((4a<i>R</i>,8a<i>S</i>)-1-(4-Fluorophenyl)-6-((1-methyl-1<i>H</i>-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8,8a,9-octahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (<b>54</b>)</h3><div class="NLM_p last">Compound <b>54</b> was prepared using the same procedure as described for the synthesis of <b>12</b> by treating (4a<i>R</i>,8a<i>S</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8,8a,9-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>11</b> with TFA/DCM followed by 1-methyl-1<i>H</i>-pyrazole-4-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 589 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.84 (1H, d, <i>J</i> = 5.0 Hz), 8.10 (1H, m), 7.66–7.65 (3H, m), 7.50–7.45 (2H, m), 7.33 (1H, s), 7.18–7.12 (2H, m), 5.47 (1H, dd, <i>J</i> = 11.8, 2.0 Hz), 4.22 (1H, d, <i>J</i> = 16.2 Hz), 3.92 (3H, s), 3.85–3.83 (1H, m), 3.42 (1H, dd, <i>J</i> = 16.5, 11.4 Hz), 2.71 (1H, dd, <i>J</i> = 16.5, 5.8 Hz), 2.60 (1H, d, <i>J</i> = 16.2 Hz), 2.46–2.34 (2H, m), 2.29 (1H, d, <i>J</i> = 12.0 Hz), 1.84–1.70 (2H, m).</div></div><div id="sec5_1_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> ((4a<i>R</i>,8a<i>S</i>)-1-(4-Fluorophenyl)-6-((1-methyl-1<i>H</i>-pyrazol-3-yl)sulfonyl)-4,4a,5,6,7,8,8a,9-octahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (<b>55</b>)</h3><div class="NLM_p last">Compound <b>55</b> was prepared using the same procedure as described for the synthesis of <b>12</b> by treating (4a<i>R</i>,8a<i>S</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8,8a,9-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>11</b> with TFA/DCM followed by 1-methyl-1<i>H</i>-pyrazole-3-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 589 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.85 (1H, d, <i>J</i> = 5.0 Hz), 8.10–8.09 (1H, m), 7.65–7.63 (1H, m), 7.50–7.45 (2H, m), 7.38 (1H, d, <i>J</i> = 2.5 Hz), 7.34 (1H, s), 7.18–7.12 (2H, m), 6.55 (1H, d, <i>J</i> = 2.5 Hz), 5.57 (1H, dd, <i>J</i> = 11.8, 2.0 Hz), 4.27 (1H, d, <i>J</i> = 16.2 Hz), 3.97 (3H, s), 3.93–3.89 (1H, m), 3.44 (1H, dd, <i>J</i> = 16.2, 10.9 Hz), 2.71 (1H, dd, <i>J</i> = 16.4, 6.0 Hz), 2.63–2.55 (2H, m), 2.54 (1H, d, <i>J</i> = 12.2 Hz), 2.45–2.34 (1H, m), 1.82–1.74 (2H, m).</div></div><div id="sec5_1_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> ((4a<i>R</i>,8a<i>S</i>)-1-(4-Fluorophenyl)-6-((1-methyl-1<i>H</i>-1,2,3-triazol-4-yl)sulfonyl)-4,4a,5,6,7,8,8a,9-octahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (<b>56</b>)</h3><div class="NLM_p last">Compound <b>56</b> was prepared using the same procedure as described for the synthesis of <b>12</b> by treating (4a<i>R</i>,8a<i>S</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8,8a,9-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>11</b> with HCl/dioxane followed by 1-methyl-1<i>H</i>-1,2,3-triazole-4-sulfonyl chloride <b>18</b>. LC/MS <i>m</i>/<i>z</i> 590 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.85 (1H, d, <i>J</i> = 5.0 Hz), 8.11–8.10 (1H, m), 7.88 (1H, s), 7.66–7.65 (1H, m), 7.50–7.45 (2H, m), 7.34 (1H, s), 7.18–7.12 (2H, m), 5.68 (1H, dd, <i>J</i> = 12.6, 2.0 Hz), 4.26 (1H, d, <i>J</i> = 16.4 Hz), 4.15 (3H, s), 3.97–3.92 (1H, m), 3.43 (1H, dd, <i>J</i> = 16.4, 11.1 Hz), 2.78–2.70 (3H, m), 2.63 (1H, d, <i>J</i> = 16.2 Hz), 2.47–2.36 (1H, m), 1.87–1.78 (2H, m).</div></div><div id="sec5_1_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> ((4a<i>R</i>,8a<i>S</i>)-1-(4-Fluorophenyl)-6-((1-methyl-1<i>H</i>-1,2,3-triazol-5-yl)sulfonyl)-4,4a,5,6,7,8,8a,9-octahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (<b>57</b>)</h3><div class="NLM_p last">Compound <b>57</b> was prepared using the same procedure as described for the synthesis of <b>12</b> by treating (4a<i>R</i>,8a<i>S</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8,8a,9-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>11</b> with HCl/dioxane followed by 1-methyl-1<i>H</i>-1,2,3-triazole-5-sulfonyl chloride <b>20</b>. LC/MS <i>m</i>/<i>z</i> 590 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.77 (1H, d, <i>J</i> = 5.0 Hz), 8.04 (1H, m), 7.89 (1H, s), 7.69–7.67 (1H, m), 7.48–7.43 (2H, m), 7.28 (1H, s), 7.18–7.12 (2H, m), 5.59 (1H, dd, <i>J</i> = 12.6, 2.0 Hz), 4.12 (1H, d, <i>J</i> = 16.3 Hz), 4.06 (3H, s), 4.06–4.01 (1H, m), 3.35 (1H, dd, <i>J</i> = 16.4, 11.2 Hz), 2.82–2.72 (3H, m), 2.61 (1H, d, <i>J</i> = 16.2 Hz), 2.47–2.36 (1H, qd, <i>J</i> = 13.0, 5.2 Hz), 1.91–1.82 (2H, m).</div></div><div id="sec5_1_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> ((4a<i>R</i>,8a<i>S</i>)-6-((1-Ethyl-1<i>H</i>-pyrazol-5-yl)sulfonyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8,8a,9-octahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (<b>58</b>)</h3><div class="NLM_p last">Compound <b>58</b> was prepared using the same procedure as described for the synthesis of <b>12</b> by treating (4a<i>R</i>,8a<i>S</i>)-<i>tert</i>-butyl 1-(4-fluorophenyl)-4a-(4-(trifluoromethyl)picolinoyl)-4a,5,7,8,8a,9-hexahydro-1<i>H</i>-pyrazolo[3,4-<i>g</i>]isoquinoline-6(4<i>H</i>)-carboxylate <b>11</b> with HCl/dioxane followed by 1-ethyl-1<i>H</i>-pyrazole-5-sulfonyl chloride. LC/MS <i>m</i>/<i>z</i> 603 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.78 (1H, d, <i>J</i> = 5.0 Hz), 8.07 (1H, m), 7.66–7.64 (1H, m), 7.49–7.44 (2H, m), 7.36 (1H, d, <i>J</i> = 2.0 Hz), 7.29 (1H, s), 7.18–7.12 (2H, m), 6.58 (1H, d, <i>J</i> = 2.0 Hz), 5.57 (1H, dd, <i>J</i> = 12.5, 2.0 Hz), 4.32 (3H, m), 3.98–3.94 (1H, m), 3.38 (1H, dd, <i>J</i> = 16.2, 10.8 Hz), 2.76–2.69 (2H, m), 2.66 (1H, d, <i>J</i> = 12.6 Hz), 2.61 (1H, d, <i>J</i> = 16.2 Hz), 2.51–2.40 (1H, m), 1.89–1.80 (2H, m), 1.39 (3H, t, <i>J</i> = 7.2 Hz).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Human GR Fluoresence Polarization Assay</h3><div class="NLM_p">The concentrations of fluorescent glucocorticoid (Fluormone GS Red; Panvera P2894) ligand (<i>K</i><sub>d</sub> = 0.3 ± 0.01 nM) and GR (Panvera P2812) were chosen so that the polarization signal was approximately 60% of the maximal response (0.5 nM Fluormone GS Red and 1 nM GR). Maximal response (high polarization) was measured in the presence of 1% (v/v) final DMSO, and basal response (low polarization) was measured in the presence of 1 μM dexamethasone. The assays were performed in duplicate using increasing concentrations of inhibitor compounds (0–100 nM), at a final volume of 20 μL and 1% (v/v) DMSO. The plates were mixed and incubated for 4 h at room temperature.</div><div class="NLM_p">All fluorescence polarization (FP) assays were performed on PerkinElmer Envision 2104 multiplate reader. Corning 3575 384-well, black, nonbinding surface, round-bottom, polypropylene microtiter plates were used loaded with 20 μL of assay solution per well. For Fluormone GS Red, 535 nm excitation and 590 nm emission filters were used. The FP assays were performed in ice cold 10 mM potassium phosphate (pH 7.4), 20 mM Na<sub>2</sub>MoO<sub>4</sub>, 0.1 mM EDTA, 3% DMSO (PanVera P2814), 0.1 mM stabilizing peptide (PanVera P2815), and 5 μM DTT. All aqueous solutions were prepared using deionized water collected from a Millipore water purification system.</div><div class="NLM_p">FP was determined by measuring the parallel and perpendicular fluorescence intensity (<i>F</i><sub>∥</sub>and <i>F</i><sub>⊥</sub>) with respect to the linearly polarized excitation light. The millifluorescence polarization (mP) is expressed by <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>.<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/jm-2017-00162r_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span>where <i>G</i> factor (<i>G</i>) is 1.07.</div><div class="NLM_p last">The percentage inhibition of the competitor at each concentration point was determined by using <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a>, and the IC<sub>50</sub> of an inhibitor was determined from the plot of % inhibition against inhibitor concentration using <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>.<span class="NLM_disp-formula" id="eq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/jm-2017-00162r_m002.gif" alt="" /></img><span class="labelSpan">(2)</span></span><span class="NLM_disp-formula" id="eq3"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/jm-2017-00162r_m003.gif" alt="" /></img><span class="labelSpan">(3)</span></span>where <i>x</i> = log[inhibitor], mP<sub>min</sub> = 100% inhibiton, and mP<sub>max</sub> = 0% inhibiton. Compound IC<sub>50</sub> values were calculated by plotting compound concentration vs % inhibition curve and fitting the data to a four-parameter, one-site dose–response equation. Compound <i>K</i><sub>i</sub> values were determined from the experimental IC<sub>50</sub> values using a ligand depletion correction equation<span class="NLM_disp-formula" id="eq4"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/jm-2017-00162r_m004.gif" alt="" /></img><span class="labelSpan">(4)</span></span>where equilibrium dissociation constant of GS red ligand <i>K</i><sub>d</sub> = 0.3 nM, concentration of bound ligand <i>L</i><sub>b</sub> = 0.3 nM, total ligand concentration <i>L</i><sub>0</sub> = 0.5 nM, and total receptor concentration <i>R</i><sub>0</sub> = 1.0 nM. The minimum significant ratio for this assay is 1.91, with limits of agreement between 0.46 and 1.69.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> HepG2 TAT Assay</h3><div class="NLM_p">HepG2 cell lines were purchased from the European Collection of Authenticated Cell Cultures (ECACC 85011430). Cells were cultured in minimum essential medium (MEME; Sigma, M2279) supplemented with 10% (v/v) fetal bovine serum (FBS; Gemini BioProducts), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Sigma, G7513), and 1% (v/v) nonessential amino acids (NEAA; Sigma, M7145). Cells were cultured at 37 °C in a humidified atmosphere with 5% CO<sub>2</sub>.</div><div class="NLM_p">HepG2 cells were counted and adjusted to a concentration of 1.25 × 10<sup>5</sup> cells/mL in growth medium comprising RPMI-1640 without phenol red, 10% (v/v) charcoal-stripped FBS, and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, and a 200 μL volume (25 000 cells/well) was added into a 96-well, sterile tissue culture plate and incubated at 37 °C, 5% CO<sub>2</sub> for 24 h.</div><div class="NLM_p">Growth medium was carefully removed and replaced with assay medium (RPMI-1640 without phenol red, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine + 10 μM forskolin). For testing compounds in the antagonist mode, an eight-point half-log compound dilution curve was generated with a final assay concentration range from 10 μM to 0.003 μM in 0.1% DMSO. Test compounds were preincubated with HepG2 cells for 30 min at 37 °C, 5% CO<sub>2</sub>, before the addition of 100 nM dexamethasone challenge and then subsequently incubated for 20 h (37 °C, 5% CO<sub>2</sub>). For testing compounds in the agonist mode, an eight-point half-log compound dilution curve was generated with a final assay concentration range from 10 μM to 0.003 μM in 0.1% DMSO. HepG2 cells were preincubated with assay medium containing 0.1% DMSO for 30 min at 37 °C, 5% CO<sub>2</sub>, before the addition of test compounds and then subsequently incubated for 20 h (37 °C, 5% CO<sub>2</sub>).</div><div class="NLM_p">HepG2 cells were then lysed with 30 μL of cell lysis buffer containing a protease inhibitor cocktail for 15 min at 4 °C. 155 μL of substrate mixture was then added containing 5.4 mM tyrosine Na salt, 10.8 mM α-ketoglutarate, and 0.06 mM pyridoxal 5′-phosphate in 0.1 M potassium phosphate buffer (pH 7.4). After a 2 h incubation at 37 °C, the reaction was terminated by the addition of 15 μL of 10 M KOH, and the plates were incubated for a further 30 min at 37 °C. TAT activation was measured by reading the absorbance at λ of 340 nm.</div><div class="NLM_p">IC<sub>50</sub> values were obtained by fitting percent inhibition of 100 nM dexamethasone response versus compound concentration data to a four-parameter, one-site dose–response equation. <i>K</i><sub>i</sub> values were calculated using the Cheng and Prusoff (1973) equation. EC<sub>50</sub> values were obtained by fitting percent activation of basal TAT response versus compound concentration data to a four-parameter, one-site dose–response equation. An EC<sub>50</sub> value of 20 nM for dexamethasone (which was measured on numerous occasions) was used to calculate the <i>K</i><sub>i</sub> values of the test compounds.</div><div class="NLM_p last">The assay variance was determined, and the calculated minimum significant ratio (MSR) was 2.21 at the 95% confidence level, with the limits of agreement of MSR between 0.45 and 2.21. The overall standard deviation of the assay was <0.2.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Rat Cassette PK Studies</h3><div class="NLM_p last">Three male Sprague Dawley CD-1 rats (220–250 g, Charles River UK) with implanted jugular vein catheters were dosed by oral gavage with the selected three test compounds and a reference compound, with each compound administered at a dose of 3 mg/kg. The compounds were formulated in DMSO/methylcellulose (0.5% in water), 10:90, at a concentration of 2.4 mg/mL (0.6 mg/mL for each compound) in a dosing volume of 5 mL/kg. Serial blood samples were collected predose and at 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h postdose for preparation of plasma and analysis of compound concentrations. Samples were analyzed by LC/MS.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Rat iv/po PK Studies</h3><div class="NLM_p last">Five male Sprague Dawley CD-1 rats (220–250 g, Charles River UK) with implanted jugular vein catheters were dosed by oral gavage with the selected test compound. The compound was formulated in DMSO/methylcellulose (0.5% in water), 10:90, at a concentration of 1 mg/mL for dosing by oral gavage. This provided a dose of 5 mg/kg in a dosing volume of 5 mL/kg. Serial blood samples were collected predose and at 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h postdose for preparation of plasma and analysis of compound concentrations. Three rats were used for iv dosing, and the compound was dissolved in DMSO/PEG400/propylene glycol, 10:45:45, and a concentration of 0.5 mg/mL. Serial blood samples were collected predose and at 0.08, 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h postdose for preparation of plasma and analysis of compound concentrations. Samples were analyzed by LC/MS.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Cortisone-Induced Insulin Resistance in Rats</h3><div class="NLM_p last">Male Sprague Dawley rats (200–250g) underwent a 3-day baseline period in which they were dosed daily with vehicle. This procedure has been found to reduce the incidence of stress-induced effects in subsequent studies. Groups of eight rats were administered vehicle, cortisone 21-acetate alone, or cortisone 21-acetate and the appropriate test compound. Test compounds were formulated as a suspension in DMSO/Tween 80/HPMC (0.5%), 10:0.1:89.9, and administered twice a day for 6 days at the appropriate doses by oral gavage. Cortisone 21-acetate (formulated as a fine suspension in 1% methylcellulose) was administered once a day sc at a dose of 30 mg/kg. 24 h after the final dose of cortisone 21-acetate (12 hours after the final administration of test compound) blood samples were taken from the lateral tail vein for analysis of glucose and insulin. Glucose was measured using a commercial clinical reagent (Thermoelectron Infinity glucose reagent TR15421), and insulin was measured using the Mercodia ultrasensitive rat insulin ELISA. The rats were terminated by carbon dioxide asphyxiation followed by cervical dislocation.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00162">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44338" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44338" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00162" class="ext-link">10.1021/acs.jmedchem.7b00162</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00162/suppl_file/jm7b00162_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00162/suppl_file/jm7b00162_si_001.csv">jm7b00162_si_001.csv (0.23 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00162" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57677" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57677" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hazel J. Hunt</span> - <span class="hlFld-Affiliation affiliation">Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, California 94025, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4316-1301" title="Orcid link">http://orcid.org/0000-0002-4316-1301</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#442c2c312a3004272b36272134306a272b29"><span class="__cf_email__" data-cfemail="a2cacad7ccd6e2c1cdd0c1c7d2d68cc1cdcf">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph K. Belanoff</span> - <span class="hlFld-Affiliation affiliation">Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, California 94025, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Iain Walters</span> - <span class="hlFld-Affiliation affiliation">Sygnature
Discovery, BioCity, Pennyfoot Street, Nottingham, NG1 1GF, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benoit Gourdet</span> - <span class="hlFld-Affiliation affiliation">Sygnature
Discovery, BioCity, Pennyfoot Street, Nottingham, NG1 1GF, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer Thomas</span> - <span class="hlFld-Affiliation affiliation">Sygnature
Discovery, BioCity, Pennyfoot Street, Nottingham, NG1 1GF, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naomi Barton</span> - <span class="hlFld-Affiliation affiliation">Sygnature
Discovery, BioCity, Pennyfoot Street, Nottingham, NG1 1GF, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Unitt</span> - <span class="hlFld-Affiliation affiliation">Sygnature
Discovery, BioCity, Pennyfoot Street, Nottingham, NG1 1GF, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy Phillips</span> - <span class="hlFld-Affiliation affiliation">Sygnature
Discovery, BioCity, Pennyfoot Street, Nottingham, NG1 1GF, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Denise Swift</span> - <span class="hlFld-Affiliation affiliation">Sygnature
Discovery, BioCity, Pennyfoot Street, Nottingham, NG1 1GF, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emily Eaton</span> - <span class="hlFld-Affiliation affiliation">Sygnature
Discovery, BioCity, Pennyfoot Street, Nottingham, NG1 1GF, U.K.</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d276e6926-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41627" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41627" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors acknowledge RenSci for conducting the cortisone-induced insulin resistance model in rats, Saretius for undertaking rat PK studies, Xenogesis for the provision of in vitro DMPK data and MPI for monkey PK and all toxicology data. We also thank Colin Sambrook-Smith at Sygnature for providing the compound overlays.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i83" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i83"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i84" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i84"> Abbreviations Used</h2><tr><td class="NLM_term">GR</td><td class="NLM_def"><p class="first last">glucocorticoid receptor</p></td></tr><tr><td class="NLM_term">GRE</td><td class="NLM_def"><p class="first last">glucocorticoid response element</p></td></tr><tr><td class="NLM_term">PR</td><td class="NLM_def"><p class="first last">progesterone receptor</p></td></tr><tr><td class="NLM_term">TAT</td><td class="NLM_def"><p class="first last">tyrosine amino transferase</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i85">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54850" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54850" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 23 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Cole, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blendy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaghan, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieglstein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantuzzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unsicker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutz, G.</span><span> </span><span class="NLM_article-title">Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin development and severely retards lung maturation</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1608</span><span class="NLM_x">–</span> <span class="NLM_lpage">1621</span><span class="refDoi"> DOI: 10.1101/gad.9.13.1608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1101%2Fgad.9.13.1608" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=1608-1621&author=T.+J.+Coleauthor=J.+A.+Blendyauthor=A.+P.+Monaghanauthor=K.+Krieglsteinauthor=W.+Schmidauthor=A.+Aguzziauthor=G.+Fantuzziauthor=E.+Hummlerauthor=K.+Unsickerauthor=G.+Schutz&title=Targeted+disruption+of+the+glucocorticoid+receptor+gene+blocks+adrenergic+chromaffin+development+and+severely+retards+lung+maturation&doi=10.1101%2Fgad.9.13.1608"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1101%2Fgad.9.13.1608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.9.13.1608%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DT.%2BJ.%26aulast%3DBlendy%26aufirst%3DJ.%2BA.%26aulast%3DMonaghan%26aufirst%3DA.%2BP.%26aulast%3DKrieglstein%26aufirst%3DK.%26aulast%3DSchmid%26aufirst%3DW.%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DFantuzzi%26aufirst%3DG.%26aulast%3DHummler%26aufirst%3DE.%26aulast%3DUnsicker%26aufirst%3DK.%26aulast%3DSchutz%26aufirst%3DG.%26atitle%3DTargeted%2520disruption%2520of%2520the%2520glucocorticoid%2520receptor%2520gene%2520blocks%2520adrenergic%2520chromaffin%2520development%2520and%2520severely%2520retards%2520lung%2520maturation%26jtitle%3DGenes%2520Dev.%26date%3D1995%26volume%3D9%26spage%3D1608%26epage%3D1621%26doi%3D10.1101%2Fgad.9.13.1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cidlowski, J. A.</span><span> </span><span class="NLM_article-title">The human glucocorticoid receptor: one gene, multiple proteins and diverse responses</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span><span class="refDoi"> DOI: 10.1016/j.steroids.2005.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.steroids.2005.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=15862824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=407-417&author=J.+Zhouauthor=J.+A.+Cidlowski&title=The+human+glucocorticoid+receptor%3A+one+gene%2C+multiple+proteins+and+diverse+responses&doi=10.1016%2Fj.steroids.2005.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The human glucocorticoid receptor: One gene, multiple proteins and diverse responses</span></div><div class="casAuthors">Zhou, Junguo; Cidlowski, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Steroids</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5-7</span>),
    <span class="NLM_cas:pages">407-417</span>CODEN:
                <span class="NLM_cas:coden">STEDAM</span>;
        ISSN:<span class="NLM_cas:issn">0039-128X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Glucocorticoids are a vital class of endogenous steroid hormones that regulate essential biol. processes including growth, development, metab., behavior and apoptosis.  Most, if not all, of these actions are thought to be mediated through the glucocorticoid receptor.  The exact mechanisms of how one hormone, via one receptor, modulates such diverse biol. functions are largely unknown.  However, recent studies from our lab and others have suggested that a contribution for the diversity results from multiple isoforms of the glucocorticoid receptor that result from alternative RNA splicing and translation initiation of the glucocorticoid receptor mRNA.  Addnl., each isoform is subject to several post-translational modifications, including phosphorylation, ubiquitination and sumoylation, which have been shown to modulate the receptor protein stability and/or function.  Together these data provide potentially diverse mechanisms to establish cell type specific regulation of gene expression by a single transcription factor.  Here, we summarize the recent advances and processes that generate these receptor isoforms and these post-translational modifications.  We speculate that the compn. and proportion of individual isoforms expressed in particular cellular contexts account for the diverse effects of glucocorticoid hormones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmTrMelvxssrVg90H21EOLACvtfcHk0lg3ryokeili7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOitLg%253D&md5=6a5abe8c565f849c0330cd36b82bba1f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2005.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2005.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DCidlowski%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520human%2520glucocorticoid%2520receptor%253A%2520one%2520gene%252C%2520multiple%2520proteins%2520and%2520diverse%2520responses%26jtitle%3DSteroids%26date%3D2005%26volume%3D70%26spage%3D407%26epage%3D417%26doi%3D10.1016%2Fj.steroids.2005.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Adcock, I. M.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of glucocorticosteroid actions</span> <span class="citation_source-journal">Pulm. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.1006/pupt.2000.0243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1006%2Fpupt.2000.0243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10873549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=115-126&author=I.+M.+Adcock&title=Molecular+mechanisms+of+glucocorticosteroid+actions&doi=10.1006%2Fpupt.2000.0243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of glucocorticosteroid actions</span></div><div class="casAuthors">Adcock, Ian M.</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">115-126</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review, with 121 refs., of the mol. mechanisms in glucocorticosteroid actions.  Topics discussed were: treatment of inflammatory disease; the glucocorticosteroid receptor; induction of gene transcription; transrepression; dissocd. glucocorticosteroids; glucocorticosteroid resistance and therapeutic implications.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2m-rHCCb2ALVg90H21EOLACvtfcHk0lgDIY8YBjQWQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1KntLo%253D&md5=84178278553b3c54fa260ed162a771ff</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1006%2Fpupt.2000.0243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fpupt.2000.0243%26sid%3Dliteratum%253Aachs%26aulast%3DAdcock%26aufirst%3DI.%2BM.%26atitle%3DMolecular%2520mechanisms%2520of%2520glucocorticosteroid%2520actions%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2000%26volume%3D13%26spage%3D115%26epage%3D126%26doi%3D10.1006%2Fpupt.2000.0243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Grad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picard, D.</span><span> </span><span class="NLM_article-title">The glucocorticoid responses are shaped by molecular chaperones</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1016/j.mce.2007.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.mce.2007.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=17628337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Sktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2007&pages=2-12&author=L.+Gradauthor=D.+Picard&title=The+glucocorticoid+responses+are+shaped+by+molecular+chaperones&doi=10.1016%2Fj.mce.2007.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The glucocorticoid responses are shaped by molecular chaperones</span></div><div class="casAuthors">Grad, Iwona; Picard, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">2-12</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The glucocorticoid receptor is a known regulator of a variety of physiol. processes.  Its mode of action is well defined: upon hormone binding, it undergoes a conformational change, translocates to the nucleus and modulates the transcription of target genes.  Mol. chaperones have a widely recognized role in the folding of newly made proteins, but their participation in further maturation of folded proteins to their active states and beyond tends to be underestimated.  This review presents the current knowledge on how the Hsp70 and Hsp90 chaperone machines help to shape the responses to glucocorticoids.  We discuss the contributions of these mol. chaperones to folding, activation, intracellular transport, transcriptional regulation, and decay of the glucocorticoid receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsS9KUvvmh8rVg90H21EOLACvtfcHk0lgDIY8YBjQWQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Sktb0%253D&md5=0007d5a4189ed5413cc633a2063c9ea1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2007.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2007.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DGrad%26aufirst%3DL.%26aulast%3DPicard%26aufirst%3DD.%26atitle%3DThe%2520glucocorticoid%2520responses%2520are%2520shaped%2520by%2520molecular%2520chaperones%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2007%26volume%3D275%26spage%3D2%26epage%3D12%26doi%3D10.1016%2Fj.mce.2007.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Kadmiel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cidlowski, J. A.</span><span> </span><span class="NLM_article-title">Glucocorticoid receptor signalling in health and diseases</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span><span class="refDoi"> DOI: 10.1016/j.tips.2013.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.tips.2013.07.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=518-530&author=M.+Kadmielauthor=J.+A.+Cidlowski&title=Glucocorticoid+receptor+signalling+in+health+and+diseases&doi=10.1016%2Fj.tips.2013.07.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DKadmiel%26aufirst%3DM.%26aulast%3DCidlowski%26aufirst%3DJ.%2BA.%26atitle%3DGlucocorticoid%2520receptor%2520signalling%2520in%2520health%2520and%2520diseases%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D518%26epage%3D530%26doi%3D10.1016%2Fj.tips.2013.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Oakley, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cidlowski, J. A.</span><span> </span><span class="NLM_article-title">The biology of the glucocorticoid receptor: new signalling mechanisms in health and disease</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span><span class="refDoi"> DOI: 10.1016/j.jaci.2013.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.jaci.2013.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=24084075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCiurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2013&pages=1033-1044&author=R.+D.+Oakleyauthor=J.+A.+Cidlowski&title=The+biology+of+the+glucocorticoid+receptor%3A+new+signalling+mechanisms+in+health+and+disease&doi=10.1016%2Fj.jaci.2013.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease</span></div><div class="casAuthors">Oakley, Robert H.; Cidlowski, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1033-1044</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Glucocorticoids are primary stress hormones necessary for life that regulate numerous physiol. processes in an effort to maintain homeostasis.  Synthetic derivs. of these hormones have been mainstays in the clinic for treating inflammatory diseases, autoimmune disorders, and hematol. cancers.  The physiol. and pharmacol. actions of glucocorticoids are mediated by the glucocorticoid receptor (GR), a member of the nuclear receptor superfamily of ligand-dependent transcription factors.  Ligand-occupied GR induces or represses the transcription of thousands of genes through direct binding to DNA response elements, phys. assocg. with other transcription factors, or both.  The traditional view that glucocorticoids act through a single GR protein has changed dramatically with the discovery of a large cohort of receptor isoforms with unique expression, gene-regulatory, and functional profiles.  These GR subtypes are derived from a single gene by means of alternative splicing and alternative translation initiation mechanisms.  Posttranslational modification of these GR isoforms further expands the diversity of glucocorticoid responses.  Here we discuss the origin and mol. properties of the GR isoforms and their contribution to the specificity and sensitivity of glucocorticoid signaling in healthy and diseased tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwz6x0tM48ibVg90H21EOLACvtfcHk0lgDIY8YBjQWQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCiurjK&md5=3e92529060398d597a150128d3ef5353</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2013.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2013.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DOakley%26aufirst%3DR.%2BD.%26aulast%3DCidlowski%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520biology%2520of%2520the%2520glucocorticoid%2520receptor%253A%2520new%2520signalling%2520mechanisms%2520in%2520health%2520and%2520disease%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2013%26volume%3D132%26spage%3D1033%26epage%3D1044%26doi%3D10.1016%2Fj.jaci.2013.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">De Bosscher, K.</span><span> </span><span class="NLM_article-title">Selective glucocorticoid receptor modulators</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span><span class="refDoi"> DOI: 10.1016/j.jsbmb.2010.02.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.jsbmb.2010.02.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=20206690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVGisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2010&pages=96-104&author=K.+De+Bosscher&title=Selective+glucocorticoid+receptor+modulators&doi=10.1016%2Fj.jsbmb.2010.02.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Glucocorticoid Receptor modulators</span></div><div class="casAuthors">De Bosscher, Karolien</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">96-104</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The ancient two-faced Roman god Janus is often used as a metaphor to describe the characteristics of the Glucocorticoid Receptor (NR3C1), which exhibits both a beneficial side, that serves to halt inflammation, and a detrimental side responsible for undesirable effects.  However, recent developments suggest that the Glucocorticoid Receptor has many more faces with the potential to express a range of different functionalities, depending on factors that include the tissue type, ligand type, receptor variants, cofactor surroundings and target gene promoters.  This behavior of the receptor has made the development of safer ligands, that trigger the expression program of only a desirable subset of genes, a real challenge.  Thus more knowledge-based fundamental research is needed to ensure the design and development of selective Glucocorticoid Receptor modulators capable of reaching the clinic.  Recent advances in the characterization of novel selective Glucocorticoid Receptor modulators, specifically in the context of anti-inflammatory strategies, will be described in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8M8FgnsmairVg90H21EOLACvtfcHk0lizbL2OyRCdXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVGisrY%253D&md5=6c58e80f4a7966e56a615bc6bb2e9a6f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2010.02.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2010.02.027%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBosscher%26aufirst%3DK.%26atitle%3DSelective%2520glucocorticoid%2520receptor%2520modulators%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D120%26spage%3D96%26epage%3D104%26doi%3D10.1016%2Fj.jsbmb.2010.02.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Clark, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belvisi, M. G.</span><span> </span><span class="NLM_article-title">Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2011.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.pharmthera.2011.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=22212616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtV2rtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=54-67&author=A.+R.+Clarkauthor=M.+G.+Belvisi&title=Maps+and+legends%3A+the+quest+for+dissociated+ligands+of+the+glucocorticoid+receptor&doi=10.1016%2Fj.pharmthera.2011.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Maps and legends: The quest for dissociated ligands of the glucocorticoid receptor</span></div><div class="casAuthors">Clark, Andrew R.; Belvisi, Maria G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-67</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Glucocorticoids are steroid hormones that have pleiotropic effects on development, metab., cognitive function and other aspects of physiol.  Since the demonstration more than sixty years ago of their capacity to suppress inflammation, synthetic glucocorticoids have been extremely widely used in the treatment of inflammatory diseases.  However, their clin. use is limited by numerous, unpredictable and potentially serious side effects.  Glucocorticoids regulate gene expression both pos. and neg.  Both of these effects are mediated by the glucocorticoid receptor, a ligand-dependent transcription factor.  It has become widely accepted that anti-inflammatory effects of glucocorticoids are mostly due to inhibition of transcription, whereas the activation of transcription by the glucocorticoid receptor accounts for the majority of side effects.  This dogma (which we refer to as the "transrepression hypothesis") predicts the possibility of uncoupling therapeutic, anti-inflammatory effects from side effects by identifying novel, selective ligands of the glucocorticoid receptor, which preferentially mediate inhibition rather than activation of transcription.  It is argued that such "dissocd." glucocorticoid receptor ligands should retain anti-inflammatory potency but cause fewer side effects.  Here we critically re-examine the history and foundations of the transrepression hypothesis.  We argue that it is incompatible with the complexity of gene regulation by glucocorticoids and poorly supported by exptl. evidence; that it no longer aids clear thinking about the actions of the glucocorticoid receptor; and that it will not prove a fruitful basis for continued refinement and improvement of anti-inflammatory drugs that target the glucocorticoid receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6zUg2geJoS7Vg90H21EOLACvtfcHk0lizbL2OyRCdXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtV2rtbc%253D&md5=693fab780fa2775b68eb175200522b93</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2011.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2011.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DA.%2BR.%26aulast%3DBelvisi%26aufirst%3DM.%2BG.%26atitle%3DMaps%2520and%2520legends%253A%2520the%2520quest%2520for%2520dissociated%2520ligands%2520of%2520the%2520glucocorticoid%2520receptor%26jtitle%3DPharmacol.%2520Ther.%26date%3D2012%26volume%3D134%26spage%3D54%26epage%3D67%26doi%3D10.1016%2Fj.pharmthera.2011.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Lindholm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joergensen, J. O. L.</span><span> </span><span class="NLM_article-title">Incidence and late prognosis of Cushing’s syndrome: a population-based study</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span><span class="refDoi"> DOI: 10.1210/jc.86.1.117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1210%2Fjc.86.1.117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=11231987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtVGnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2001&pages=117-123&author=J.+Lindholmauthor=S.+Juulauthor=J.+O.+L.+Joergensen&title=Incidence+and+late+prognosis+of+Cushing%E2%80%99s+syndrome%3A+a+population-based+study&doi=10.1210%2Fjc.86.1.117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Incidence and late prognosis of Cushing's syndrome: a population-based study</span></div><div class="casAuthors">Lindholm, J.; Juul, S.; Jorgensen, J. O. L.; Astrup, J.; Bjerre, P.; Feldt-Rasmussen, U.; Hagen, C.; Jorgensen, J.; Kosteljanetz, M.; Kristensen, L. O.; Laurberg, P.; Schmidt, K.; Weeke, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">117-123</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The main purpose was to assess the incidence and late outcome of Cushing's syndrome, particularly in Cushing's disease.  Information for all patients diagnosed with Cushing's syndrome during an 11-yr period in Denmark was retrieved.  The incidence was 1.2-1.7/million·yr (Cushing's disease), 0.6/million·yr (adrenal adenoma) and 0.2/million·yr (adrenal carcinoma).  Other types of Cushing's syndrome were rare.  In 139 patients with nonmalignant disease, 11.1% had died during follow-up (median, 8.1 yr; range, 3.1-14.0), yielding a std. mortality ratio (SMR) of 3.68 [95% confidence interval (CI), 2.34-5.33].  The SMR was partly attributable to an increased mortality within the first year after diagnosis.  Eight patients died before treatment could be undertaken.  The prognosis in patients with malignant disease was very poor.  Patients in whom more than 5 yr had elapsed since initial surgery were studied sep., including a questionnaire on their perceived quality of health.  In 45 patients with Cushing's disease who had been cured through transsphenoidal neurosurgery, only 1 had died (SMR, 0.31; CI, 0.01-1.72) compared with 6 of 20 patients with persistent hypercortisolism after initial neurosurgery (SMR, 5.06; CI, 1.86-11.0).  In patients with adrenal adenoma, SMR was 3.95 (CI, 0.81-11.5).  The perceived quality of health was significantly impaired only in patients with Cushing's disease and appeared independent of disease control or presence of hypopituitarism.  It is concluded that 1) Cushing's syndrome is rare and is assocd. with increased mortality, in patients with no concurrent malignancy also; 2) the excess mortality was mainly obsd. during the first year of disease; and 3) the impaired quality of health in long-term survivors of Cushing's disease is not fully explained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEwP71mjo7Z7Vg90H21EOLACvtfcHk0lizbL2OyRCdXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtVGnsrs%253D&md5=20d63a078e2873c51d9d822f619a2af1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1210%2Fjc.86.1.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.86.1.117%26sid%3Dliteratum%253Aachs%26aulast%3DLindholm%26aufirst%3DJ.%26aulast%3DJuul%26aufirst%3DS.%26aulast%3DJoergensen%26aufirst%3DJ.%2BO.%2BL.%26atitle%3DIncidence%2520and%2520late%2520prognosis%2520of%2520Cushing%25E2%2580%2599s%2520syndrome%253A%2520a%2520population-based%2520study%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2001%26volume%3D86%26spage%3D117%26epage%3D123%26doi%3D10.1210%2Fjc.86.1.117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Steffensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bak, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoylner Rubeck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, J. O. L.</span><span> </span><span class="NLM_article-title">Epidemiology of Cushing’s syndrome</span> <span class="citation_source-journal">Neuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span><span class="refDoi"> DOI: 10.1159/000314297</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1159%2F000314297" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2010&pages=1-5&issue=Suppl.+1&author=C.+Steffensenauthor=A.+M.+Bakauthor=K.+Zoylner+Rubeckauthor=J.+O.+L.+Jorgensen&title=Epidemiology+of+Cushing%E2%80%99s+syndrome&doi=10.1159%2F000314297"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1159%2F000314297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000314297%26sid%3Dliteratum%253Aachs%26aulast%3DSteffensen%26aufirst%3DC.%26aulast%3DBak%26aufirst%3DA.%2BM.%26aulast%3DZoylner%2BRubeck%26aufirst%3DK.%26aulast%3DJorgensen%26aufirst%3DJ.%2BO.%2BL.%26atitle%3DEpidemiology%2520of%2520Cushing%25E2%2580%2599s%2520syndrome%26jtitle%3DNeuroendocrinology%26date%3D2010%26volume%3D92%26issue%3DSuppl.%25201%26spage%3D1%26epage%3D5%26doi%3D10.1159%2F000314297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Nieman, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findling, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murad, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell-Price, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabarin, A.</span><span> </span><span class="NLM_article-title">Treatment of Cushing’s syndrome: an Endocrine Society clinical practice guideline</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">2807</span><span class="NLM_x">–</span> <span class="NLM_lpage">2831</span><span class="refDoi"> DOI: 10.1210/jc.2015-1818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1210%2Fjc.2015-1818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=26222757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVGks7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=2807-2831&author=L.+K.+Niemanauthor=B.+M.+Billerauthor=J.+W.+Findlingauthor=M.+H.+Muradauthor=J.+Newell-Priceauthor=M.+O.+Savageauthor=A.+Tabarin&title=Treatment+of+Cushing%E2%80%99s+syndrome%3A+an+Endocrine+Society+clinical+practice+guideline&doi=10.1210%2Fjc.2015-1818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of Cushing's syndrome: an endocrine society clinical practice guideline</span></div><div class="casAuthors">Nieman, Lynnette K.; Biller, Beverly M. K.; Findling, James W.; Murad, M. Hassan; Newell-Price, John; Savage, Martin O.; Tabarin, Antoine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2807-2831</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Objective: The objective is to formulate clin. practice guidelines for treating Cushing's syndrome.  Participants: Participants include an Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer.  The European Society for Endocrinol. co-sponsored the guideline.  Evidence: The Task Force used the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence.  The Task Force commissioned three systematic reviews and used the best available evidence from other published systematic reviews and individual studies.  Consensus Process: The Task Force achieved consensus through one group meeting, several conference calls, and numerous e-mail communications.  Committees and members of The Endocrine Society and the European Society of Endocrinol. reviewed and commented on preliminary drafts of these guidelines.  Conclusions: Treatment of Cushing's syndrome is essential to reduce mortality and assocd. comorbidities.  Effective treatment includes the normalization of cortisol levels or action.  It also includes the normalization of comorbidities via directly treating the cause of Cushing's syndrome and by adjunctive treatments (eg, antihypertensives).  Surgical resection of the causal lesion(s) is generally the first-line approach.  The choice of second-line treatments, including medication, bilateral adrenalectomy, and radiation therapy (for corticotrope tumors), must be individualized to each patient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZuB0U1q9MVLVg90H21EOLACvtfcHk0lglA2GG0FKjlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVGks7bE&md5=9037cd9af59e6c31fddd8654b838e22b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1210%2Fjc.2015-1818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2015-1818%26sid%3Dliteratum%253Aachs%26aulast%3DNieman%26aufirst%3DL.%2BK.%26aulast%3DBiller%26aufirst%3DB.%2BM.%26aulast%3DFindling%26aufirst%3DJ.%2BW.%26aulast%3DMurad%26aufirst%3DM.%2BH.%26aulast%3DNewell-Price%26aufirst%3DJ.%26aulast%3DSavage%26aufirst%3DM.%2BO.%26aulast%3DTabarin%26aufirst%3DA.%26atitle%3DTreatment%2520of%2520Cushing%25E2%2580%2599s%2520syndrome%253A%2520an%2520Endocrine%2520Society%2520clinical%2520practice%2520guideline%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2015%26volume%3D100%26spage%3D2807%26epage%3D2831%26doi%3D10.1210%2Fjc.2015-1818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Cuevas-Ramos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleseriu, M.</span><span> </span><span class="NLM_article-title">Treatment of Cushing’s disease: a mechanistic update</span> <span class="citation_source-journal">J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">223</span><span class="NLM_x">, </span> <span class="NLM_fpage">R19</span><span class="NLM_x">–</span> <span class="NLM_lpage">R39</span><span class="refDoi"> DOI: 10.1530/JOE-14-0300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1530%2FJOE-14-0300" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2014&pages=R19-R39&author=D.+Cuevas-Ramosauthor=M.+Fleseriu&title=Treatment+of+Cushing%E2%80%99s+disease%3A+a+mechanistic+update&doi=10.1530%2FJOE-14-0300"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1530%2FJOE-14-0300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252FJOE-14-0300%26sid%3Dliteratum%253Aachs%26aulast%3DCuevas-Ramos%26aufirst%3DD.%26aulast%3DFleseriu%26aufirst%3DM.%26atitle%3DTreatment%2520of%2520Cushing%25E2%2580%2599s%2520disease%253A%2520a%2520mechanistic%2520update%26jtitle%3DJ.%2520Endocrinol.%26date%3D2014%26volume%3D223%26spage%3DR19%26epage%3DR39%26doi%3D10.1530%2FJOE-14-0300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Fleseriu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, B. M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findling, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molitch, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schteingart, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, C.</span><span> </span><span class="NLM_article-title">Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing’s syndrome</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">20139</span><span class="NLM_x">–</span> <span class="NLM_lpage">2049</span><span class="refDoi"> DOI: 10.1210/jc.2011-3350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1210%2Fjc.2011-3350" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2012&pages=20139-2049&author=M.+Fleseriuauthor=B.+M.+K.+Billerauthor=J.+W.+Findlingauthor=M.+E.+Molitchauthor=D.+E.+Schteingartauthor=C.+Gross&title=Mifepristone%2C+a+glucocorticoid+receptor+antagonist%2C+produces+clinical+and+metabolic+benefits+in+patients+with+Cushing%E2%80%99s+syndrome&doi=10.1210%2Fjc.2011-3350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1210%2Fjc.2011-3350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2011-3350%26sid%3Dliteratum%253Aachs%26aulast%3DFleseriu%26aufirst%3DM.%26aulast%3DBiller%26aufirst%3DB.%2BM.%2BK.%26aulast%3DFindling%26aufirst%3DJ.%2BW.%26aulast%3DMolitch%26aufirst%3DM.%2BE.%26aulast%3DSchteingart%26aufirst%3DD.%2BE.%26aulast%3DGross%26aufirst%3DC.%26atitle%3DMifepristone%252C%2520a%2520glucocorticoid%2520receptor%2520antagonist%252C%2520produces%2520clinical%2520and%2520metabolic%2520benefits%2520in%2520patients%2520with%2520Cushing%25E2%2580%2599s%2520syndrome%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2012%26volume%3D97%26spage%3D20139%26epage%3D2049%26doi%3D10.1210%2Fjc.2011-3350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Clark, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crackett, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyke, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porres, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bright, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanoff, J.</span><span> </span><span class="NLM_article-title">1<i>H</i>-pyrazolo[3,4-<i>g</i>]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1312</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.01.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.bmcl.2008.01.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1312-1317&author=R.+D.+Clarkauthor=N.+C.+Rayauthor=K.+Williamsauthor=P.+Blaneyauthor=S.+Wardauthor=P.+H.+Crackettauthor=C.+Hurleyauthor=H.+J.+Dykeauthor=D.+E.+Clarkauthor=P.+Lockeyauthor=R.+Devosauthor=M.+Wongauthor=S.+S.+Porresauthor=C.+P.+Brightauthor=R.+E.+Jenkinsauthor=J.+Belanoff&title=1H-pyrazolo%5B3%2C4-g%5Dhexahydro-isoquinolines+as+selective+glucocorticoid+receptor+antagonists+with+high+functional+activity&doi=10.1016%2Fj.bmcl.2008.01.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.01.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.01.027%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BD.%26aulast%3DRay%26aufirst%3DN.%2BC.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DBlaney%26aufirst%3DP.%26aulast%3DWard%26aufirst%3DS.%26aulast%3DCrackett%26aufirst%3DP.%2BH.%26aulast%3DHurley%26aufirst%3DC.%26aulast%3DDyke%26aufirst%3DH.%2BJ.%26aulast%3DClark%26aufirst%3DD.%2BE.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DDevos%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DPorres%26aufirst%3DS.%2BS.%26aulast%3DBright%26aufirst%3DC.%2BP.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DBelanoff%26aufirst%3DJ.%26atitle%3D1H-pyrazolo%255B3%252C4-g%255Dhexahydro-isoquinolines%2520as%2520selective%2520glucocorticoid%2520receptor%2520antagonists%2520with%2520high%2520functional%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1312%26epage%3D1317%26doi%3D10.1016%2Fj.bmcl.2008.01.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Hunt, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanoff, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swift, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unitt, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, I.</span><span> </span><span class="NLM_article-title">1<i>H</i>-Pyrazolo[3,4-<i>g</i>]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profile</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5720</span><span class="NLM_x">–</span> <span class="NLM_lpage">5725</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.10.097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.bmcl.2015.10.097" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=5720-5725&author=H.+J.+Huntauthor=J.+K.+Belanoffauthor=E.+Goldingauthor=B.+Gourdetauthor=T.+Phillipsauthor=D.+Swiftauthor=J.+Thomasauthor=J.+F.+Unittauthor=I.+Walters&title=1H-Pyrazolo%5B3%2C4-g%5Dhexahydro-isoquinolines+as+potent+GR+antagonists+with+reduced+hERG+inhibition+and+an+improved+pharmacokinetic+profile&doi=10.1016%2Fj.bmcl.2015.10.097"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.10.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.10.097%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DH.%2BJ.%26aulast%3DBelanoff%26aufirst%3DJ.%2BK.%26aulast%3DGolding%26aufirst%3DE.%26aulast%3DGourdet%26aufirst%3DB.%26aulast%3DPhillips%26aufirst%3DT.%26aulast%3DSwift%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DUnitt%26aufirst%3DJ.%2BF.%26aulast%3DWalters%26aufirst%3DI.%26atitle%3D1H-Pyrazolo%255B3%252C4-g%255Dhexahydro-isoquinolines%2520as%2520potent%2520GR%2520antagonists%2520with%2520reduced%2520hERG%2520inhibition%2520and%2520an%2520improved%2520pharmacokinetic%2520profile%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D5720%26epage%3D5725%26doi%3D10.1016%2Fj.bmcl.2015.10.097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Vendruscolo, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodell, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macshane, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logrip, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlosburg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinn, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamora-Martinez, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanoff, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koob, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, B. J.</span><span> </span><span class="NLM_article-title">Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol dependence</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">3193</span><span class="NLM_x">–</span> <span class="NLM_lpage">3197</span><span class="refDoi"> DOI: 10.1172/JCI79828</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1172%2FJCI79828" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=3193-3197&author=L.+F.+Vendruscoloauthor=D.+Esteyauthor=V.+Goodellauthor=L.+G.+Macshaneauthor=M.+L.+Logripauthor=J.+E.+Schlosburgauthor=M.+A.+McGinnauthor=E.+R.+Zamora-Martinezauthor=J.+K.+Belanoffauthor=H.+J.+Huntauthor=P.+P.+Sannaauthor=O.+Georgeauthor=G.+F.+Koobauthor=S.+Edwardsauthor=B.+J.+Mason&title=Glucocorticoid+receptor+antagonism+decreases+alcohol+seeking+in+alcohol+dependence&doi=10.1172%2FJCI79828"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1172%2FJCI79828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI79828%26sid%3Dliteratum%253Aachs%26aulast%3DVendruscolo%26aufirst%3DL.%2BF.%26aulast%3DEstey%26aufirst%3DD.%26aulast%3DGoodell%26aufirst%3DV.%26aulast%3DMacshane%26aufirst%3DL.%2BG.%26aulast%3DLogrip%26aufirst%3DM.%2BL.%26aulast%3DSchlosburg%26aufirst%3DJ.%2BE.%26aulast%3DMcGinn%26aufirst%3DM.%2BA.%26aulast%3DZamora-Martinez%26aufirst%3DE.%2BR.%26aulast%3DBelanoff%26aufirst%3DJ.%2BK.%26aulast%3DHunt%26aufirst%3DH.%2BJ.%26aulast%3DSanna%26aufirst%3DP.%2BP.%26aulast%3DGeorge%26aufirst%3DO.%26aulast%3DKoob%26aufirst%3DG.%2BF.%26aulast%3DEdwards%26aufirst%3DS.%26aulast%3DMason%26aufirst%3DB.%2BJ.%26atitle%3DGlucocorticoid%2520receptor%2520antagonism%2520decreases%2520alcohol%2520seeking%2520in%2520alcohol%2520dependence%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2015%26volume%3D125%26spage%3D3193%26epage%3D3197%26doi%3D10.1172%2FJCI79828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Pineau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desrumaux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevallier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ollivier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanoff, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Givalois, L.</span><span> </span><span class="NLM_article-title">New selective glucocorticoid receptor modulators reverse amyloid-b peptide-induced hippocampus toxicity</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span><span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2016.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.neurobiolaging.2016.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=27459932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslylsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=109-122&author=F.+Pineauauthor=G.+Canetauthor=C.+Desrumauxauthor=H.+Huntauthor=N.+Chevallierauthor=M.+Ollivierauthor=J.+K.+Belanoffauthor=L.+Givalois&title=New+selective+glucocorticoid+receptor+modulators+reverse+amyloid-b+peptide-induced+hippocampus+toxicity&doi=10.1016%2Fj.neurobiolaging.2016.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">New selective glucocorticoid receptor modulators reverse amyloid-β peptide-induced hippocampus toxicity</span></div><div class="casAuthors">Pineau, Fanny; Canet, Geoffrey; Desrumaux, Catherine; Hunt, Hazel; Chevallier, Nathalie; Ollivier, Matthias; Belanoff, Joseph K.; Givalois, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109-122</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In Alzheimer's disease (AD), cognitive deficits and psychol. symptoms are assocd. with an early deregulation of the hypothalamic-pituitary-adrenal axis.  Here, in an acute model of AD, we investigated if antiglucocorticoid strategies with selective glucocorticoid receptor (GR) modulators (CORT108297 and CORT113176) that combine antagonistic and agonistic GR properties could offer an interesting therapeutic approach in the future.  We confirm the expected properties of the nonselective GR antagonist (mifepristone) because in addn. to restoring basal circulating glucocorticoids levels, mifepristone totally reverses synaptic deficits and hippocampal apoptosis processes.  However, mifepristone only partially reverses cognitive deficit, effects of the hippocampal amyloidogenic pathway, and neuroinflammatory processes, suggesting limits in its efficacy.  By contrast, selective GR modulators CORT108297 and CORT113176 at a dose of 20 and 10 mg/kg, resp., reverse hippocampal amyloid-β peptide generation, neuroinflammation, and apoptotic processes, restore the hippocampal levels of synaptic markers, re-establish basal plasma levels of glucocorticoids, and improve cognitive function.  In conclusion, selective GR modulators are particularly attractive and may pave the way to new strategies for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0k-Go35N_GbVg90H21EOLACvtfcHk0lgVqbFozOdpHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslylsLo%253D&md5=e77d051061a65e2baa6ac2e46e840d09</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2016.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2016.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DPineau%26aufirst%3DF.%26aulast%3DCanet%26aufirst%3DG.%26aulast%3DDesrumaux%26aufirst%3DC.%26aulast%3DHunt%26aufirst%3DH.%26aulast%3DChevallier%26aufirst%3DN.%26aulast%3DOllivier%26aufirst%3DM.%26aulast%3DBelanoff%26aufirst%3DJ.%2BK.%26aulast%3DGivalois%26aufirst%3DL.%26atitle%3DNew%2520selective%2520glucocorticoid%2520receptor%2520modulators%2520reverse%2520amyloid-b%2520peptide-induced%2520hippocampus%2520toxicity%26jtitle%3DNeurobiol.%2520Aging%26date%3D2016%26volume%3D45%26spage%3D109%26epage%3D122%26doi%3D10.1016%2Fj.neurobiolaging.2016.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Cioffl, C. L.; Wolf, M. A.; Guzzo, P. R.; Liu, S.; Sadalapure, K.; Parthasarathy, V.; Maeng, J.-H.</span><span> </span><span class="NLM_article-title">Glycine transporter-1 inhibitors, methods of making them, and uses thereof</span>. WO2011153359,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+L.+Cioffl&author=M.+A.+Wolf&author=P.+R.+Guzzo&author=S.+Liu&author=K.+Sadalapure&author=V.+Parthasarathy&author=J.-H.+Maeng&title=Glycine+transporter-1+inhibitors%2C+methods+of+making+them%2C+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCioffl%26aufirst%3DC.%2BL.%26atitle%3DGlycine%2520transporter-1%2520inhibitors%252C%2520methods%2520of%2520making%2520them%252C%2520and%2520uses%2520thereof%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Begtrup, M.</span><span> </span><span class="NLM_article-title">Reactions between azolium salts and nucleophilic reagents</span> <span class="citation_source-journal">Acta Chem. Scand.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1243</span><span class="NLM_x">–</span> <span class="NLM_lpage">1257</span><span class="refDoi"> DOI: 10.3891/acta.chem.scand.26-1243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.3891%2Facta.chem.scand.26-1243" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1972&pages=1243-1257&author=M.+Begtrup&title=Reactions+between+azolium+salts+and+nucleophilic+reagents&doi=10.3891%2Facta.chem.scand.26-1243"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3891%2Facta.chem.scand.26-1243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3891%252Facta.chem.scand.26-1243%26sid%3Dliteratum%253Aachs%26aulast%3DBegtrup%26aufirst%3DM.%26atitle%3DReactions%2520between%2520azolium%2520salts%2520and%2520nucleophilic%2520reagents%26jtitle%3DActa%2520Chem.%2520Scand.%26date%3D1972%26volume%3D26%26spage%3D1243%26epage%3D1257%26doi%3D10.3891%2Facta.chem.scand.26-1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Hunt, H.; Johnson, T.; Ray, N.; Wlters, I.</span><span> </span><span class="NLM_article-title">Heteroarylcarbonyl-substituted fused azadecalin as glucocorticoid receptor modulators and their preparation</span>. WO2013177559.<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+Hunt&author=T.+Johnson&author=N.+Ray&author=I.+Wlters&title=Heteroarylcarbonyl-substituted+fused+azadecalin+as+glucocorticoid+receptor+modulators+and+their+preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DH.%26atitle%3DHeteroarylcarbonyl-substituted%2520fused%2520azadecalin%2520as%2520glucocorticoid%2520receptor%2520modulators%2520and%2520their%2520preparation%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span>Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Hunt, H.; Walters, I.; Gourdet, B.</span><span> </span><span class="NLM_article-title">Octahydro fused azadecalin glucocorticoid receptor modulators</span>. WO2015077530.<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Hunt&author=I.+Walters&author=B.+Gourdet&title=Octahydro+fused+azadecalin+glucocorticoid+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DH.%26atitle%3DOctahydro%2520fused%2520azadecalin%2520glucocorticoid%2520receptor%2520modulators%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Clark, R. D.; Ray, N. C.; Blaney, P. M.; Hurley, C. A.; Williams, K.</span><span> </span><span class="NLM_article-title">Fused ring azadecalin glucocorticoid receptor modulators</span>. WO2005087769,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+D.+Clark&author=N.+C.+Ray&author=P.+M.+Blaney&author=C.+A.+Hurley&author=K.+Williams&title=Fused+ring+azadecalin+glucocorticoid+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BD.%26atitle%3DFused%2520ring%2520azadecalin%2520glucocorticoid%2520receptor%2520modulators%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 26 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Jonas Boström</span>. </span><span class="cited-content_cbyCitation_article-title">Where Do Recent Small Molecule Clinical Development Candidates Come From?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9442-9468. <a href="https://doi.org/10.1021/acs.jmedchem.8b00675" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00675%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhere%252BDo%252BRecent%252BSmall%252BMolecule%252BClinical%252BDevelopment%252BCandidates%252BCome%252BFrom%25253F%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27042018%26date%3D09072018%26date%3D19062018%26volume%3D61%26issue%3D21%26spage%3D9442%26epage%3D9468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yosup Rew, Xiaohui Du, John Eksterowicz, Haiying Zhou, Nadine Jahchan, Liusheng Zhu, Xuelei Yan, Hiroyuki Kawai, Lawrence R. McGee, Julio C. Medina, Tom Huang, Chelsea Chen, Tatiana Zavorotinskaya, Dena Sutimantanapi, Joanna Waszczuk, Erica Jackson, Elizabeth Huang, Qiuping Ye, Valeria R. Fantin, <span class="NLM_string-name hlFld-ContribAuthor">Daqing Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (17)
                                     , 7767-7784. <a href="https://doi.org/10.1021/acs.jmedchem.8b00743" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00743</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00743%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252Band%252BSelective%252BSteroidal%252BGlucocorticoid%252BReceptor%252BAntagonist%252B%252528ORIC-101%252529%26aulast%3DRew%26aufirst%3DYosup%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D08052018%26date%3D23082018%26date%3D09082018%26volume%3D61%26issue%3D17%26spage%3D7767%26epage%3D7784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Joice Thomas, <span class="NLM_string-name hlFld-ContribAuthor">Valery V. Fokin</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective Synthesis of Fluorosulfonyl 1,2,3-Triazoles from Bromovinylsulfonyl Fluoride. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (13)
                                     , 3749-3752. <a href="https://doi.org/10.1021/acs.orglett.8b01309" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b01309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b01309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b01309%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRegioselective%252BSynthesis%252Bof%252BFluorosulfonyl%252B1%25252C2%25252C3-Triazoles%252Bfrom%252BBromovinylsulfonyl%252BFluoride%26aulast%3DThomas%26aufirst%3DJoice%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D25042018%26date%3D15062018%26volume%3D20%26issue%3D13%26spage%3D3749%26epage%3D3752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosario  Pivonello</span>, <span class="hlFld-ContribAuthor ">Irina  Bancos</span>, <span class="hlFld-ContribAuthor ">Richard A.  Feelders</span>, <span class="hlFld-ContribAuthor ">Atil Y.  Kargi</span>, <span class="hlFld-ContribAuthor ">Janice M.  Kerr</span>, <span class="hlFld-ContribAuthor ">Murray B.  Gordon</span>, <span class="hlFld-ContribAuthor ">Cary N.  Mariash</span>, <span class="hlFld-ContribAuthor ">Massimo  Terzolo</span>, <span class="hlFld-ContribAuthor ">Noel  Ellison</span>, <span class="hlFld-ContribAuthor ">Andreas G.  Moraitis</span>. </span><span class="cited-content_cbyCitation_article-title">Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Endocrinology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fendo.2021.662865" title="DOI URL">https://doi.org/10.3389/fendo.2021.662865</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fendo.2021.662865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffendo.2021.662865%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Endocrinology%26atitle%3DRelacorilant%25252C%252Ba%252BSelective%252BGlucocorticoid%252BReceptor%252BModulator%25252C%252BInduces%252BClinical%252BImprovements%252Bin%252BPatients%252BWith%252BCushing%252BSyndrome%25253A%252BResults%252BFrom%252BA%252BProspective%25252C%252BOpen-Label%252BPhase%252B2%252BStudy%26aulast%3DPivonello%26aufirst%3DRosario%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew E.  Greenstein</span>, <span class="hlFld-ContribAuthor ">Hazel J.  Hunt</span>. </span><span class="cited-content_cbyCitation_article-title">Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2021,</strong> <em>12 </em>
                                    (13)
                                     , 1243-1255. <a href="https://doi.org/10.18632/oncotarget.27989" title="DOI URL">https://doi.org/10.18632/oncotarget.27989</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.27989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.27989%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DGlucocorticoid%252Breceptor%252Bantagonism%252Bpromotes%252Bapoptosis%252Bin%252Bsolid%252Btumor%252Bcells%26aulast%3DGreenstein%26aufirst%3DAndrew%2BE.%26date%3D2021%26volume%3D12%26issue%3D13%26spage%3D1243%26epage%3D1255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Syeda  Rasool</span>, <span class="hlFld-ContribAuthor ">Brian W  Skinner</span>. </span><span class="cited-content_cbyCitation_article-title">Osilodrostat for the treatment of Cushing’s disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Pharmacotherapy</span><span> <strong>2021,</strong> <em>22 </em>
                                    (9)
                                     , 1099-1106. <a href="https://doi.org/10.1080/14656566.2021.1897106" title="DOI URL">https://doi.org/10.1080/14656566.2021.1897106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14656566.2021.1897106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14656566.2021.1897106%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Pharmacotherapy%26atitle%3DOsilodrostat%252Bfor%252Bthe%252Btreatment%252Bof%252BCushing%2525E2%252580%252599s%252Bdisease%26aulast%3DRasool%26aufirst%3DSyeda%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D9%26spage%3D1099%26epage%3D1106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Kroon</span>, <span class="hlFld-ContribAuthor ">Eva M.G.  Viho</span>, <span class="hlFld-ContribAuthor ">Max  Gentenaar</span>, <span class="hlFld-ContribAuthor ">Lisa L.  Koorneef</span>, <span class="hlFld-ContribAuthor ">Cees  van Kooten</span>, <span class="hlFld-ContribAuthor ">Patrick C.N.  Rensen</span>, <span class="hlFld-ContribAuthor ">Sander  Kooijman</span>, <span class="hlFld-ContribAuthor ">Hazel  Hunt</span>, <span class="hlFld-ContribAuthor ">Onno C.  Meijer</span>. </span><span class="cited-content_cbyCitation_article-title">The development of novel glucocorticoid receptor antagonists: From rational chemical design to therapeutic efficacy in metabolic disease models. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>168 </em>, 105588. <a href="https://doi.org/10.1016/j.phrs.2021.105588" title="DOI URL">https://doi.org/10.1016/j.phrs.2021.105588</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2021.105588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2021.105588%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DThe%252Bdevelopment%252Bof%252Bnovel%252Bglucocorticoid%252Breceptor%252Bantagonists%25253A%252BFrom%252Brational%252Bchemical%252Bdesign%252Bto%252Btherapeutic%252Befficacy%252Bin%252Bmetabolic%252Bdisease%252Bmodels%26aulast%3DKroon%26aufirst%3DJan%26date%3D2021%26volume%3D168%26spage%3D105588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masamitsu  Tsukamoto</span>, <span class="hlFld-ContribAuthor ">Tadashi  Nakamura</span>, <span class="hlFld-ContribAuthor ">Hirohiko  Kimura</span>, <span class="hlFld-ContribAuthor ">Hitoshi  Nakayama</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and application of trifluoromethylpyridines as a key structural motif in active agrochemical and pharmaceutical ingredients. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pesticide Science</span><span> <strong>2021,</strong> <em>46 </em>
                                    (2)
                                     , 125-142. <a href="https://doi.org/10.1584/jpestics.D21-012" title="DOI URL">https://doi.org/10.1584/jpestics.D21-012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1584/jpestics.D21-012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1584%2Fjpestics.D21-012%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pesticide%2520Science%26atitle%3DSynthesis%252Band%252Bapplication%252Bof%252Btrifluoromethylpyridines%252Bas%252Ba%252Bkey%252Bstructural%252Bmotif%252Bin%252Bactive%252Bagrochemical%252Band%252Bpharmaceutical%252Bingredients%26aulast%3DTsukamoto%26aufirst%3DMasamitsu%26date%3D2021%26volume%3D46%26issue%3D2%26spage%3D125%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. Adrienne  McGinn</span>, <span class="hlFld-ContribAuthor ">Brendan J.  Tunstall</span>, <span class="hlFld-ContribAuthor ">Joel E.  Schlosburg</span>, <span class="hlFld-ContribAuthor ">Adriana  Gregory-Flores</span>, <span class="hlFld-ContribAuthor ">Olivier  George</span>, <span class="hlFld-ContribAuthor ">Giordano  de Guglielmo</span>, <span class="hlFld-ContribAuthor ">Barbara J.  Mason</span>, <span class="hlFld-ContribAuthor ">Hazel J.  Hunt</span>, <span class="hlFld-ContribAuthor ">George F.  Koob</span>, <span class="hlFld-ContribAuthor ">Leandro F.  Vendruscolo</span>. </span><span class="cited-content_cbyCitation_article-title">Glucocorticoid receptor modulators decrease alcohol self-administration in male rats. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2021,</strong> <em>188 </em>, 108510. <a href="https://doi.org/10.1016/j.neuropharm.2021.108510" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2021.108510</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2021.108510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2021.108510%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DGlucocorticoid%252Breceptor%252Bmodulators%252Bdecrease%252Balcohol%252Bself-administration%252Bin%252Bmale%252Brats%26aulast%3DMcGinn%26aufirst%3DM.%2BAdrienne%26date%3D2021%26volume%3D188%26spage%3D108510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph M.  Custodio</span>, <span class="hlFld-ContribAuthor ">Kirsteen M.  Donaldson</span>, <span class="hlFld-ContribAuthor ">Hazel J.  Hunt</span>. </span><span class="cited-content_cbyCitation_article-title">An In Vitro and In Vivo Evaluation of the Effect of Relacorilant on the Activity of Cytochrome P450 Drug Metabolizing Enzymes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Clinical Pharmacology</span><span> <strong>2021,</strong> <em>61 </em>
                                    (2)
                                     , 244-253. <a href="https://doi.org/10.1002/jcph.1731" title="DOI URL">https://doi.org/10.1002/jcph.1731</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcph.1731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcph.1731%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Clinical%2520Pharmacology%26atitle%3DAn%252BIn%252BVitro%252Band%252BIn%252BVivo%252BEvaluation%252Bof%252Bthe%252BEffect%252Bof%252BRelacorilant%252Bon%252Bthe%252BActivity%252Bof%252BCytochrome%252BP450%252BDrug%252BMetabolizing%252BEnzymes%26aulast%3DCustodio%26aufirst%3DJoseph%2BM.%26date%3D2021%26date%3D2020%26volume%3D61%26issue%3D2%26spage%3D244%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan  Kelsall</span>, <span class="hlFld-ContribAuthor ">John  Newell-Price</span>. </span><span class="cited-content_cbyCitation_article-title">Medical management of Cushing's disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 231-244. <a href="https://doi.org/10.1016/B978-0-12-819949-7.00046-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-819949-7.00046-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-819949-7.00046-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-819949-7.00046-9%26sid%3Dliteratum%253Aachs%26atitle%3DMedical%252Bmanagement%252Bof%252BCushing%252527s%252Bdisease%26aulast%3DKelsall%26aufirst%3DAlan%26date%3D2021%26spage%3D231%26epage%3D244%26pub%3DElsevier%26atitle%3DPituitary%252BTumors%26date%3D2021%26volume%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosario  Pivonello</span>, <span class="hlFld-ContribAuthor ">Rosario  Ferrigno</span>, <span class="hlFld-ContribAuthor ">Maria Cristina  De Martino</span>, <span class="hlFld-ContribAuthor ">Chiara  Simeoli</span>, <span class="hlFld-ContribAuthor ">Nicola  Di Paola</span>, <span class="hlFld-ContribAuthor ">Claudia  Pivonello</span>, <span class="hlFld-ContribAuthor ">Livia  Barba</span>, <span class="hlFld-ContribAuthor ">Mariarosaria  Negri</span>, <span class="hlFld-ContribAuthor ">Cristina  De Angelis</span>, <span class="hlFld-ContribAuthor ">Annamaria  Colao</span>. </span><span class="cited-content_cbyCitation_article-title">Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Endocrinology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fendo.2020.00648" title="DOI URL">https://doi.org/10.3389/fendo.2020.00648</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fendo.2020.00648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffendo.2020.00648%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Endocrinology%26atitle%3DMedical%252BTreatment%252Bof%252BCushing%252527s%252BDisease%25253A%252BAn%252BOverview%252Bof%252Bthe%252BCurrent%252Band%252BRecent%252BClinical%252BTrials%26aulast%3DPivonello%26aufirst%3DRosario%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kanchan  Vishnoi</span>, <span class="hlFld-ContribAuthor ">Navin  Viswakarma</span>, <span class="hlFld-ContribAuthor ">Ajay  Rana</span>, <span class="hlFld-ContribAuthor ">Basabi  Rana</span>. </span><span class="cited-content_cbyCitation_article-title">Transcription Factors in Cancer Development and Therapy. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (8)
                                     , 2296. <a href="https://doi.org/10.3390/cancers12082296" title="DOI URL">https://doi.org/10.3390/cancers12082296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12082296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12082296%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTranscription%252BFactors%252Bin%252BCancer%252BDevelopment%252Band%252BTherapy%26aulast%3DVishnoi%26aufirst%3DKanchan%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D8%26spage%3D2296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrey  Bubyrev</span>, <span class="hlFld-ContribAuthor ">Dmitry  Dar'in</span>, <span class="hlFld-ContribAuthor ">Grigory  Kantin</span>, <span class="hlFld-ContribAuthor ">Mikhail  Krasavin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Studies towards CH‐Diazomethane Sulfonamides: a Novel Type of Diazo Reagents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (27)
                                     , 4112-4115. <a href="https://doi.org/10.1002/ejoc.202000446" title="DOI URL">https://doi.org/10.1002/ejoc.202000446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202000446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202000446%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthetic%252BStudies%252Btowards%252BCH%2525E2%252580%252590Diazomethane%252BSulfonamides%25253A%252Ba%252BNovel%252BType%252Bof%252BDiazo%252BReagents%26aulast%3DBubyrev%26aufirst%3DAndrey%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D27%26spage%3D4112%26epage%3D4115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marianna  Lucafò</span>, <span class="hlFld-ContribAuthor ">Martina  Franzin</span>, <span class="hlFld-ContribAuthor ">Giuliana  Decorti</span>, <span class="hlFld-ContribAuthor ">Gabriele  Stocco</span>. </span><span class="cited-content_cbyCitation_article-title">A patent review of anticancer glucocorticoid receptor modulators (2014-present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (5)
                                     , 313-324. <a href="https://doi.org/10.1080/13543776.2020.1740206" title="DOI URL">https://doi.org/10.1080/13543776.2020.1740206</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1740206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1740206%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252Bpatent%252Breview%252Bof%252Banticancer%252Bglucocorticoid%252Breceptor%252Bmodulators%252B%2525282014-present%252529%26aulast%3DLucaf%25C3%25B2%26aufirst%3DMarianna%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D5%26spage%3D313%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leah T.  Braun</span>, <span class="hlFld-ContribAuthor ">Martin  Reincke</span>. </span><span class="cited-content_cbyCitation_article-title">What is the role of medical therapy in adrenal-dependent Cushing's syndrome?. </span><span class="cited-content_cbyCitation_journal-name">Best Practice & Research Clinical Endocrinology & Metabolism</span><span> <strong>2020,</strong> <em>34 </em>
                                    (3)
                                     , 101376. <a href="https://doi.org/10.1016/j.beem.2020.101376" title="DOI URL">https://doi.org/10.1016/j.beem.2020.101376</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.beem.2020.101376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.beem.2020.101376%26sid%3Dliteratum%253Aachs%26jtitle%3DBest%2520Practice%2520%2526%2520Research%2520Clinical%2520Endocrinology%2520%2526%2520Metabolism%26atitle%3DWhat%252Bis%252Bthe%252Brole%252Bof%252Bmedical%252Btherapy%252Bin%252Badrenal-dependent%252BCushing%252527s%252Bsyndrome%25253F%26aulast%3DBraun%26aufirst%3DLeah%2BT.%26date%3D2020%26volume%3D34%26issue%3D3%26spage%3D101376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sherice  Williams</span>, <span class="hlFld-ContribAuthor ">Chaitali  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">Neurovascular glucocorticoid receptors and glucocorticoids: implications in health, neurological disorders and drug therapy. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (1)
                                     , 89-106. <a href="https://doi.org/10.1016/j.drudis.2019.09.009" title="DOI URL">https://doi.org/10.1016/j.drudis.2019.09.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2019.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2019.09.009%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DNeurovascular%252Bglucocorticoid%252Breceptors%252Band%252Bglucocorticoids%25253A%252Bimplications%252Bin%252Bhealth%25252C%252Bneurological%252Bdisorders%252Band%252Bdrug%252Btherapy%26aulast%3DWilliams%26aufirst%3DSherice%26date%3D2020%26volume%3D25%26issue%3D1%26spage%3D89%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva  Tonsing-Carter</span>, <span class="hlFld-ContribAuthor ">Kyle M.  Hernandez</span>, <span class="hlFld-ContribAuthor ">Caroline R.  Kim</span>, <span class="hlFld-ContribAuthor ">Ryan V.  Harkless</span>, <span class="hlFld-ContribAuthor ">Alyce  Oh</span>, <span class="hlFld-ContribAuthor ">Kathleen R.  Bowie</span>, <span class="hlFld-ContribAuthor ">Diana C.  West-Szymanski</span>, <span class="hlFld-ContribAuthor ">Mayra A.  Betancourt-Ponce</span>, <span class="hlFld-ContribAuthor ">Bradley D.  Green</span>, <span class="hlFld-ContribAuthor ">Ricardo R.  Lastra</span>, <span class="hlFld-ContribAuthor ">Gini F.  Fleming</span>, <span class="hlFld-ContribAuthor ">Sarat  Chandarlapaty</span>, <span class="hlFld-ContribAuthor ">Suzanne D.  Conzen</span>. </span><span class="cited-content_cbyCitation_article-title">Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Research</span><span> <strong>2019,</strong> <em>21 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13058-019-1164-6" title="DOI URL">https://doi.org/10.1186/s13058-019-1164-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13058-019-1164-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13058-019-1164-6%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Research%26atitle%3DGlucocorticoid%252Breceptor%252Bmodulation%252Bdecreases%252BER-positive%252Bbreast%252Bcancer%252Bcell%252Bproliferation%252Band%252Bsuppresses%252Bwild-type%252Band%252Bmutant%252BER%252Bchromatin%252Bassociation%26aulast%3DTonsing-Carter%26aufirst%3DEva%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ineke H.N.  Luijten</span>, <span class="hlFld-ContribAuthor ">Barbara  Cannon</span>, <span class="hlFld-ContribAuthor ">Jan  Nedergaard</span>. </span><span class="cited-content_cbyCitation_article-title">Glucocorticoids and Brown Adipose Tissue: Do glucocorticoids really inhibit thermogenesis?. </span><span class="cited-content_cbyCitation_journal-name">Molecular Aspects of Medicine</span><span> <strong>2019,</strong> <em>68 </em>, 42-59. <a href="https://doi.org/10.1016/j.mam.2019.07.002" title="DOI URL">https://doi.org/10.1016/j.mam.2019.07.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mam.2019.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mam.2019.07.002%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Aspects%2520of%2520Medicine%26atitle%3DGlucocorticoids%252Band%252BBrown%252BAdipose%252BTissue%25253A%252BDo%252Bglucocorticoids%252Breally%252Binhibit%252Bthermogenesis%25253F%26aulast%3DLuijten%26aufirst%3DIneke%2BH.N.%26date%3D2019%26volume%3D68%26spage%3D42%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José Miguel  Hinojosa-Amaya</span>, <span class="hlFld-ContribAuthor ">Daniel  Cuevas-Ramos</span>, <span class="hlFld-ContribAuthor ">Maria  Fleseriu</span>. </span><span class="cited-content_cbyCitation_article-title">Medical Management of Cushing’s Syndrome: Current and Emerging Treatments. </span><span class="cited-content_cbyCitation_journal-name">Drugs</span><span> <strong>2019,</strong> <em>79 </em>
                                    (9)
                                     , 935-956. <a href="https://doi.org/10.1007/s40265-019-01128-7" title="DOI URL">https://doi.org/10.1007/s40265-019-01128-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40265-019-01128-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40265-019-01128-7%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%26atitle%3DMedical%252BManagement%252Bof%252BCushing%2525E2%252580%252599s%252BSyndrome%25253A%252BCurrent%252Band%252BEmerging%252BTreatments%26aulast%3DHinojosa-Amaya%26aufirst%3DJos%25C3%25A9%2BMiguel%26date%3D2019%26date%3D2019%26volume%3D79%26issue%3D9%26spage%3D935%26epage%3D956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernd Peter  Kost</span>, <span class="hlFld-ContribAuthor ">Susanne  Beyer</span>, <span class="hlFld-ContribAuthor ">Lennard  Schröder</span>, <span class="hlFld-ContribAuthor ">Junyan  Zhou</span>, <span class="hlFld-ContribAuthor ">Doris  Mayr</span>, <span class="hlFld-ContribAuthor ">Christina  Kuhn</span>, <span class="hlFld-ContribAuthor ">Sandra  Schulze</span>, <span class="hlFld-ContribAuthor ">Simone  Hofmann</span>, <span class="hlFld-ContribAuthor ">Sven  Mahner</span>, <span class="hlFld-ContribAuthor ">Udo  Jeschke</span>, <span class="hlFld-ContribAuthor ">Helene  Heidegger</span>. </span><span class="cited-content_cbyCitation_article-title">Glucocorticoid receptor in cervical cancer: an immunhistochemical analysis. </span><span class="cited-content_cbyCitation_journal-name">Archives of Gynecology and Obstetrics</span><span> <strong>2019,</strong> <em>299 </em>
                                    (1)
                                     , 203-209. <a href="https://doi.org/10.1007/s00404-018-4928-9" title="DOI URL">https://doi.org/10.1007/s00404-018-4928-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00404-018-4928-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00404-018-4928-9%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Gynecology%2520and%2520Obstetrics%26atitle%3DGlucocorticoid%252Breceptor%252Bin%252Bcervical%252Bcancer%25253A%252Ban%252Bimmunhistochemical%252Banalysis%26aulast%3DKost%26aufirst%3DBernd%2BPeter%26date%3D2019%26date%3D2018%26volume%3D299%26issue%3D1%26spage%3D203%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diana C.  West</span>, <span class="hlFld-ContribAuthor ">Masha  Kocherginsky</span>, <span class="hlFld-ContribAuthor ">Eva Y.  Tonsing-Carter</span>, <span class="hlFld-ContribAuthor ">D. Nesli  Dolcen</span>, <span class="hlFld-ContribAuthor ">David J.  Hosfield</span>, <span class="hlFld-ContribAuthor ">Ricardo R.  Lastra</span>, <span class="hlFld-ContribAuthor ">Jason P.  Sinnwell</span>, <span class="hlFld-ContribAuthor ">Kevin J.  Thompson</span>, <span class="hlFld-ContribAuthor ">Kathleen R.  Bowie</span>, <span class="hlFld-ContribAuthor ">Ryan V.  Harkless</span>, <span class="hlFld-ContribAuthor ">Maxwell N.  Skor</span>, <span class="hlFld-ContribAuthor ">Charles F.  Pierce</span>, <span class="hlFld-ContribAuthor ">Sarah C.  Styke</span>, <span class="hlFld-ContribAuthor ">Caroline R.  Kim</span>, <span class="hlFld-ContribAuthor ">Larischa  de Wet</span>, <span class="hlFld-ContribAuthor ">Geoffrey L.  Greene</span>, <span class="hlFld-ContribAuthor ">Judy C.  Boughey</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Goetz</span>, <span class="hlFld-ContribAuthor ">Krishna R.  Kalari</span>, <span class="hlFld-ContribAuthor ">Liewei  Wang</span>, <span class="hlFld-ContribAuthor ">Gini F.  Fleming</span>, <span class="hlFld-ContribAuthor ">Balázs  Györffy</span>, <span class="hlFld-ContribAuthor ">Suzanne D.  Conzen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2018,</strong> <em>24 </em>
                                    (14)
                                     , 3433-3446. <a href="https://doi.org/10.1158/1078-0432.CCR-17-2793" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-17-2793</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-17-2793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-17-2793%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DDiscovery%252Bof%252Ba%252BGlucocorticoid%252BReceptor%252B%252528GR%252529%252BActivity%252BSignature%252BUsing%252BSelective%252BGR%252BAntagonism%252Bin%252BER-Negative%252BBreast%252BCancer%26aulast%3DWest%26aufirst%3DDiana%2BC.%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D14%26spage%3D3433%26epage%3D3446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Onno C.  Meijer</span>, <span class="hlFld-ContribAuthor ">Lisa L.  Koorneef</span>, <span class="hlFld-ContribAuthor ">Jan  Kroon</span>. </span><span class="cited-content_cbyCitation_article-title">Glucocorticoid receptor modulators. </span><span class="cited-content_cbyCitation_journal-name">Annales d'Endocrinologie</span><span> <strong>2018,</strong> <em>79 </em>
                                    (3)
                                     , 107-111. <a href="https://doi.org/10.1016/j.ando.2018.03.004" title="DOI URL">https://doi.org/10.1016/j.ando.2018.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ando.2018.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ando.2018.03.004%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnales%2520d%2527Endocrinologie%26atitle%3DGlucocorticoid%252Breceptor%252Bmodulators%26aulast%3DMeijer%26aufirst%3DOnno%2BC.%26date%3D2018%26volume%3D79%26issue%3D3%26spage%3D107%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hazel  Hunt</span>, <span class="hlFld-ContribAuthor ">Kirsteen  Donaldson</span>, <span class="hlFld-ContribAuthor ">Mark  Strem</span>, <span class="hlFld-ContribAuthor ">Vanessa  Zann</span>, <span class="hlFld-ContribAuthor ">Pui  Leung</span>, <span class="hlFld-ContribAuthor ">Suzanne  Sweet</span>, <span class="hlFld-ContribAuthor ">Alyson  Connor</span>, <span class="hlFld-ContribAuthor ">Dan  Combs</span>, <span class="hlFld-ContribAuthor ">Joseph  Belanoff</span>. </span><span class="cited-content_cbyCitation_article-title">Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacological Effect of Orally Administered CORT125134: An Adaptive, Double-Blind, Randomized, Placebo-Controlled Phase 1 Clinical Study. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology in Drug Development</span><span> <strong>2018,</strong> <em>7 </em>
                                    (4)
                                     , 408-421. <a href="https://doi.org/10.1002/cpdd.389" title="DOI URL">https://doi.org/10.1002/cpdd.389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpdd.389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpdd.389%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520in%2520Drug%2520Development%26atitle%3DAssessment%252Bof%252BSafety%25252C%252BTolerability%25252C%252BPharmacokinetics%25252C%252Band%252BPharmacological%252BEffect%252Bof%252BOrally%252BAdministered%252BCORT125134%25253A%252BAn%252BAdaptive%25252C%252BDouble-Blind%25252C%252BRandomized%25252C%252BPlacebo-Controlled%252BPhase%252B1%252BClinical%252BStudy%26aulast%3DHunt%26aufirst%3DHazel%26date%3D2018%26date%3D2017%26volume%3D7%26issue%3D4%26spage%3D408%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew W.  Brown</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Developments in the Chemistry of Pyrazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 55-107. <a href="https://doi.org/10.1016/bs.aihch.2018.02.001" title="DOI URL">https://doi.org/10.1016/bs.aihch.2018.02.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2018.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2018.02.001%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BDevelopments%252Bin%252Bthe%252BChemistry%252Bof%252BPyrazoles%26aulast%3DBrown%26aufirst%3DAndrew%2BW.%26date%3D2018%26spage%3D55%26epage%3D107%26pub%3DElsevier%26date%3D2018%26volume%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Kroon</span>, <span class="hlFld-ContribAuthor ">Lisa L  Koorneef</span>, <span class="hlFld-ContribAuthor ">Jose K  van den Heuvel</span>, <span class="hlFld-ContribAuthor ">Cristy R C  Verzijl</span>, <span class="hlFld-ContribAuthor ">Nienke M  van de Velde</span>, <span class="hlFld-ContribAuthor ">Isabel M  Mol</span>, <span class="hlFld-ContribAuthor ">Hetty C M  Sips</span>, <span class="hlFld-ContribAuthor ">Hazel  Hunt</span>, <span class="hlFld-ContribAuthor ">Patrick C N  Rensen</span>, <span class="hlFld-ContribAuthor ">Onno C  Meijer</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Glucocorticoid Receptor Antagonist CORT125281 Activates Brown Adipose Tissue and Alters Lipid Distribution in Male Mice. </span><span class="cited-content_cbyCitation_journal-name">Endocrinology</span><span> <strong>2018,</strong> <em>159 </em>
                                    (1)
                                     , 535-546. <a href="https://doi.org/10.1210/en.2017-00512" title="DOI URL">https://doi.org/10.1210/en.2017-00512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1210/en.2017-00512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1210%2Fen.2017-00512%26sid%3Dliteratum%253Aachs%26jtitle%3DEndocrinology%26atitle%3DSelective%252BGlucocorticoid%252BReceptor%252BAntagonist%252BCORT125281%252BActivates%252BBrown%252BAdipose%252BTissue%252Band%252BAlters%252BLipid%252BDistribution%252Bin%252BMale%252BMice%26aulast%3DKroon%26aufirst%3DJan%26date%3D2018%26date%3D2017%26volume%3D159%26issue%3D1%26spage%3D535%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of compounds <b>1</b>, <b>2</b>, and mifepristone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Keto-sulfonamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-bromopyridine, <i>n</i>-BuLi, THF, −78 °C, 45 min, 53%; (b) (i) TFA, DCM, rt, 1 h; (ii) 3-methylbenzene-1-sulfonyl chloride, Hunig’s base, DCM, rt, 0.5 h, 38%; (c) (i) isopropylmagnesium chloride, 2-bromo-4-(trifluoromethyl)pyridine, ether/THF, 0 °C → rt, 2 h; (ii) aq HCl, MeCN, rt, 30 min, 84%; (d) (i) TFA, DCM, rt, 1.5 h; (ii) 1-methyl-1<i>H</i>-pyrazole-4-sulfonyl chloride, K<sub>2</sub>CO<sub>3</sub>, DCM/water, rt, 20 min, 73%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Alternative Synthesis of Keto-sulfonamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) HCl, dioxane, rt, 45 min; (ii) 3,4-difluorobenzene-1-sulfonyl chloride, Hunig’s base, DCM, rt, 15 min, 92%; (b) 2-bromothiazole, <i>n</i>-BuLi, diethyl ether, −78 °C, 45 min, 36%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Reduced Core Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>, Pd/C, 55 °C, 45 min, H-cube, 1 mL/min, 99%; (b) 2-bromo-4-(trifluoromethyl)pyridine, isopropylmagnesium bromide, toluene, 0 °C → rt, 18 h, 45%; (i) TFA, DCM, rt, 45 min; (ii) 2-methyl-2<i>H</i>-1,2,3-triazole-4-sulfonyl chloride, Hunig’s base, DCM, rt, 2 h, 72%.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of <b>12</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Triazolesulfonyl Chlorides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnBr, EtOH, 0 °C → rt, 20 min, 87%; (b) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, 0 °C → rt, 1 h, 22% (<b>15</b>)/40% (<b>16</b>)/20% (<b>17</b>); (c) NCS, AcOH/water, rt, 2 h, 64% (<b>18</b>)/82% (<b>19</b>); (d) Cl<sub>2</sub>, DCM/water, 0 °C, 5 min, 90%.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlay of <b>1</b> and mifepristone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of compound <b>7</b> in the cortisone model of exogenous Cushing’s syndrome. ∗∗∗ denotes <i>p</i> < 0.001 compared with vehicle treated mice. ### denotes <i>p</i> < 0.001 compared with cortisone treated mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structure of <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/medium/jm-2017-00162r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Overlay of compounds <b>7</b> and <b>12</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-8/acs.jmedchem.7b00162/20170421/images/large/jm-2017-00162r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00162&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i85">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 23 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Cole, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blendy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaghan, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieglstein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantuzzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hummler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unsicker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutz, G.</span><span> </span><span class="NLM_article-title">Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin development and severely retards lung maturation</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1608</span><span class="NLM_x">–</span> <span class="NLM_lpage">1621</span><span class="refDoi"> DOI: 10.1101/gad.9.13.1608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1101%2Fgad.9.13.1608" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=1608-1621&author=T.+J.+Coleauthor=J.+A.+Blendyauthor=A.+P.+Monaghanauthor=K.+Krieglsteinauthor=W.+Schmidauthor=A.+Aguzziauthor=G.+Fantuzziauthor=E.+Hummlerauthor=K.+Unsickerauthor=G.+Schutz&title=Targeted+disruption+of+the+glucocorticoid+receptor+gene+blocks+adrenergic+chromaffin+development+and+severely+retards+lung+maturation&doi=10.1101%2Fgad.9.13.1608"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1101%2Fgad.9.13.1608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.9.13.1608%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DT.%2BJ.%26aulast%3DBlendy%26aufirst%3DJ.%2BA.%26aulast%3DMonaghan%26aufirst%3DA.%2BP.%26aulast%3DKrieglstein%26aufirst%3DK.%26aulast%3DSchmid%26aufirst%3DW.%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DFantuzzi%26aufirst%3DG.%26aulast%3DHummler%26aufirst%3DE.%26aulast%3DUnsicker%26aufirst%3DK.%26aulast%3DSchutz%26aufirst%3DG.%26atitle%3DTargeted%2520disruption%2520of%2520the%2520glucocorticoid%2520receptor%2520gene%2520blocks%2520adrenergic%2520chromaffin%2520development%2520and%2520severely%2520retards%2520lung%2520maturation%26jtitle%3DGenes%2520Dev.%26date%3D1995%26volume%3D9%26spage%3D1608%26epage%3D1621%26doi%3D10.1101%2Fgad.9.13.1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cidlowski, J. A.</span><span> </span><span class="NLM_article-title">The human glucocorticoid receptor: one gene, multiple proteins and diverse responses</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span><span class="refDoi"> DOI: 10.1016/j.steroids.2005.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.steroids.2005.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=15862824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=407-417&author=J.+Zhouauthor=J.+A.+Cidlowski&title=The+human+glucocorticoid+receptor%3A+one+gene%2C+multiple+proteins+and+diverse+responses&doi=10.1016%2Fj.steroids.2005.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The human glucocorticoid receptor: One gene, multiple proteins and diverse responses</span></div><div class="casAuthors">Zhou, Junguo; Cidlowski, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Steroids</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5-7</span>),
    <span class="NLM_cas:pages">407-417</span>CODEN:
                <span class="NLM_cas:coden">STEDAM</span>;
        ISSN:<span class="NLM_cas:issn">0039-128X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Glucocorticoids are a vital class of endogenous steroid hormones that regulate essential biol. processes including growth, development, metab., behavior and apoptosis.  Most, if not all, of these actions are thought to be mediated through the glucocorticoid receptor.  The exact mechanisms of how one hormone, via one receptor, modulates such diverse biol. functions are largely unknown.  However, recent studies from our lab and others have suggested that a contribution for the diversity results from multiple isoforms of the glucocorticoid receptor that result from alternative RNA splicing and translation initiation of the glucocorticoid receptor mRNA.  Addnl., each isoform is subject to several post-translational modifications, including phosphorylation, ubiquitination and sumoylation, which have been shown to modulate the receptor protein stability and/or function.  Together these data provide potentially diverse mechanisms to establish cell type specific regulation of gene expression by a single transcription factor.  Here, we summarize the recent advances and processes that generate these receptor isoforms and these post-translational modifications.  We speculate that the compn. and proportion of individual isoforms expressed in particular cellular contexts account for the diverse effects of glucocorticoid hormones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmTrMelvxssrVg90H21EOLACvtfcHk0li6NH6focuYFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOitLg%253D&md5=6a5abe8c565f849c0330cd36b82bba1f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2005.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2005.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DCidlowski%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520human%2520glucocorticoid%2520receptor%253A%2520one%2520gene%252C%2520multiple%2520proteins%2520and%2520diverse%2520responses%26jtitle%3DSteroids%26date%3D2005%26volume%3D70%26spage%3D407%26epage%3D417%26doi%3D10.1016%2Fj.steroids.2005.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Adcock, I. M.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of glucocorticosteroid actions</span> <span class="citation_source-journal">Pulm. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.1006/pupt.2000.0243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1006%2Fpupt.2000.0243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10873549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=115-126&author=I.+M.+Adcock&title=Molecular+mechanisms+of+glucocorticosteroid+actions&doi=10.1006%2Fpupt.2000.0243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of glucocorticosteroid actions</span></div><div class="casAuthors">Adcock, Ian M.</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">115-126</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review, with 121 refs., of the mol. mechanisms in glucocorticosteroid actions.  Topics discussed were: treatment of inflammatory disease; the glucocorticosteroid receptor; induction of gene transcription; transrepression; dissocd. glucocorticosteroids; glucocorticosteroid resistance and therapeutic implications.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2m-rHCCb2ALVg90H21EOLACvtfcHk0lg0cb9nl2N7Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1KntLo%253D&md5=84178278553b3c54fa260ed162a771ff</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1006%2Fpupt.2000.0243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fpupt.2000.0243%26sid%3Dliteratum%253Aachs%26aulast%3DAdcock%26aufirst%3DI.%2BM.%26atitle%3DMolecular%2520mechanisms%2520of%2520glucocorticosteroid%2520actions%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2000%26volume%3D13%26spage%3D115%26epage%3D126%26doi%3D10.1006%2Fpupt.2000.0243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Grad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picard, D.</span><span> </span><span class="NLM_article-title">The glucocorticoid responses are shaped by molecular chaperones</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1016/j.mce.2007.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.mce.2007.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=17628337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Sktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2007&pages=2-12&author=L.+Gradauthor=D.+Picard&title=The+glucocorticoid+responses+are+shaped+by+molecular+chaperones&doi=10.1016%2Fj.mce.2007.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The glucocorticoid responses are shaped by molecular chaperones</span></div><div class="casAuthors">Grad, Iwona; Picard, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">2-12</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The glucocorticoid receptor is a known regulator of a variety of physiol. processes.  Its mode of action is well defined: upon hormone binding, it undergoes a conformational change, translocates to the nucleus and modulates the transcription of target genes.  Mol. chaperones have a widely recognized role in the folding of newly made proteins, but their participation in further maturation of folded proteins to their active states and beyond tends to be underestimated.  This review presents the current knowledge on how the Hsp70 and Hsp90 chaperone machines help to shape the responses to glucocorticoids.  We discuss the contributions of these mol. chaperones to folding, activation, intracellular transport, transcriptional regulation, and decay of the glucocorticoid receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsS9KUvvmh8rVg90H21EOLACvtfcHk0lg0cb9nl2N7Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Sktb0%253D&md5=0007d5a4189ed5413cc633a2063c9ea1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2007.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2007.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DGrad%26aufirst%3DL.%26aulast%3DPicard%26aufirst%3DD.%26atitle%3DThe%2520glucocorticoid%2520responses%2520are%2520shaped%2520by%2520molecular%2520chaperones%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2007%26volume%3D275%26spage%3D2%26epage%3D12%26doi%3D10.1016%2Fj.mce.2007.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Kadmiel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cidlowski, J. A.</span><span> </span><span class="NLM_article-title">Glucocorticoid receptor signalling in health and diseases</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span><span class="refDoi"> DOI: 10.1016/j.tips.2013.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.tips.2013.07.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=518-530&author=M.+Kadmielauthor=J.+A.+Cidlowski&title=Glucocorticoid+receptor+signalling+in+health+and+diseases&doi=10.1016%2Fj.tips.2013.07.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DKadmiel%26aufirst%3DM.%26aulast%3DCidlowski%26aufirst%3DJ.%2BA.%26atitle%3DGlucocorticoid%2520receptor%2520signalling%2520in%2520health%2520and%2520diseases%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D518%26epage%3D530%26doi%3D10.1016%2Fj.tips.2013.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Oakley, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cidlowski, J. A.</span><span> </span><span class="NLM_article-title">The biology of the glucocorticoid receptor: new signalling mechanisms in health and disease</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span><span class="refDoi"> DOI: 10.1016/j.jaci.2013.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.jaci.2013.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=24084075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCiurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2013&pages=1033-1044&author=R.+D.+Oakleyauthor=J.+A.+Cidlowski&title=The+biology+of+the+glucocorticoid+receptor%3A+new+signalling+mechanisms+in+health+and+disease&doi=10.1016%2Fj.jaci.2013.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease</span></div><div class="casAuthors">Oakley, Robert H.; Cidlowski, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1033-1044</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Glucocorticoids are primary stress hormones necessary for life that regulate numerous physiol. processes in an effort to maintain homeostasis.  Synthetic derivs. of these hormones have been mainstays in the clinic for treating inflammatory diseases, autoimmune disorders, and hematol. cancers.  The physiol. and pharmacol. actions of glucocorticoids are mediated by the glucocorticoid receptor (GR), a member of the nuclear receptor superfamily of ligand-dependent transcription factors.  Ligand-occupied GR induces or represses the transcription of thousands of genes through direct binding to DNA response elements, phys. assocg. with other transcription factors, or both.  The traditional view that glucocorticoids act through a single GR protein has changed dramatically with the discovery of a large cohort of receptor isoforms with unique expression, gene-regulatory, and functional profiles.  These GR subtypes are derived from a single gene by means of alternative splicing and alternative translation initiation mechanisms.  Posttranslational modification of these GR isoforms further expands the diversity of glucocorticoid responses.  Here we discuss the origin and mol. properties of the GR isoforms and their contribution to the specificity and sensitivity of glucocorticoid signaling in healthy and diseased tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwz6x0tM48ibVg90H21EOLACvtfcHk0lh4-OF_4YKwMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCiurjK&md5=3e92529060398d597a150128d3ef5353</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2013.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2013.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DOakley%26aufirst%3DR.%2BD.%26aulast%3DCidlowski%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520biology%2520of%2520the%2520glucocorticoid%2520receptor%253A%2520new%2520signalling%2520mechanisms%2520in%2520health%2520and%2520disease%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2013%26volume%3D132%26spage%3D1033%26epage%3D1044%26doi%3D10.1016%2Fj.jaci.2013.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">De Bosscher, K.</span><span> </span><span class="NLM_article-title">Selective glucocorticoid receptor modulators</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span><span class="refDoi"> DOI: 10.1016/j.jsbmb.2010.02.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.jsbmb.2010.02.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=20206690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVGisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2010&pages=96-104&author=K.+De+Bosscher&title=Selective+glucocorticoid+receptor+modulators&doi=10.1016%2Fj.jsbmb.2010.02.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Glucocorticoid Receptor modulators</span></div><div class="casAuthors">De Bosscher, Karolien</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">96-104</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The ancient two-faced Roman god Janus is often used as a metaphor to describe the characteristics of the Glucocorticoid Receptor (NR3C1), which exhibits both a beneficial side, that serves to halt inflammation, and a detrimental side responsible for undesirable effects.  However, recent developments suggest that the Glucocorticoid Receptor has many more faces with the potential to express a range of different functionalities, depending on factors that include the tissue type, ligand type, receptor variants, cofactor surroundings and target gene promoters.  This behavior of the receptor has made the development of safer ligands, that trigger the expression program of only a desirable subset of genes, a real challenge.  Thus more knowledge-based fundamental research is needed to ensure the design and development of selective Glucocorticoid Receptor modulators capable of reaching the clinic.  Recent advances in the characterization of novel selective Glucocorticoid Receptor modulators, specifically in the context of anti-inflammatory strategies, will be described in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8M8FgnsmairVg90H21EOLACvtfcHk0lh4-OF_4YKwMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVGisrY%253D&md5=6c58e80f4a7966e56a615bc6bb2e9a6f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2010.02.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2010.02.027%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBosscher%26aufirst%3DK.%26atitle%3DSelective%2520glucocorticoid%2520receptor%2520modulators%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D120%26spage%3D96%26epage%3D104%26doi%3D10.1016%2Fj.jsbmb.2010.02.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Clark, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belvisi, M. G.</span><span> </span><span class="NLM_article-title">Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2011.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.pharmthera.2011.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=22212616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtV2rtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=54-67&author=A.+R.+Clarkauthor=M.+G.+Belvisi&title=Maps+and+legends%3A+the+quest+for+dissociated+ligands+of+the+glucocorticoid+receptor&doi=10.1016%2Fj.pharmthera.2011.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Maps and legends: The quest for dissociated ligands of the glucocorticoid receptor</span></div><div class="casAuthors">Clark, Andrew R.; Belvisi, Maria G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-67</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Glucocorticoids are steroid hormones that have pleiotropic effects on development, metab., cognitive function and other aspects of physiol.  Since the demonstration more than sixty years ago of their capacity to suppress inflammation, synthetic glucocorticoids have been extremely widely used in the treatment of inflammatory diseases.  However, their clin. use is limited by numerous, unpredictable and potentially serious side effects.  Glucocorticoids regulate gene expression both pos. and neg.  Both of these effects are mediated by the glucocorticoid receptor, a ligand-dependent transcription factor.  It has become widely accepted that anti-inflammatory effects of glucocorticoids are mostly due to inhibition of transcription, whereas the activation of transcription by the glucocorticoid receptor accounts for the majority of side effects.  This dogma (which we refer to as the "transrepression hypothesis") predicts the possibility of uncoupling therapeutic, anti-inflammatory effects from side effects by identifying novel, selective ligands of the glucocorticoid receptor, which preferentially mediate inhibition rather than activation of transcription.  It is argued that such "dissocd." glucocorticoid receptor ligands should retain anti-inflammatory potency but cause fewer side effects.  Here we critically re-examine the history and foundations of the transrepression hypothesis.  We argue that it is incompatible with the complexity of gene regulation by glucocorticoids and poorly supported by exptl. evidence; that it no longer aids clear thinking about the actions of the glucocorticoid receptor; and that it will not prove a fruitful basis for continued refinement and improvement of anti-inflammatory drugs that target the glucocorticoid receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6zUg2geJoS7Vg90H21EOLACvtfcHk0lh4-OF_4YKwMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtV2rtbc%253D&md5=693fab780fa2775b68eb175200522b93</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2011.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2011.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DA.%2BR.%26aulast%3DBelvisi%26aufirst%3DM.%2BG.%26atitle%3DMaps%2520and%2520legends%253A%2520the%2520quest%2520for%2520dissociated%2520ligands%2520of%2520the%2520glucocorticoid%2520receptor%26jtitle%3DPharmacol.%2520Ther.%26date%3D2012%26volume%3D134%26spage%3D54%26epage%3D67%26doi%3D10.1016%2Fj.pharmthera.2011.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Lindholm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joergensen, J. O. L.</span><span> </span><span class="NLM_article-title">Incidence and late prognosis of Cushing’s syndrome: a population-based study</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span><span class="refDoi"> DOI: 10.1210/jc.86.1.117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1210%2Fjc.86.1.117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=11231987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtVGnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2001&pages=117-123&author=J.+Lindholmauthor=S.+Juulauthor=J.+O.+L.+Joergensen&title=Incidence+and+late+prognosis+of+Cushing%E2%80%99s+syndrome%3A+a+population-based+study&doi=10.1210%2Fjc.86.1.117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Incidence and late prognosis of Cushing's syndrome: a population-based study</span></div><div class="casAuthors">Lindholm, J.; Juul, S.; Jorgensen, J. O. L.; Astrup, J.; Bjerre, P.; Feldt-Rasmussen, U.; Hagen, C.; Jorgensen, J.; Kosteljanetz, M.; Kristensen, L. O.; Laurberg, P.; Schmidt, K.; Weeke, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">117-123</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The main purpose was to assess the incidence and late outcome of Cushing's syndrome, particularly in Cushing's disease.  Information for all patients diagnosed with Cushing's syndrome during an 11-yr period in Denmark was retrieved.  The incidence was 1.2-1.7/million·yr (Cushing's disease), 0.6/million·yr (adrenal adenoma) and 0.2/million·yr (adrenal carcinoma).  Other types of Cushing's syndrome were rare.  In 139 patients with nonmalignant disease, 11.1% had died during follow-up (median, 8.1 yr; range, 3.1-14.0), yielding a std. mortality ratio (SMR) of 3.68 [95% confidence interval (CI), 2.34-5.33].  The SMR was partly attributable to an increased mortality within the first year after diagnosis.  Eight patients died before treatment could be undertaken.  The prognosis in patients with malignant disease was very poor.  Patients in whom more than 5 yr had elapsed since initial surgery were studied sep., including a questionnaire on their perceived quality of health.  In 45 patients with Cushing's disease who had been cured through transsphenoidal neurosurgery, only 1 had died (SMR, 0.31; CI, 0.01-1.72) compared with 6 of 20 patients with persistent hypercortisolism after initial neurosurgery (SMR, 5.06; CI, 1.86-11.0).  In patients with adrenal adenoma, SMR was 3.95 (CI, 0.81-11.5).  The perceived quality of health was significantly impaired only in patients with Cushing's disease and appeared independent of disease control or presence of hypopituitarism.  It is concluded that 1) Cushing's syndrome is rare and is assocd. with increased mortality, in patients with no concurrent malignancy also; 2) the excess mortality was mainly obsd. during the first year of disease; and 3) the impaired quality of health in long-term survivors of Cushing's disease is not fully explained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEwP71mjo7Z7Vg90H21EOLACvtfcHk0ljyPbKO7Mlylg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtVGnsrs%253D&md5=20d63a078e2873c51d9d822f619a2af1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1210%2Fjc.86.1.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.86.1.117%26sid%3Dliteratum%253Aachs%26aulast%3DLindholm%26aufirst%3DJ.%26aulast%3DJuul%26aufirst%3DS.%26aulast%3DJoergensen%26aufirst%3DJ.%2BO.%2BL.%26atitle%3DIncidence%2520and%2520late%2520prognosis%2520of%2520Cushing%25E2%2580%2599s%2520syndrome%253A%2520a%2520population-based%2520study%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2001%26volume%3D86%26spage%3D117%26epage%3D123%26doi%3D10.1210%2Fjc.86.1.117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Steffensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bak, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoylner Rubeck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, J. O. L.</span><span> </span><span class="NLM_article-title">Epidemiology of Cushing’s syndrome</span> <span class="citation_source-journal">Neuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span><span class="refDoi"> DOI: 10.1159/000314297</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1159%2F000314297" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2010&pages=1-5&issue=Suppl.+1&author=C.+Steffensenauthor=A.+M.+Bakauthor=K.+Zoylner+Rubeckauthor=J.+O.+L.+Jorgensen&title=Epidemiology+of+Cushing%E2%80%99s+syndrome&doi=10.1159%2F000314297"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1159%2F000314297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000314297%26sid%3Dliteratum%253Aachs%26aulast%3DSteffensen%26aufirst%3DC.%26aulast%3DBak%26aufirst%3DA.%2BM.%26aulast%3DZoylner%2BRubeck%26aufirst%3DK.%26aulast%3DJorgensen%26aufirst%3DJ.%2BO.%2BL.%26atitle%3DEpidemiology%2520of%2520Cushing%25E2%2580%2599s%2520syndrome%26jtitle%3DNeuroendocrinology%26date%3D2010%26volume%3D92%26issue%3DSuppl.%25201%26spage%3D1%26epage%3D5%26doi%3D10.1159%2F000314297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Nieman, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findling, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murad, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell-Price, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabarin, A.</span><span> </span><span class="NLM_article-title">Treatment of Cushing’s syndrome: an Endocrine Society clinical practice guideline</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">2807</span><span class="NLM_x">–</span> <span class="NLM_lpage">2831</span><span class="refDoi"> DOI: 10.1210/jc.2015-1818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1210%2Fjc.2015-1818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=26222757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVGks7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=2807-2831&author=L.+K.+Niemanauthor=B.+M.+Billerauthor=J.+W.+Findlingauthor=M.+H.+Muradauthor=J.+Newell-Priceauthor=M.+O.+Savageauthor=A.+Tabarin&title=Treatment+of+Cushing%E2%80%99s+syndrome%3A+an+Endocrine+Society+clinical+practice+guideline&doi=10.1210%2Fjc.2015-1818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of Cushing's syndrome: an endocrine society clinical practice guideline</span></div><div class="casAuthors">Nieman, Lynnette K.; Biller, Beverly M. K.; Findling, James W.; Murad, M. Hassan; Newell-Price, John; Savage, Martin O.; Tabarin, Antoine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2807-2831</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Objective: The objective is to formulate clin. practice guidelines for treating Cushing's syndrome.  Participants: Participants include an Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer.  The European Society for Endocrinol. co-sponsored the guideline.  Evidence: The Task Force used the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence.  The Task Force commissioned three systematic reviews and used the best available evidence from other published systematic reviews and individual studies.  Consensus Process: The Task Force achieved consensus through one group meeting, several conference calls, and numerous e-mail communications.  Committees and members of The Endocrine Society and the European Society of Endocrinol. reviewed and commented on preliminary drafts of these guidelines.  Conclusions: Treatment of Cushing's syndrome is essential to reduce mortality and assocd. comorbidities.  Effective treatment includes the normalization of cortisol levels or action.  It also includes the normalization of comorbidities via directly treating the cause of Cushing's syndrome and by adjunctive treatments (eg, antihypertensives).  Surgical resection of the causal lesion(s) is generally the first-line approach.  The choice of second-line treatments, including medication, bilateral adrenalectomy, and radiation therapy (for corticotrope tumors), must be individualized to each patient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZuB0U1q9MVLVg90H21EOLACvtfcHk0ljyPbKO7Mlylg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVGks7bE&md5=9037cd9af59e6c31fddd8654b838e22b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1210%2Fjc.2015-1818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2015-1818%26sid%3Dliteratum%253Aachs%26aulast%3DNieman%26aufirst%3DL.%2BK.%26aulast%3DBiller%26aufirst%3DB.%2BM.%26aulast%3DFindling%26aufirst%3DJ.%2BW.%26aulast%3DMurad%26aufirst%3DM.%2BH.%26aulast%3DNewell-Price%26aufirst%3DJ.%26aulast%3DSavage%26aufirst%3DM.%2BO.%26aulast%3DTabarin%26aufirst%3DA.%26atitle%3DTreatment%2520of%2520Cushing%25E2%2580%2599s%2520syndrome%253A%2520an%2520Endocrine%2520Society%2520clinical%2520practice%2520guideline%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2015%26volume%3D100%26spage%3D2807%26epage%3D2831%26doi%3D10.1210%2Fjc.2015-1818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Cuevas-Ramos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleseriu, M.</span><span> </span><span class="NLM_article-title">Treatment of Cushing’s disease: a mechanistic update</span> <span class="citation_source-journal">J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">223</span><span class="NLM_x">, </span> <span class="NLM_fpage">R19</span><span class="NLM_x">–</span> <span class="NLM_lpage">R39</span><span class="refDoi"> DOI: 10.1530/JOE-14-0300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1530%2FJOE-14-0300" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2014&pages=R19-R39&author=D.+Cuevas-Ramosauthor=M.+Fleseriu&title=Treatment+of+Cushing%E2%80%99s+disease%3A+a+mechanistic+update&doi=10.1530%2FJOE-14-0300"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1530%2FJOE-14-0300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252FJOE-14-0300%26sid%3Dliteratum%253Aachs%26aulast%3DCuevas-Ramos%26aufirst%3DD.%26aulast%3DFleseriu%26aufirst%3DM.%26atitle%3DTreatment%2520of%2520Cushing%25E2%2580%2599s%2520disease%253A%2520a%2520mechanistic%2520update%26jtitle%3DJ.%2520Endocrinol.%26date%3D2014%26volume%3D223%26spage%3DR19%26epage%3DR39%26doi%3D10.1530%2FJOE-14-0300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Fleseriu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, B. M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findling, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molitch, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schteingart, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, C.</span><span> </span><span class="NLM_article-title">Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing’s syndrome</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">20139</span><span class="NLM_x">–</span> <span class="NLM_lpage">2049</span><span class="refDoi"> DOI: 10.1210/jc.2011-3350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1210%2Fjc.2011-3350" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2012&pages=20139-2049&author=M.+Fleseriuauthor=B.+M.+K.+Billerauthor=J.+W.+Findlingauthor=M.+E.+Molitchauthor=D.+E.+Schteingartauthor=C.+Gross&title=Mifepristone%2C+a+glucocorticoid+receptor+antagonist%2C+produces+clinical+and+metabolic+benefits+in+patients+with+Cushing%E2%80%99s+syndrome&doi=10.1210%2Fjc.2011-3350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1210%2Fjc.2011-3350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2011-3350%26sid%3Dliteratum%253Aachs%26aulast%3DFleseriu%26aufirst%3DM.%26aulast%3DBiller%26aufirst%3DB.%2BM.%2BK.%26aulast%3DFindling%26aufirst%3DJ.%2BW.%26aulast%3DMolitch%26aufirst%3DM.%2BE.%26aulast%3DSchteingart%26aufirst%3DD.%2BE.%26aulast%3DGross%26aufirst%3DC.%26atitle%3DMifepristone%252C%2520a%2520glucocorticoid%2520receptor%2520antagonist%252C%2520produces%2520clinical%2520and%2520metabolic%2520benefits%2520in%2520patients%2520with%2520Cushing%25E2%2580%2599s%2520syndrome%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2012%26volume%3D97%26spage%3D20139%26epage%3D2049%26doi%3D10.1210%2Fjc.2011-3350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Clark, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crackett, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyke, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porres, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bright, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanoff, J.</span><span> </span><span class="NLM_article-title">1<i>H</i>-pyrazolo[3,4-<i>g</i>]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1312</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.01.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.bmcl.2008.01.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1312-1317&author=R.+D.+Clarkauthor=N.+C.+Rayauthor=K.+Williamsauthor=P.+Blaneyauthor=S.+Wardauthor=P.+H.+Crackettauthor=C.+Hurleyauthor=H.+J.+Dykeauthor=D.+E.+Clarkauthor=P.+Lockeyauthor=R.+Devosauthor=M.+Wongauthor=S.+S.+Porresauthor=C.+P.+Brightauthor=R.+E.+Jenkinsauthor=J.+Belanoff&title=1H-pyrazolo%5B3%2C4-g%5Dhexahydro-isoquinolines+as+selective+glucocorticoid+receptor+antagonists+with+high+functional+activity&doi=10.1016%2Fj.bmcl.2008.01.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.01.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.01.027%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BD.%26aulast%3DRay%26aufirst%3DN.%2BC.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DBlaney%26aufirst%3DP.%26aulast%3DWard%26aufirst%3DS.%26aulast%3DCrackett%26aufirst%3DP.%2BH.%26aulast%3DHurley%26aufirst%3DC.%26aulast%3DDyke%26aufirst%3DH.%2BJ.%26aulast%3DClark%26aufirst%3DD.%2BE.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DDevos%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DPorres%26aufirst%3DS.%2BS.%26aulast%3DBright%26aufirst%3DC.%2BP.%26aulast%3DJenkins%26aufirst%3DR.%2BE.%26aulast%3DBelanoff%26aufirst%3DJ.%26atitle%3D1H-pyrazolo%255B3%252C4-g%255Dhexahydro-isoquinolines%2520as%2520selective%2520glucocorticoid%2520receptor%2520antagonists%2520with%2520high%2520functional%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1312%26epage%3D1317%26doi%3D10.1016%2Fj.bmcl.2008.01.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Hunt, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanoff, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swift, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unitt, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, I.</span><span> </span><span class="NLM_article-title">1<i>H</i>-Pyrazolo[3,4-<i>g</i>]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profile</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5720</span><span class="NLM_x">–</span> <span class="NLM_lpage">5725</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.10.097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.bmcl.2015.10.097" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=5720-5725&author=H.+J.+Huntauthor=J.+K.+Belanoffauthor=E.+Goldingauthor=B.+Gourdetauthor=T.+Phillipsauthor=D.+Swiftauthor=J.+Thomasauthor=J.+F.+Unittauthor=I.+Walters&title=1H-Pyrazolo%5B3%2C4-g%5Dhexahydro-isoquinolines+as+potent+GR+antagonists+with+reduced+hERG+inhibition+and+an+improved+pharmacokinetic+profile&doi=10.1016%2Fj.bmcl.2015.10.097"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.10.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.10.097%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DH.%2BJ.%26aulast%3DBelanoff%26aufirst%3DJ.%2BK.%26aulast%3DGolding%26aufirst%3DE.%26aulast%3DGourdet%26aufirst%3DB.%26aulast%3DPhillips%26aufirst%3DT.%26aulast%3DSwift%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DUnitt%26aufirst%3DJ.%2BF.%26aulast%3DWalters%26aufirst%3DI.%26atitle%3D1H-Pyrazolo%255B3%252C4-g%255Dhexahydro-isoquinolines%2520as%2520potent%2520GR%2520antagonists%2520with%2520reduced%2520hERG%2520inhibition%2520and%2520an%2520improved%2520pharmacokinetic%2520profile%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D5720%26epage%3D5725%26doi%3D10.1016%2Fj.bmcl.2015.10.097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Vendruscolo, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodell, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macshane, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logrip, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlosburg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinn, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamora-Martinez, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanoff, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koob, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, B. J.</span><span> </span><span class="NLM_article-title">Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol dependence</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">3193</span><span class="NLM_x">–</span> <span class="NLM_lpage">3197</span><span class="refDoi"> DOI: 10.1172/JCI79828</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1172%2FJCI79828" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=3193-3197&author=L.+F.+Vendruscoloauthor=D.+Esteyauthor=V.+Goodellauthor=L.+G.+Macshaneauthor=M.+L.+Logripauthor=J.+E.+Schlosburgauthor=M.+A.+McGinnauthor=E.+R.+Zamora-Martinezauthor=J.+K.+Belanoffauthor=H.+J.+Huntauthor=P.+P.+Sannaauthor=O.+Georgeauthor=G.+F.+Koobauthor=S.+Edwardsauthor=B.+J.+Mason&title=Glucocorticoid+receptor+antagonism+decreases+alcohol+seeking+in+alcohol+dependence&doi=10.1172%2FJCI79828"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1172%2FJCI79828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI79828%26sid%3Dliteratum%253Aachs%26aulast%3DVendruscolo%26aufirst%3DL.%2BF.%26aulast%3DEstey%26aufirst%3DD.%26aulast%3DGoodell%26aufirst%3DV.%26aulast%3DMacshane%26aufirst%3DL.%2BG.%26aulast%3DLogrip%26aufirst%3DM.%2BL.%26aulast%3DSchlosburg%26aufirst%3DJ.%2BE.%26aulast%3DMcGinn%26aufirst%3DM.%2BA.%26aulast%3DZamora-Martinez%26aufirst%3DE.%2BR.%26aulast%3DBelanoff%26aufirst%3DJ.%2BK.%26aulast%3DHunt%26aufirst%3DH.%2BJ.%26aulast%3DSanna%26aufirst%3DP.%2BP.%26aulast%3DGeorge%26aufirst%3DO.%26aulast%3DKoob%26aufirst%3DG.%2BF.%26aulast%3DEdwards%26aufirst%3DS.%26aulast%3DMason%26aufirst%3DB.%2BJ.%26atitle%3DGlucocorticoid%2520receptor%2520antagonism%2520decreases%2520alcohol%2520seeking%2520in%2520alcohol%2520dependence%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2015%26volume%3D125%26spage%3D3193%26epage%3D3197%26doi%3D10.1172%2FJCI79828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Pineau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desrumaux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevallier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ollivier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanoff, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Givalois, L.</span><span> </span><span class="NLM_article-title">New selective glucocorticoid receptor modulators reverse amyloid-b peptide-induced hippocampus toxicity</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span><span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2016.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.1016%2Fj.neurobiolaging.2016.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=27459932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslylsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=109-122&author=F.+Pineauauthor=G.+Canetauthor=C.+Desrumauxauthor=H.+Huntauthor=N.+Chevallierauthor=M.+Ollivierauthor=J.+K.+Belanoffauthor=L.+Givalois&title=New+selective+glucocorticoid+receptor+modulators+reverse+amyloid-b+peptide-induced+hippocampus+toxicity&doi=10.1016%2Fj.neurobiolaging.2016.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">New selective glucocorticoid receptor modulators reverse amyloid-β peptide-induced hippocampus toxicity</span></div><div class="casAuthors">Pineau, Fanny; Canet, Geoffrey; Desrumaux, Catherine; Hunt, Hazel; Chevallier, Nathalie; Ollivier, Matthias; Belanoff, Joseph K.; Givalois, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109-122</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In Alzheimer's disease (AD), cognitive deficits and psychol. symptoms are assocd. with an early deregulation of the hypothalamic-pituitary-adrenal axis.  Here, in an acute model of AD, we investigated if antiglucocorticoid strategies with selective glucocorticoid receptor (GR) modulators (CORT108297 and CORT113176) that combine antagonistic and agonistic GR properties could offer an interesting therapeutic approach in the future.  We confirm the expected properties of the nonselective GR antagonist (mifepristone) because in addn. to restoring basal circulating glucocorticoids levels, mifepristone totally reverses synaptic deficits and hippocampal apoptosis processes.  However, mifepristone only partially reverses cognitive deficit, effects of the hippocampal amyloidogenic pathway, and neuroinflammatory processes, suggesting limits in its efficacy.  By contrast, selective GR modulators CORT108297 and CORT113176 at a dose of 20 and 10 mg/kg, resp., reverse hippocampal amyloid-β peptide generation, neuroinflammation, and apoptotic processes, restore the hippocampal levels of synaptic markers, re-establish basal plasma levels of glucocorticoids, and improve cognitive function.  In conclusion, selective GR modulators are particularly attractive and may pave the way to new strategies for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0k-Go35N_GbVg90H21EOLACvtfcHk0lhv3SGukWDm-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslylsLo%253D&md5=e77d051061a65e2baa6ac2e46e840d09</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2016.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2016.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DPineau%26aufirst%3DF.%26aulast%3DCanet%26aufirst%3DG.%26aulast%3DDesrumaux%26aufirst%3DC.%26aulast%3DHunt%26aufirst%3DH.%26aulast%3DChevallier%26aufirst%3DN.%26aulast%3DOllivier%26aufirst%3DM.%26aulast%3DBelanoff%26aufirst%3DJ.%2BK.%26aulast%3DGivalois%26aufirst%3DL.%26atitle%3DNew%2520selective%2520glucocorticoid%2520receptor%2520modulators%2520reverse%2520amyloid-b%2520peptide-induced%2520hippocampus%2520toxicity%26jtitle%3DNeurobiol.%2520Aging%26date%3D2016%26volume%3D45%26spage%3D109%26epage%3D122%26doi%3D10.1016%2Fj.neurobiolaging.2016.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Cioffl, C. L.; Wolf, M. A.; Guzzo, P. R.; Liu, S.; Sadalapure, K.; Parthasarathy, V.; Maeng, J.-H.</span><span> </span><span class="NLM_article-title">Glycine transporter-1 inhibitors, methods of making them, and uses thereof</span>. WO2011153359,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+L.+Cioffl&author=M.+A.+Wolf&author=P.+R.+Guzzo&author=S.+Liu&author=K.+Sadalapure&author=V.+Parthasarathy&author=J.-H.+Maeng&title=Glycine+transporter-1+inhibitors%2C+methods+of+making+them%2C+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCioffl%26aufirst%3DC.%2BL.%26atitle%3DGlycine%2520transporter-1%2520inhibitors%252C%2520methods%2520of%2520making%2520them%252C%2520and%2520uses%2520thereof%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Begtrup, M.</span><span> </span><span class="NLM_article-title">Reactions between azolium salts and nucleophilic reagents</span> <span class="citation_source-journal">Acta Chem. Scand.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1243</span><span class="NLM_x">–</span> <span class="NLM_lpage">1257</span><span class="refDoi"> DOI: 10.3891/acta.chem.scand.26-1243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;key=10.3891%2Facta.chem.scand.26-1243" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1972&pages=1243-1257&author=M.+Begtrup&title=Reactions+between+azolium+salts+and+nucleophilic+reagents&doi=10.3891%2Facta.chem.scand.26-1243"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3891%2Facta.chem.scand.26-1243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3891%252Facta.chem.scand.26-1243%26sid%3Dliteratum%253Aachs%26aulast%3DBegtrup%26aufirst%3DM.%26atitle%3DReactions%2520between%2520azolium%2520salts%2520and%2520nucleophilic%2520reagents%26jtitle%3DActa%2520Chem.%2520Scand.%26date%3D1972%26volume%3D26%26spage%3D1243%26epage%3D1257%26doi%3D10.3891%2Facta.chem.scand.26-1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Hunt, H.; Johnson, T.; Ray, N.; Wlters, I.</span><span> </span><span class="NLM_article-title">Heteroarylcarbonyl-substituted fused azadecalin as glucocorticoid receptor modulators and their preparation</span>. WO2013177559.<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+Hunt&author=T.+Johnson&author=N.+Ray&author=I.+Wlters&title=Heteroarylcarbonyl-substituted+fused+azadecalin+as+glucocorticoid+receptor+modulators+and+their+preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DH.%26atitle%3DHeteroarylcarbonyl-substituted%2520fused%2520azadecalin%2520as%2520glucocorticoid%2520receptor%2520modulators%2520and%2520their%2520preparation%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span>Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Hunt, H.; Walters, I.; Gourdet, B.</span><span> </span><span class="NLM_article-title">Octahydro fused azadecalin glucocorticoid receptor modulators</span>. WO2015077530.<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Hunt&author=I.+Walters&author=B.+Gourdet&title=Octahydro+fused+azadecalin+glucocorticoid+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DH.%26atitle%3DOctahydro%2520fused%2520azadecalin%2520glucocorticoid%2520receptor%2520modulators%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Clark, R. D.; Ray, N. C.; Blaney, P. M.; Hurley, C. A.; Williams, K.</span><span> </span><span class="NLM_article-title">Fused ring azadecalin glucocorticoid receptor modulators</span>. WO2005087769,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+D.+Clark&author=N.+C.+Ray&author=P.+M.+Blaney&author=C.+A.+Hurley&author=K.+Williams&title=Fused+ring+azadecalin+glucocorticoid+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BD.%26atitle%3DFused%2520ring%2520azadecalin%2520glucocorticoid%2520receptor%2520modulators%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3H52" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3H52','PDB','3H52'); return false;">PDB: 3H52</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i80"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00162">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_58223"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00162">10.1021/acs.jmedchem.7b00162</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00162/suppl_file/jm7b00162_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00162/suppl_file/jm7b00162_si_001.csv">jm7b00162_si_001.csv (0.23 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00162%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-8%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00162" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b3934d6832b5","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
